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PREFACE 
In 1809 Jean-Baptiste Lamarck described a theory once held by Hippocrates and 
Aristotle which ascribed evolutionary adaptation as a process that occurred directly from 
one generation to the next- that physiological adaptations acquired during an organism’s 
lifetime in response to environmental pressures were passed immediately to offspring. 
Short lived, the notion was widely discredited in part by experiments executed by August 
Weismann which asserted that germ cells alone could account for inheritance of traits and 
were incapable of being affected by somatic cells and thus, environmental pressure. 
Charles Darwin’s theories of evolution and natural selection, along with Gregor Mendel’s 
work on inheritance effectively replaced Lamarckism by the early 20th century and have 
endured as the principle mechanisms for evolutionary adaptation and inheritance of traits.  
The emergence of epigenetics, or the study of stably heritable phenotypes 
resulting from chromosomal changes without alterations to the DNA sequence, has 
prompted a re-examination of Lamarckian theory and challenged the long-held belief that 
genetics bear the sole weight of organismal physiology, functionality, and adaptation. 
Though the heritability of epigenetic modifications remains a subject of contention 
among experts and limits the evolutionary scope of the mechanism, decades of past and 
emerging research have illuminated very clear and biologically relevant roles for 
epigenetics which rival, or, more accurately, complement the principles of genetics in 
guiding organismal physiology.  
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THE REGULATORY ROLE AND ENVIRONMENTAL SENSITIVITY OF DNA 
METHYLATION IN NEURODEVELOPMENT 
 
 The emerging field of epigenetics is expanding our understanding of how 
biological diversity is generated in the face of genetic limitations. One epigenetic 
mechanism in particular, DNA methylation, has demonstrated a dynamic range during 
neural development. Here, we provide evidence that DNA methylation occurs as a cell-
unique program aiding in the regulation of neurodevelopmental gene expression. DNA 
methylation has demonstrated sensitivity to external inputs ranging from stress to 
chemical exposure and dietary factors. To explore DNA methylation as a means of 
communicating early-life stress to the brain, we utilized a mouse model of fetal alcohol 
spectrum disorders (FASD). FASD presents a range of neurodevelopmental deficits and 
is a leading cause of neurodevelopmental disabilities in the United States. Predicated on 
the knowledge of alcohol's teratogenic role in brain development, we describe that the 
normal pattern of cortical DNA methylation and epigenetic correlates is similarly 
impacted by prenatal alcohol exposure. Due to the biochemical interaction of alcohol 
metabolism and the pathways regulating DNA methylation synthesis, we further 
investigated whether dietary manipulation could normalize the cortical DNA methylation 
program and aid in the protection of FASD characteristics. We found that the alcohol-
sensitive DNA methylation landscape is dually capable of registering dietary 
intervention, demonstrating normalization of disease-related patterns in the cortex and 
ix 
improved neurodevelopmental gene expression and morphology. Finally, we investigated 
the DNA methylation landscape in a crucial corticodevelopmental gene to more 
accurately define the breadth and scope of the environmental impacts at the nucleotide 
level. We found that alcohol and dietary supplementation are selective for regions 
associated with transcriptional control. Collectively, the evidence supports that DNA 
methylation plays a regulatory role in development and that its sensitivity to external 
inputs is dynamic and detectable at the smallest genomic level. Importantly, DNA 
methylation landscapes are adaptable and thus bear diagnostic and therapeutic potential. 
Feng C. Zhou, Ph.D., Chair  
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DISSERTATION OUTLINE 
Chapter 1: Cell-unique DNA methylation dynamics in the normally-developing brain  
 Goal: characterize DNA methylation dynamics during normal, cellular 
development 
 Rationale: DNA methylation has been implicated in gene regulation and 
cellular specification, though an in-depth characterization of cell-specific 
epigenetic landscapes has not been performed 
 Hypothesis: DNA methylation is unique and dynamic during neural 
specification, guiding developmental cues through transcriptional regulation  
 Approach: Examination of DNA methylation in two major cell types of the 
developing cerebellum (CB) and the neocortex 
Chapter 2: Dysregulation of neurodevelopment and DNA methylation by alcohol  
 Goal: Investigate alcohol-mediated cortico-deficits and alteration of 
developmental DNA methylation patterns  
 Rationale: Evidence suggests that alcohol disrupts normal epigenetic 
landscapes and manifests neurodevelopmental dysregulation 
 Hypothesis: DNA methylation is a window by which alcohol exposure may 
disrupt critical transcriptional profiles, leading to neurodevelopmental 
obstruction  
 Approach: Investigate parallel DNA methylation correlates of cortical laminar 
formation in a mouse model of fetal alcohol spectrum disorder (FASD) 
Chapter 3: The normalizing capacity of S-adenosylmethionine supplementation in a 
mouse model of FASD 
2 
 Goal: Investigate the role of S-adenosylmethionine supplementation in the 
mitigation of alcohol-induced DNA methylation and developmental disruption  
 Rationale: Alcohol has demonstrated inhibitory capacity on methyl-
metabolism, closely associated with DNA methylation biosynthesis 
 Hypothesis: S-AMe supplementation will ameliorate the epigenetic and 
phenotypic dysregulation of alcohol in FASD 
 Approach: Supplement liquid alcohol diet with S-AMe to evaluate its 
normalizing potential in FASD 
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CHAPTER 1: CELL-UNIQUE DNA METHYLATION DYNAMICS IN THE 
NORMALLY-DEVELOPING BRAIN 
1.1 INTRODUCTION 
1.1.1 Structural Regulation Conveys Biological Heterogeneity 
The genetic code, which instructs the production of all organismal proteins, is 
limited in its intrinsic diversity to account for changes in biological heterogeneity. While 
some endogenous mechanisms exist at the pre-transcriptional level (i.e. alternative 
splicing, genetic variants, DNA transposons, etc.), other post-translational modifications 
have been identified as contributors of proteomic diversity. In essence, due to the 
interdependent nature of the genetic code, intermediary transcripts, and the translated 
protein product,  structural influences (at every level) presumably bear significant impact 
on end point production and as such, are important contributors to biological 
heterogeneity. In the past few decades, a sophisticated understanding of an array of 
modifications that influence gene expression without altering the underlying sequence. 
Broadly termed “epigenetic modifications”, these alterations bear important structural 
implications; and while the examination of all is beyond the scope of this Dissertation, 
much attention will be given to one particular class.  
1.1.2 Epigenetic Modifications 
Epigenetic mechanisms are largely classified by their ability to alter genetic 
outputs via the impact on the structural characteristics of chromatin, consequently 
regulating the accessibility of transcriptional elements. One well-studied class is known 
as histone modifications, referring to factors influencing the chemical (structural) bonds 
between DNA and histone proteins. Due to the negative charge of the DNA phosphate 
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backbone relative to the positively-charged histone octamers of the nucleosome, factors 
such as post-translational chemical modifications of histones (i.e. methylation, 
acetylation, phosphorylation, ubiquitination, sumoylation) may collectively impact the 
electro-dynamics of the DNA-protein bonds. Another class of epigenetic modifications 
which may influence chromatin or impact gene expression is known as non-coding RNA. 
These include a variety of mRNA or genomic-targeting sequences, typically 
accompanied by chromatin modifying enzymes or translation-inhibiting enzymes. 
Finally, in a vein similar to histone modifications, DNA methylation refers to covalent 
chemical modifications occurring on cytosine bases of the genome which can alter the 
electrodynamics of DNA-DNA or DNA-protein bonds underlying the three dimensional 
structure of chromatin.  
While the highly likely scenario is that a multitude of epigenetic marks converge 
on critical loci to affect meaningful structural change, more often than not, these 
alterations are investigated independently. Although several lines of evidence suggest 
that cross-talk indeed exists between epigenetic modifications (i.e., DNA methylation 
recruitment of histone modification enzymes, etc.), fundamental epigenetic study, in 
order to form a more complete and in-depth characterization, continues to be examined in 
singularity. Ultimately, as a clearer understanding emerges, investigators can begin to 
shift attention to inter-epigenetic relationships.  
1.1.3 DNA Methylation 
The focus of this study centered on DNA methylation, the oldest and most well-
studied epigenetic modification class. DNA methylation was originally defined by the 
addition of a methyl group to the 5’ carbon of a cytosine base (termed 5-methylcytosine 
5 
and hereto denoted as “5mC”), though, as described below, has in recent years expanded 
to include a handful of derivations. This chemical reaction is performed by the enzyme 
family of DNA methyltransferases (DNMTs). It is commonly accepted that DNMT1 and 
DNMT2 are involved in methyl transfer during DNA replication and repair to maintain a 
previously methylated cytosine state. This notion is partially supported by the increased 
affinity of DNMT1 for hemi-methylated DNA (Bestor 1992). On the other hand, the 
DNMT3a and DNMT3b isoforms are believed to play a role in de novo methyl transfer, 
with DNMT3a proposed to play a slightly larger neurogenic role (Wu, Coskun et al. 
2010). Coincidentally, DNMTs have displayed differential expression across 
developmental stages, with loss of function experiments demonstrating a relatively larger 
role for DNMT3a and 3b during the early developmental stages (Okano, Bell et al. 1999).  
Other than the reported predilection of DNMT1 for hemi-methylated DNA, the 
particulars of DNMT recruitment remain the subject of active research. In cancer cells, 
for example, high-throughput screening has allowed the identification of methylation-
prone and methylation-resistant loci (Feltus, Lee et al. 2006), with results supporting a 
previously held notion that CG-rich loci display selective association with DNMT1 
(Robert, Morin et al. 2003). More broadly, these findings suggest that DNMTs may be 
recruited by intrinsic sequence features. Other reported recruitment factors include 
phosphorylation of RelA/p65 in mouse embryonic fibroblasts and the stem-cell 
associated transcription factor SALL4 (Liu, Mayo et al. 2012, Yang, Corsello et al. 
2012). Interestingly, one 2006 study demonstrated the direct recruitment of DNMTs by 
the Polycomb group (PcG) protein EZH2 to EZH2-targeting sequences (Vire, Brenner et 
6 
al. 2006), presenting evidence of a link between genomic sequence and DNMT-recruiting 
proteins.  
DNA methylation may influence transcription in two ways. First, due to the 
electrostatic interaction of positively charged histone octamers (which form the basis of 
the nucleosome protein cores) and negatively charged DNA (maintaining the DNA-
protein bond), the cumulative effect of even subtle DNA methylation changes may 
influence the electrostatic dynamics and alter the structural profile of DNA-protein 
bonds. In turn, the strength or weakness of those bonds dictates the level of chromatin 
compactness, defining the accessibility of the DNA to transcriptional machinery such as 
RNA polymerases and transcription factors. Importantly, just as methylation of cytosines 
may strengthen the DNA-protein bond and condense the chromatin, other modifications 
(i.e. histone acetylation) may weaken the DNA-protein bond, decreasing chromatin 
compaction and increasing accessibility of transcriptional elements. Second, a variety of 
methyl-DNA binding proteins exist which demonstrate an affinity toward methylated 
DNA. These proteins are recruited to methylated DNA sites and often bind repressive, 
chromatin remodeling complexes, among other proteins. For example, methyl-binding 
domain 2 (MBD2) has been shown to play a role in cancer (Detich, Theberge et al. 2002) 
while MBD3 has been implicated in stem cell differentiation (Kaji, Nichols et al. 2007). 
Additionally emerging evidence has identified some methyl-binding proteins with unique 
features (such as MBD1, MBD4) which are capable of binding unmethylated DNA 
(Jorgensen, Ben-Porath et al. 2004) and which demonstrate endonuclease activity 
(Bellacosa, Cicchillitti et al. 1999). These and other proteins have been reviewed in 
mammalian tissues by Lan et al. (Lan, Hua et al. 2010).  
7 
Previously, it was believed that DNA methylation was a transient modification, 
though years of research has revealed that DNA methylation can be lasting, in some cases 
reported to be transmissible to subsequent generations through the germline (Sharma 
2013). Importantly, in 2009 a group of researchers confirmed the mammalian existence 
of 5-hydroxymethylcytosine (hereto referred as “5hmC”), a derivative of 5mC catalyzed 
by the Ten-eleven translocation protein family (TET1-3) (Kriaucionis and Heintz 2009, 
Tahiliani, Koh et al. 2009). TET enzymes can further convert 5hmC to 5-formylcytosine 
(5fC) and subsequently 5-carboxycytosine (5caC) in a step-wise manner, though these are 
found at very low levels (Ito, Shen et al. 2011). Because 5hmC is a substrate for TET 
enzymes, it is considered as an intermediary of DNA demethylation. Due to the 
incompatibility of 5hmC with DNMT enzymes, the presence of 5hmC may indicate a 
mechanism of passive demethylation. The discovery of 5hmC is particularly meaningful 
in the absence of confirmed active demethylation pathway elements (Schiesser, Hackner 
et al. 2012).  
1.1.4 DNA Methylation Dynamics 
Previous understanding held that DNA methylation was a purely repressive mark, 
acting to silence the expression of DNA. Today, a clearer picture has emerged revealing 
that DNA methylation is dynamic, acting in both activating and repressive capacity 
(Jones and Takai 2001, Ball, Li et al. 2009) likely influenced by genomic positioning (i.e. 
promoter or intragenic, Figure 1).  Complimentary to 5mC, 5hmC offers a similar 
diversity that appears to be rooted in genomic positioning (Pastor, Pape et al. 2011, Wu, 
D'Alessio et al. 2011). Various reports have identified 5hmC in regions complimentary to 
5mC and highly enriched in activated regions of the genome (Song, Szulwach et al. 2011, 
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Szulwach, Li et al. 2011, Serandour, Avner et al. 2012). 5hmC, though less abundant than 
5mC, is highly enriched in the brain and in maturing neuronal cells and tissues, making 
the marker of particular relevance in neurological research (Munzel, Globisch et al. 
2010). Further, emerging study has identified the diverse binding capacity of the two 
major methyl marks, further suggesting their diverse roles in biological function (Chen, 
Damayanti et al. 2014). As commercial scientific technology advances the capability for 
differentiation of 5mC and 5hmC, overlapping and distinct profiles of the two will 
become even clearer.   
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Figure 1. Two distinct forms of DNA methylation 
DNMT transfers a methyl group to cytosine bases to form 5-methylcytosine (5mC). 5mC 
is found at CpG rich islands in the promoter regions of the gene. Canonically, CpG 
methylation is associated with silenced gene activation (represented by the ‘X’), often 
through methyl CpG-binding proteins (i.e., MBD1), which recognize 5mC sites and 
recruit negative transcriptional regulatory proteins. The Tet family enzymes can further 
bind 5mC and hydroxylate the methyl group into 5-hydroxylmethylcytosine (5hmC). A 
shift of 5hmC from promoter to the gene-body regions is genomically observed. 5hmC 
have shown preference for differential methyl CpG-binding proteins (e.g., MBD3) and 
increasingly found to link to transcriptionally activating complexes. The complementary 
distribution and differential role of 5mC and 5hmC provide a new dynamic for epigenetic 
regulation of the complex development.C: Cytosine; DNMT: DNA methyl transferase; 
Me: Methylation; TSS: Transcription start site. 
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1.1.5 Role of DNA Methylation in Neural Development 
The capacity of DNA methylation to influence three dimensional chromatin 
structure endows the important biological function of steering the progression of cell and 
tissue development. Alternatively, DNA methylation status may ensure the stability and 
maintenance of a cell-specific program. The advancement of high-throughput DNA 
methylation analyses has provided furthered insight into the modification’s role in 
cellular and organismal development, maintenance and plasticity. Contrary to pre-
existing beliefs, DNA methylation is earning a new reputation as a dynamic and 
programmable epigenetic marker, consequently allowing for a greater role in 
development and plasticity. The dire consequences of deletions and mutations of 
epigenetic genes such as DNMT and MeCP2, embryonic lethality (Li, Bestor et al. 1992, 
Okano, Bell et al. 1999) and detrimental nervous system development (Amir, Van den 
Veyver et al. 1999, Guy, Hendrich et al. 2001) respectively, have confirmed the 
developmental importance of DNA methylation. Further, the relevance of 5hmC in neural 
development (and in the brain during adulthood) appears to be supported by its relatively 
high abundance in neural tissues (Munzel, Globisch et al. 2010).  
At the level of the neural stem cell, 5mC has been shown to be upregulated during 
neuroepithelial (NE) commitment, followed by a rapid drop during NE specification into 
mature neuronal populations (Chen, Damayanti et al. 2014). Alternatively, 5hmC appears 
to be enriched at sites of active maturation compared to neuroprogenitor sites (Stroud, 
Feng et al. 2011, Wu, D'Alessio et al. 2011, Kubiura, Okano et al. 2012). At the gene-
level, 5mC appears to play a dynamic role in various genes required for differentiation, 
implicating 5mC hyper and hypomethylation as necessary strategies for neural 
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conversion of stem cells (Singh, Shiue et al. 2009, Cortese, Lewin et al. 2011, 
Hirabayashi, Shiota et al. 2013). Moreover, it has been proposed that while 5hmC may 
not be directly responsible for mediating gene activation, its enrichment at neural gene 
clusters during early neural progenitor specification suggests a role for 5hmC as a 
“primer” for eventual demethylation (and consequent expression) of those genes (Tan, 
Xiong et al. 2013).  
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Figure 2. Global epigenetic trends in neural stem cell differentiation 
Schematic diagram of cellular epigenetic program during neurogenesis. The top panel 
shows cell states during neurogenesis, from self-renewing neural progenitor cells (NPCs) 
to fate-determined neuroblasts, to differentiating and maturating neurons. The epigenetic 
programing is mapped in the bottom panel accordingly: cells gain 5 mC at the beginning 
of cell specification and sequentially gain 5 hmC at the beginning of cell differentiation; 
both 5 mC and 5 hmC accumulate during neuronal differentiation and maturation while at 
later stages of neuronal maturation, 5 mC levels decrease (Chen, Ozturk et al. 2013). 
Global trends in H3 and H4 acetylation have been traced in vivo to find that mature cells 
such as those in the mouse cortical plate are richer for these markers than the neural 
progenitor cells that preceed them (Cho, Kim et al. 2011). Histone 3 lysine 4 
dimethylation (H3K4me2) is primarily acquired in the neural progenitor cell stage and 
becomes pronounced in the matured brain cell stage (Zhang, Parvin et al. 2012). 
H3K27me3 has been shown to be negatively correlated with 5 hmC on intergenic regions 
during NPC differentiation (Hahn, Qiu et al. 2013). Finally, MicroRNAs that support 
proliferative gene expression are diminished as self-renewable NPCs become specified 
neural precursors while pro-neurogenesis non coding RNA are upregulated during neural 
stem cell (NSC) conversion to mature neuronal states (Meza-Sosa, Pedraza-Alva et al. 
2014). 
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Epigenetic modifications have been identified throughout various stages of neural 
differentiation including at the level of cell cycle regulation, neuronal and glial fate 
specification, all the way to late-stage feature specification and plasticity (Resendiz, 
Mason et al. 2014). For example, the pluipotency-maintaining genes Oct4, Nanog, and 
Sox2 have been identified as targets of DNA methylation reprogramming during 
development, with Nanog trading enhancer 5hmC methylation for promoter 5mC 
methylation during silencing (Kim, Park et al. 2014). NSC differentiation analysis has 
also identified the differential methylation of Notch1, Hes5, and a number of downstream 
Notch1 targets. These are particularly relevant due to the prominent role that Notch1 
signaling plays in directing astroglial and opposing pro-neural fates (Hisahara, Chiba et 
al. 2008, Das, Choi et al. 2013). Finally, large scale DNA methylation modifications have 
been shown to be critical for memory consolidation and synaptic plasticity in the 
hippocampus during adulthood (Vecsey, Hawk et al. 2007, Miller, Campbell et al. 2008), 
expanding the relevance of DNA methylation in neuronal systems beyond the 
developmental stage. 
Importantly, while DNA methylation landscapes are changed throughout the 
course of neural specification (Figure 2), it is critical to acknowledge that these 
modifications do not occur independently of other epigenetic modifications. In fact, 
several lines of evidence exist for inter-epigenetic crosstalk (Jobe, McQuate et al. 2012). 
For example, acquisition of intragenic 5hmC during neural differentiation has been linked 
to loss of H3K27me3 and concomitant loss of promoter Polycomb repressor marks 
(Hahn, Qiu et al. 2013). As such, though evidence of DNA methylation as a 
guidingdevelopmental program is presented, the future of epigenetic investigation most 
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certainly requires the consideration of parallel histone modifications and non-coding 
RNA.  
From a rational perspective, the reprogrammability of the chromatin landscape 
during cell specification makes sense in order to accommodate the fluctuating 
transcriptional profiles which are necessary to guide cellular change. Indeed, studies 
using DNMT-inhibiting agents such as 5-azacitadine and histone de-acetylases (HDACs) 
confirm the importance of normally occurring epigenetic landscapes for the proper and 
timely transition of the transcriptional profiles which dictate cellular specificity in the 
brain (Singh, Shiue et al. 2009).   
1.1.6 Developmental DNA Methylation Programs in the Brain 
Similar to the observed pattern of DNA methylation in neural stem cell 
progression, DNA methylation changes are highly orchestrated during mouse embryonic 
development. From the pronuclear stage of an embryo, paternal and maternal genomes 
are asynchronously altered by a wave of cell-wide demethylation through the blastocyte 
stage. This demethylation occurs passively and is predominantly mediated by loss of 
DNMT1 and DNMT3 and subsequent replication-dependent loss of 5mC and 5hmC 
(Mayer, Niveleau et al. 2000, Inoue and Zhang 2011). A second wave of demethylation is 
observed in primordial germ cells (PGCs) as they migrate to the gonadal ridge by 
embryonic (E) day 8.5-12.5 (Hajkova, Erhardt et al. 2002, Yamazaki, Mann et al. 2003, 
Maatouk, Kellam et al. 2006). This de-methylation, however, is not fully penetrant as 
many elements escape de-methylation including some CG rich regions (also termed CpG 
islands) of both the female and male PGCs, imprinting control elements, X-inactivated 
genes, and DNA transposons (Lane, Dean et al. 2003, Popp, Dean et al. 2010). Early 
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DNA methylation reprogramming is completed by a third wave of DNMT3-mediated de 
novo methylation during gametogenesis (Hajkova, Erhardt et al. 2002).  
Pre-implantation embryos further undergo de novo methylation after implantation 
(Monk, Boubelik et al. 1987, Kafri, Ariel et al. 1992), establishing the first embryonic 
somatic methylation program which, when disrupted, can lead to the development of 
neural tube deficits (Dunlevy, Burren et al. 2006). Though this process is not fully 
understood, DNA re-methylation has been shown to occur bimodally between 
housekeeping genes and tissue-speciﬁc genes, consequently conferring speciﬁcity of 
some cells and heterogeneity of the early tissues (Lange and Schneider 2010). Post-
implantation, during early neurulation, a specific profile of the DNA methylation 
landscape becomes clearer. Present in a gradient from ventral (high) to dorsal (low), 5mC 
apparently coincides with the pattern of neural specification. This pattern is also observed 
along the neural axis, with 5mC peaking at the mid/hindbrain and diffusing rostrally and 
caudally toward the forebrain and caudal neural tube, respectively (Zhou, Chen et al. 
2011). These patterns argue that DNA methylation is spatially and temporally 
coincidental with neural tube development during early gestation. Further, the Zhou study 
reported an intranuclear shift from 5mC presentation in the form of aggregated punctates 
toward a more homogenous distribution, likely indicating a transition from genomic 
hypermethylation to a “relaxation” of genomic clusters required for embryonic 
progression.  
Progressively, throughout brain development DNA methylation landscapes and 
dynamics have been proposed to play critical roles. An examination of the hippocampus 
identified a 5mC to 5hmC transition was correlated with neural differentiation in the 
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region (Chen, Ozturk et al. 2013). Interestingly, this study revealed that distinct cell types 
of the hippocampus expressed unique DNA methylation patterns. At E15, 5mC is 
abundant in hippocampal precursors though, by E17, neuroepithelial (NE) precursors 
undergo extensive loss of 5hmC and to a lesser degree, 5mC. As NE cells initiate radial 
migration through the intermediate zone, migrating neurons re-acquire 5mC and 5hmC, 
peaking as neurons reach their mature state in the Cornus Ammonis (CA). These findings 
suggested that 5mC and 5hmC are required for neural migration and specification of 
pyramidal neurons in the CA region. Additional analysis in the dentate gyrus confirmed 
that 5hmC is co-localized with NeuN, a marker of neuronal maturity. 5mC on the other 
hand demonstrated a more complex distribution and co-localization with Sox2 positive 
progenitors. Overall, this model allowed the visualization of unique DNA methylation 
signatures specific to cellular states within the developing hippocampus. This profile 
beckoned the characterization of DNA methylation landscapes in parallel neural systems, 
where the roles of DNA methylation markers could be compared and contrasted.  
1.1.7 Research Aims 
In light of the mounting evidence positioning DNA methylation as a regulatory 
mechanism in neural development, some questions remain. For example, though across 
various studies it has been observed that DNA methylation is a feature unique to the 
maturation state, it remains unclear whether all neurons observe similar DNA 
methylation programs or whether unique cell types exhibit distinguishing epigenetic 
features throughout their developmental course. Another critical aim was the examination 
of DNA methylation at the gene level. If, as hypothesized, DNA methylation and other 
epigenetic modifications function to aid in the regulation of critical developmental genes 
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during cellular specification, relevant gene networks should reveal differential epigenetic 
signatures at the onset of their expression/quiescence. As commercial technology 
improves, investigative tools such as methyl-sensitive sequencing and high-throughput 
automation will ensure that the future of epigenetics includes a thorough profiling of the 
developmental genome. 
Another major unanswered question revolves around the extent of DNA 
methylation reprogramming. Traditionally, due to the replicative quiescence of neurons 
and the belief that methylation can only be lost through replication-dependent 
demethylation, it is thought that post-mitotic DNA methylation is very stable (Irwin, 
Pentieva et al. 2016). Thus, post-mitotic epigenetic reprogramming has not been 
thoroughly evaluated as a mechanism of cellular plasticity beyond mitosis. Though an 
active demethylase has not been demonstrated in the brain, demethylation has indeed 
been observed in the post-mitotic hippocampal neurons. Believed to play a role in the 
modulation of synaptic plasticity and memory consolidation, DNA methylation has been 
shown to be dynamically regulated in a post-mitotic, replication-independent context 
(Miller, Gavin et al. 2010, Guo, Su et al. 2011).Whether this form of DNA methylation 
reprogramming is utilized in other post-mitotic neurons remains to be examined.  
The primary aim of this thesis revolved around the characterization of DNA 
methylation dynamics during normal, cellular development in two independent neural 
regions. Though DNA methylation has been implicated in gene regulation and cellular 
specification, an in-depth characterization and evaluation of cell-specific epigenetic 
landscapes had not been previously performed in the postnatal cerebellum or the 
embryonic cortex. We hypothesized that DNA methylation is a unique and dynamic 
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element guiding developmental cues through transcriptional regulation, exhibiting precise 
spatial and temporal patterns relevant to the developing system. To examine these at 
length, we first characterized DNA methylation patterns in the two major and 
complimentary cell types of the postnatal cerebellum at various time points. Further, the 
strata of the embryonic cortex, encompassing multiple cell types in various states of 
development, were profiled.  
1.2 MATERIALS AND METHODS 
1.2.1 Animals  
C57BL/6J mice from Jackson Laboratory were used in accordance with Indiana 
University Animal Care and Use Committee protocols.  A two-hour mating paradigm 
was used to obtain embryonic tissues and pups. Pregnancies could thus be tracked to the 
nearest two-hour interval of conception. Conception was denoted as embryonic (E) day 0. 
The day of birth was denoted as postnatal day (P) 0.  After deep CO2 euthanasia, embryos 
were harvested from dams at E17 by removal from the embryonic sack. Each embryo 
was either immersion-fixed in 20 mL of fixative prepared from 4% paraformaldehyde 
(PFA) for immunohistochemistry. Five independent litters are represented in the E17 
cortex analysis.  For cerebellar analysis, six P7, four P14, six P21, four P28, and four P45 
mice were selected from at least four different litters, anesthetized by CO2 inhalation, 
and transcardially perfused with saline, followed by 4% paraformaldehyde fixation. Pup 
brains were dissected and post-fixed for a minimum of 48 hours.  
1.2.2 Immunohistochemistry 
Brains were subsequently embedded in 10% gelatin blocks and sectioned by free-
floating vibratome (Leica VIT100S) at 40µm, coronally. Prior to immunohistochemical 
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detection, sections were cleared of endogenous peroxidases using 10% H2O2 in 
phosphate-buffered saline (PBS) for 10 min and permeabilized with 1% TritonX-100 in 
PBS for 30 min. A secondary permeabilization step involved the incubation of sections in 
2N HCl for 15-30 minutes. Next, incubation with a primary antibody diluted in species-
appropriate normal serum (1.5% serum, 0.1% TritonX-100 in PBS) was performed for 
18 h at room temperature.  
Antibodies used in this study are summarized in Table 1. To address issues 
including antibody penetration and inherent reduction of Purkinje cell (PC) 
immunoreactivity, we performed an immunostain using the Purkinje cell marker 
calbindin-D28K. Additionally, to establish the specificity of the 5hmC antibody, a 
preabsorption assay was performed for the anti-5hmC antibody (1:1000, rabbit polyclonal 
IgG, Active Motif) using 5hmC synthesized DNA (Methylated DNA Standard Kit, 
#55008, Active Motif, 50 ng/μ l, at a working dilution of 1:20 molar ratio) overnight at 
4°C. 
Biotinylated secondary antibodies (Jackson ImmunoResearch, West Grove, PA) 
were used at 1:500 for 90 minutes after primary antibody incubation, followed by 90 
minutes of incubation in biotin-streptavidin conjugated tertiary antibodies (1:500). 
Optical detection of immunoreactivity was accomplished by 3,3’-Diaminobenzidine 
(DAB) (Sigma-Aldrich, St. Louis, MO) at 0.05% followed by activation with 
0.003% H2O2 over an average of 3–8 min. Sections were subsequently counterstained 
with methyl green (Nissl stain). All stainings were examined under light microscopy for 
cellular analysis (Leitz Orthoplan 2 microscope; Ernst Leitz GMBH, Wetzlar, Germany). 
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and photographed with a Spot RT color camera (Diagnostic Instruments, Inc., Sterling 
Heights, MI). 
For immunofluorescence detection, sections were incubated for 90 minutes in 
species-appropriate Alexa Fluor 488 and 546 conjugated IgG secondary antibodies 
(Thermo Fisher Scientific, Waltham MA). After PBS wash, sections were mounted on 
SuperFrost slides (Thermo Fisher Scientific, Waltham MA) and coated with DAPI Pro-
long Gold antifade mountant (Thermo Fisher Scientific, Waltham MA).  
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Table 1. Antibodies used for neurodevelopmental assessment of DNA methylation 
Primary Antibodies Company Catalog # dilution 
predicted 
wt. 
5-methylcytosine Eurogentec 
BI-MECY-
0100 1:2000 N/A 
5-methylcytosine Active Motif AM61255 1:2000 N/A 
5-hydroxymethylcytosine Active Motif AM39769 1:3000 N/A 
calbindin/D28k Bioss, USA bs-3758R 1:1000 28 kDa 
DNMT1 Abcam ab87654 1:1000 ~183 kDa 
TET1 GeneTex GTX124207 1:500 ~220 kDa 
MBD1 Santa Cruz Biotech. sc-10221 1:200 ~89 kDa 
MeCP2 Cell Signaling Tech. D4F3XP-R 1:1000 75 kDa 
5-formylcytosine Active Motif AM61224 1:2000 N/A 
5-carboxycytosine Active Motif AM61226 1:2000 N/A 
Ki67 Novus Biologicals 
NB110-
89717 1:500 324 kDa 
Tbr2 Millipore AB2283 1:500 58 kDa 
NeuN Cell Signaling Tech. D3S3I 1:500 46-55 kDa 
P2Y1 Millipore AB9263 1:1000 ~42 kDa 
Secondary Antibodies         
AlexaFlour 488 
ThermoFisher 
Scientific ab150077 1:500 ~150 kDa 
AlexaFlour 546 
ThermoFisher 
Scientific A-11003 1:500 ~150 kDa 
Goat anti Rabbit biotinylated 
Jackson 
ImmunoResearch 
111-065-
003 1:500 ~160 kDa 
Horse anti Mouse biotinylated Vector  Laboratories BA-2000 1:500 
~152-165 
kDa 
Donkey anti Guinea Pig 
biotinylated Vector  Laboratories BA-7000 1:500 
~152-165 
kDa 
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1.2.3 Confocal Microscopy 
Confocal fluorescent images were obtained with an Olympus FV1000-MPE 
Confocal Microscope mounted on an Olympus IX81 inverted microscope stand with a 
60x water-immersed objective.  Sequential excitation at 488 nm and 559 nm was 
provided by argon and diode lasers, respectively. Emission was collected by spectral 
detectors in channels one and two with user-specified min and max wavelengths. Z-stack 
images were collected over a thickness of 4.5 μm in 0.3 μm step intervals. After 
sequential excitation, green and red fluorescent images of the same cell were saved and 
analyzed by Olympus Fluoview FV10-ASW software. The term co-localization refers to 
the overlap of green and red fluorescence in an image pair, as measured by confocal 
microscopy. 
1.2.4 Quantification of 5mC and 5hmC using immunoabsorbance assays 
To independently assess quantitative cellular methylation, 25μm coronal sections 
were obtained from flash-frozen cerebellum at ages P8 (N=8) and P29 (N=8) using a 
Leica Cryostat CM1900. Sections were mounted onto 2μm thick PEN membrane slides 
(Microdissect Gmbh, Herborn, Germany) and stained with 4X Thionin solutions. Slides 
were further dehydrated in series 50%, 75%, 90%, and 100% ethanol. Sections were 
viewed under 10X magnification using a Leica laser microdissection microscope (Leica 
CTR6500). The cerebellar layers were morphologically discernible by Thionin stain and 
dissected by laser into a flat cap 0.65mL Eppendorf tube containing 65μL of DNA 
extraction buffer (Arcturus Picopure DNA Extraction kit, Applied Biosciences). DNA 
was next purified using DNA Clean and Concentrator (Zymo, Irving, CA) according to 
manufacturer’s instructions.  
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100ng and 200ng of purified cellular gDNA was used for MethylFlash™ 
Methylated DNA Quantification Kit and MethylFlash™ Hydroxymethylated DNA 
Quantification Kit respectively, according to manufacturer’s instruction (Epigentek, 
Farmingdale, NY). Absolute quantification was performed using a five-point standard 
curve and further transformed to represent the ratio of methylated DNA (5mC or 5hmC) 
to total DNA. For presentation purposes, these were further transformed to denote 
expression of the methyl mark in relation to the control group totals (normalized).  
1.2.5 Quantitative Gene Specific DNA methylation analysis 
Genomic DNA (2µg) was extracted from cerebellum samples and digested. There 
were four treatment groups for each sample: uncut, methyl-sensitive enzyme (MSRE; 
Hha I or Hpa II; New England Biolabs, Ipswich, MA), methyl-dependent enzyme 
(McrBC; New England Biolabs, Ipswich, MA), and double digest with a methyl-sensitive 
and a methyl-dependent enzyme. Each digest was conducted with 10 U enzyme and 
incubated for 12 hours at 37°C. In the double digest sample, the first digest was 
performed using the methyl-sensitive enzyme, and the enzyme was heat inactivated by 
incubating at 65°C for 20 minutes. Prior to the second digestion, we purified the singly-
digested DNA by phenol: chloroform extraction, and then precipitated the samples with 
0.2 volumes of 1.5 M ammonium acetate and 2 volumes of 100% ethanol and re-
suspended them in 1 X T10E1 buffer. Prior to amplification, all DNA was purified by 
phenol: chloroform extraction followed by ethanol precipitation and quantified by 
Nanodrop ND-1000 Spectrophotometer (NanoDrop Products, Wilmington, DE). We used 
40ng of DNA from each digestion for quantitative PCR reaction with iTaq Universal 
SYBR Green mix (BioRad, Hercules, CA) and locus-specific primers (Table B-2, 
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Appendix B) using an iCycler PCR machine (BioRad, Hercules, CA). We used the 
default setting to obtain the cycle threshold (Ct) values, and normalized the digested 
samples to the uncut samples to calculate the delta Ct value. DNA methylation levels 
were determined by the average MSRE delta Ct value based on the calculation of 100 x 2
-
ΔCt
. Three or four biological replicates for both P7 and P29 animals were used for this 
analysis.   
1.2.6 qPCR for gene expression 
We added 10 volumes of RNA Stat-60 (Tel-Test, Inc., Friendwood, TX) to the 
snap-frozen P7 or P29 cerebellum, and homogenized and incubated the sample at room 
temperature for 5 minutes. To purify the RNA, we extracted the samples for 5 minutes 
with 0.2 ml chloroform/ ml RNA Stat, and centrifuged the samples for 15 minutes at 
12,000 RPM (max) at 4°C. We transferred the aqueous layer to a new tube and 
precipitated the RNA for 10 minutes at room temperature with 0.5 ml isopropanol/ ml 
RNA Stat and then centrifuged the sample for 10 minutes at 12,000 RPM (max) at 4°C. 
The pellet was washed with 75% ethanol, vortexed, and centrifuged for 5 minutes at 
maximum speed at 4°C. We dried the pellet and dissolved it in 300 μl DEPC H2O. RNA 
concentration was measured by NanoDrop ND-1000 Spectrophotometer (NanoDrop 
Products, Wilmington, DE). We performed DNase treatment using the TURBO DNA-
free kit (Life Technologies, Grand Island, NY) to one μg of total RNA extracted from 
each sample by following the manufacture’s instruction. DNase treated RNA was then 
converted into cDNA using iScript cDNA synthesis kit (Bio-Rad, Hercules, CA).  
Quantitative RT-PCR was performed using 50 ng of cDNA as a template for qRT-PCR in 
combination with TaqMan® Gene Expression Master Mix (Life Technologies, Grand 
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Island, NY) and TaqMan Gene-specific probes (Table B-1, Appendix B; Life 
Technologies, Grand Island, NY) on a StepOnePlus™ Real-Time PCR System (Life 
Technologies, Grand Island, NY). We assayed four biological replicates for P7 and P29. 
Cycling reactions were performed in duplicate. The relative expression of each gene was 
calculated based on the ΔΔCt value, where the results were normalized to the average Ct 
value of Gapdh. 
1.2.7 Statistical analysis 
  A randomized design with a one–way arrangement of the treatments, "Age (P7 & 
P29)" data, was analyzed through the Generalized Linear Model procedure on SAS and 
comparisons between treatments were done through the Least Square Means procedure. 
All quantitative data were represented as the mean and standard error of the mean (SEM). 
Statistical analysis was performed between P7 and P29 DNA using a one tailed student t-
test assuming unequal variance (GraphPad, Prism 6.0). The threshold for statistical 
significance was p<0.05.  
1.3 RESULTS 
1.3.1 Purkinje Cell DNA Methylation Reprogramming 
Purkinje cell (PC) analysis is facilitated in part by the prominent and distinct 
morphological characteristics of its development. Purkinje cells originating from the 
ventricular zone of the cerebellar primordium begin to migrate and arrange a monolayer 
at a target region known as the Purkinje Cell Layer (PCL) ~E14.5-16.5 in mice. Purkinje 
cells contribute the primary GABAergic output to deep cerebellar nuclei which aid in 
control of movement and gait (Jayabal, Ljungberg et al. 2015, Vinueza Veloz, Zhou et al. 
2015). During early migration and PCL formation, 5mC and 5hmC appear abundantly in 
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the nucleus of PCs, with 5mC particularly displayed as aggregate punctates and 5hmC 
expressing a more euchromatin distribution (Figure 3A and 3D, red crossed arrows). A 
distinguishing feature of PCs begins to occur after the first postnatal week, wherein PCs 
embark on a morphological transformation including the formation of apical dendrites 
followed by robust outgrowth of the extensive PC dendritic arbors and parallel fiber 
synaptogenesis (McKay and Turner 2005, Paul, Cai et al. 2012). Between the first and 
second postnatal weeks of development, the Purkinje cell dendritic area grows to as much 
as 10,000 µm
2
 (Altman 1969) and a cell-unique upregulation of synaptic genes is 
observed (Rong, Wang et al. 2004, Sotelo 2004, Kirsch, Liscovitch et al. 2012, Paul, Cai 
et al. 2012). Interestingly, that period of cellular transformation was observably 
accompanied by the dramatic loss of 5mC, 5hmC, and DNA methylation correlates 
(Figure 3B, 3E, red dashed circles indicate the borders of the PC perikarya). By postnatal 
day 45, when peak PC synaptogenesis has subsided (Paul, Cai et al. 2012, Arancillo, 
White et al. 2015), PCs exhibit a partial remethylation of 5mC and 5hmC which is in 
agreement with the intranuclear distribution of mature-state 5mC (i.e. heterogeneous 
rather than aggregate or punctate distribution) (Zhou, Chen et al. 2011). Moreover, 
demethylation of PCs was observed to occur in a gradient overlapping the known 
maturation gradient of the cerebellum from the deep fissures to the superficial folia 
(Morris, Beech et al. 1985, Goodlett, Hamre et al. 1990). These phenomena were 
observed consistently throughout the rostro-caudal axis of the cerebellum. 
 To address concerns of incomplete penetrance of the DNA methyl markers in the 
mature PCs as a potential confounding factor, we performed stage matched 
immunohistochemical detection of the PC-specific marker calbindin D28-k. The calcium-
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binding protein is a reliable and abundant marker unique to Purkinje cells in the 
cerebellum (Whitney, Kemper et al. 2008). As shown in Figure 4, it is consistently 
expressed in PCs throughout maturation, indicating that diminished immunoreactivity of 
the cell is not a likely confound for the observed demethylation. Moreover, the distinct 
intranuclear distribution of the DNA methylation markers at P7 combined with antibody 
pre-absorption assays (Figure 5) provided evidence of a distinct and reliable DNA 
methylation marker immunoreactivity in the cerebellum.  
 To confirm the immunohistochemical profiles of 5mC and 5hmC, a secondary 
strategy was initiated whereby the molecular profile of 5mC and 5hmC content was 
independently assessed. First, laser capture microdissection was used to isolate 
populations of Purkinje cells and extract their genomic DNA. While PC microdissection 
(due to the presence of adjacent basket interneurons and overlapping Bergman glia 
bodies) could not totally purify the PC population, the unique DNA methylation program 
of the PCs relative to these cell types (described below) was such that we could 
confidently assume was representative of the assay results. Next, quantitative detection of 
5mC and 5hmC was carried out using the MethylFlash
TM
 Methylated DNA 
Quantification (Epigentek, Carlsbad CA) assays. As presented in Figure 6, semi-pure PC 
populations underwent a nearly ten-fold decline in genomic 5mC (Figure 6A, p<0.01), 
and an 8-fold drop in 5hmC from P7 to P29 (Figure 6B, p<0.0001).  These results are 
consistent with the PC immunostaining patterns observed in Figure 3 and confirmed 
DNA methylation reprogramming in the post-mitotic PCs.   
 As mentioned previously, a dynamic 5mC and 5hmC intranuclear distribution was 
observed in the P7 PC nuclei. 5mC presented as punctate aggregates while 5hmC 
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displayed a euchromatin distribution (Figure 7), the two of which are not overlapping. As 
PC nuclei mature, however, 5mC adopts a more homogenous distribution similar to what 
we have previously observed in the embryonic neural tube (Zhou, Chen et al. 2011). This 
dynamic DNA methylation expression harkens back to the reported genomic 
complementarity of 5mC and 5hmC and likely relates to a functional diversity (Chen, 
Damayanti et al. 2014). Further, this stage-dependent distribution of 5mC in PCs 
provides further support for the early role of 5mC as a repressor of genomic “clusters” 
compared to a more relaxed and diffuse function in mature cells. Importantly, the 
chromatin remodeling of 5mC does not appear to be a cell-unique feature, displaying 
similar chromatin re- arrangement in granule neurons. 
1.3.2 Granule Neuron DNA Methylation Reprogramming 
 While various DNA methylation landscape analyses have by now demonstrated or 
alluded to a maturation-dependent DNA methylation program, the cerebellar profile 
allowed the cross-examination of complementary cell types, complete with unique 
temporospatial developmental patterns. The most obvious was apparent in the granule 
neuron, the primary glutamatergic neuron of the cerebellum. Derived from the dorsal-
most rhombic lip of the primordial cerebellar ventricular zone, granule cells adopt a DNA 
methylation program that is distinct from the reprogramming characterized in the 
Purkinje cell.   
At P7, at the cerebellar superfice, mitotic granule precursors residing in the outer 
limits of the external granular layer (EGL
o
) are largely un-methylated. As the granule 
precursors exit the cell cycle and migrate into the inner EGL (EGL
i
) (also distinguishable 
by their elongated somata (Hatten 1990)),
 
they undergo de novo 5mC and 5hmC 
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methylation. This phenomena is clearly distinguishable by the brown coloring of the 
EGL
i
 relative to the EGL
o
 (Figure 3A and 3D, blue crossed arrows), which demarcates 
the commitment of precursors to a granule fate and the initial stages of radial migration. 
Further, as the granule cells migrate inward from the EGL
i 
toward their target position at 
the Inner
 
Granule Layer (IGL), 5mC and 5hmC levels continually increase in accordance 
with the maturation stage of the cell, peaking as they settle at their final destination. 
Granule neurons in contrast to PCs, appear to maintain the acquired 5mC and 5hmC 
marks throughout adulthood (Figure 3C, 3F; blue crossed arrows).  
Laser capture microdissection and subsequent quantitative analysis of molecular 
5mC further supported the stage-dependent acquisition of granule neuron methylation. 
Proliferating granule cells of the EGL were compared with post-mitotic granule cells of 
the IGL at P7. Between the period of cell-cycle arrest and radial migration to the IGL, 
granule neurons nearly doubled their 5mC expression (Figure 6C, p<0.02). Further, even 
after granule cells reach the IGL, they gradually continued to acquire 5mC from P7 to 
P29 (Figure 6D, p<0.007), a time-frame overlapping with granule cell parallel fiber 
synapse formation (P14-P28) (Paul, Cai et al. 2012). 
The developmental timeline of granule cells, like PCs, is coincidental with the 
DNA methylation reprogramming of the cell. The major DNA methylation 
reprogramming of the granule neuron is observed during P7-P14, coincident with peak 
migration of the cells (Komuro, Yacubova et al. 2001) and bifurcation of parallel fibers. 
Though seemingly straightforward, the developmental progression of granule neurons, 
which deliver excitatory glutamatergic drive to PCs and modulate its excitability, are 
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crucial to the proper formation and function of the cerebellar architecture (Volpe and 
Adams 1972, Hatten 1999). 
Granule and Purkinje neurons are not the only cells that demonstrate a 
temporospatial DNA methylation program in the cerebellum. Stellate interneurons of the 
Molecular Layer (ML), Golgi interneurons in the IGL, and basket cells (Figure 3, purple 
dots) surrounding PCs in the PCL similarly undergo epigenetic reprogramming unique to 
their developmental course. Interestingly, these interneurons are born from the same 
ventricular region as PCs (Zhang and Goldman 1996), yet exhibit an epigenetic course 
more closely resembling granule neurons than PCs.  Stellate and basket interneurons, for 
example, acquire DNA methylation as they complete their migratory paths around the 
second postnatal week (Stroud, Feng et al. 2011) and retain their methylation even after 
their maturation has been completed (approximately the fourth and fifth postnatal weeks).  
1.3.3 Epigenetic Correlates of Post-Mitotic DNA Methylation Reprogramming 
 To further scrutinize the cellular DNA methylation programs of the postnatal 
cerebellum, we profiled DNA methylation-conferring enzymes and methyl-DNA binding 
proteins. At P7, DNMT1 displayed a distribution similar to 5mC, as characterized by an 
intranuclear punctate distribution (Figure 8A). TET1 expression, on the other hand, 
mirrored 5hmC, as denoted by a euchromatin intranuclear distribution (Figure 8D).  By 
the third postnatal week, PC loss of both DNMT1 and TET1 were clearly observable 
(Figure 8B and 8E), re-emerging again at P45 to confer the subsequent wave of PC 
remethylation (Figure 8C and 8F). This observation supports the expression patterns of 
the enzyme products detailed previously.  
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 Further support for DNA methylation reprogramming was obtained from methyl-
DNA binding protein profiles. MeCP2 was present in P7 PCs in punctate distribution 
confirmation (Figure 9A) reminiscent of 5mC, an observation which is in agreement with 
previous reports of 5mC-MeCP2 binding complementarity. Additional evidence of a 
5mC-MeCP2 relationship was provided by the parallel remodeling of MeCP2 from P7 to 
P21 in PCs. Notably, MeCP2 does not undergo complete loss in maturing PCs, though a 
significant reduction is observed during synaptogenesis and axonal-dendritic outgrowth 
(Figure 9B). MBD1 also showed a loss of expression at P21, though some PCs appear to 
retain this methyl binding protein (Figure 9D). Collectively, the presentation of the 
epigenetic correlates of 5mC and 5hmC support the PC DNA methylation program. 
Finally, incomplete loss of the methyl-CpG binding proteins (MBDs) may be rooted in 
the proclivity of the MBDs to interact with histone methylation modifications which were 
not examined in this study (Schmitz, Albert et al. 2011, Chittka, Nitarska et al. 2012, 
Wang, Yue et al. 2014). 
As a final assessment of cerebellar DNA methylation reprogramming, we 
examined downstream intermediates of the passive demethylation pathway including 5fC 
and 5caC. We observed that the presentation of the markers was highly coordinated with 
5mC and 5hmC (Figure 10). The 5caC and 5fC were detected in abundance in PCs at P7, 
but were no longer detectable at P21-P28, in line with 5mC and 5hmC loss. The 
concordant loss of 5mC and downstream intermediates sheds some interesting light on 
the replication-independent mechanisms likely guiding post-mitotic DNA methylation 
reprogramming.   
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Figure 3. Purkinje cell DNA de-methylation and re-methylation in the postnatal 
cerebellum 
(A) 5mC-immunostaining (im) is intensively present in the nucleus (size >12μm) of 
postmitotic Purkinje Cells (PC) at P7 (red, crossed arrows) at PC layer (PCL). 5mC is 
also distinctively present only in the non-dividing granule cells of the inner portion of the 
External Granule Layer (EGLi, blue crossed arrows) but not outer portion of EGL 
(EGLo). (B) By P28, the waning of 5mC-im was evident in PCs (red, dashed circles; 
~20μm diameter). Basket cells surrounding the PCs (purple dots, <8μm) were intensively 
immunostained by 5mC (as well as all other interneurons). Mature granule cells 
inhabiting the Inner Granule Layer (IGL) retained the acquired 5mC-im throughout the 
remainder of the time-course. (C) By P45 re-methylation of PCs occurred as the 5mC-im 
returned to some but not to all de-methylated PCs (red, crossed arrows denote re-
methylated PCs). (D) At P7, 5hmC immunostaining (im) is intensively present in PCs 
(red, crossed arrows), though distributed distinctly from 5mC. Some granule cells of the 
inner EGL express 5hmC-im though not at the upper surface of the EGL, where granule 
cell progenitors reside. (E) At P28, a clear de-methylation of 5hmC occurs in the PCs 
(red, dashed circles) as occurs with 5mC. Granule cells which have migrated to the IGL 
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continue to acquire 5hmC (blue, crossed arrows) as do the emerging basket interneurons 
surrounding the perimeter of PCs (purple dots). (F) At P45, re-methylation of 5hmC 
occurs in line with 5mC re-methylation at PCs (red, crossed arrows denote re-methylated 
PCs). Interneurons and granule cells appear to refrain from de-methylation throughout 
their developmental time-course. Scale bars: A-F=20μm; Methyl Green Nissl 
counterstain. Dashed red circles depict the approximate boundaries of the PC cell body. 
Dashed black lines depict approximate boundaries of the PCL.  
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Figure 4. Persistent immunoreactivity of calbindin D-28k in Purkinje cells of the 
developing cerebellum  
The calcium-binding protein Calbindin D-28k (green) is a characteristic Purkinje cell 
protein and appears markedly immunoreactive at P7 in the PCL. At P7, 5hmC (red) is 
also abundant in PC nuclei and granule cells of the inner EGL and IGL. At P21, even 
while an abundance of DNA methylation markers undergo dramatic loss of 
immunoreactivity, Purkinje cells retain calbindin expression. In contrast, interneurons 
emerging in the ML (as well as basket cells surrounding the large Purkinje bodies) 
abundantly express 5hmC at P21. EGL: external granule layer, IGL: internal granule cell 
layer, PCL: Purkinje cell layer, ML: molecular layer. Dashed borders represent the 
approximate cytological borders of the PCL.  
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Figure 5. Pre-absorption confirms the specificity of the anti-5hmC antibody 
The specificity of the crucial anti-5hmC antibody against 5hmC was characterized by 
pre-absorption of anti-5hmC antibody (1:1000, rabbit polyclonal IgG, Active Motif) with 
5hmC synthesized DNA (Methylated DNA Standard Kit, #55008, Active Motif, 50 ng/μ 
l, at a working dilution of 1:20 molar ratio) overnight at 4°C. (A) Before absorption, the 
anti-5hmC immunostaining in the cortex shows distinct 5hmC staining pattern, (B) while 
the staining pattern was abolished or drastically reduced after 5hmC-preabsorption. 
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Figure 6. Quantitative detection of cell-specific DNA methylation confirms Purkinje cell 
de-methylation and granule cell methylation 
Purified gDNA obtained from laser micro-dissected Purkinje and Granule cells was 
quantitatively analyzed for 5-methylcytosine and 5-hydroxymethylcytosine content (%) 
via antibody-based colorimetric assay. (A-B) Purkinje cells undergo remarkable loss of 
both 5mC and 5hmC between the first and fourth post-natal weeks, coincident with the 
Purkinje cell morphological and transcriptional transformation. (C-D) Granule cells of 
the external granule surface, as they undergo radial migration into the internal granule 
layer and become post-mitotic, acquire 5mC as indicated by earlier immunohistochemical 
analysis (Figure 3). Further, granule cells of the internal granule layer (IGL) continue to 
acquire methylation between the first and fourth postnatal week as granule cells settle 
into their mature state. (A.) **P-value=0.0078; (B.) ***P-value=0.0001; N=4 per age. 
(C.) *P-value=0.0186; (D.)** P-value=0.0036; N=8 per age. 
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Figure 7. Developmental chromatin remodeling of Purkinje cells is apparent by 
intranuclear localization of 5mC and 5hmC during postnatal development  
While distributed throughout the nucleus at the embryonic stage (not shown), at P7, 
major 5mC-immunostaining (im) (red) is packed into large punctates in the DAPI dense 
(blue), heterochromatin regions of the PCs  located in the Purkinje Cell Layer (PCL) (A, 
white arrows). (B) 5hmC (green) was detected primarily in the euchromatin DAPI sparse 
regions (B, white arrows). At P7, as the granule cells in the external granular layer (EGL) 
migrate into the internal granular layer (IGL), 5mC appears to precede 5hmC expression, 
as no overlap was observed at P7 (D, crossed arrows). De-methylation of 5mC and 5hmC 
in PCs progresses through P14 and peaks between P21 and P28. Notice the loss of 5mC 
and 5hmC in most of the PCs in the PCL (E, F white arrows). In contrast, DNA 
methylation in granule cells is independent of the PC program. At P21, when migration 
from the EGL has ceased and cells have permanently settled in the IGL, there is 
significant overlap between 5mC and 5hmC as denoted by yellow fluorescence (H, 
crossed arrows). Furthermore, by P21 the characteristic punctate staining of 5mC 
observed during the first postnatal week has been replaced by a more homogenous 
distribution in the matured, rounded nuclei of the granule cells. ML: molecular layer. 
Scale bar: A-H=20µm.  
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Figure 8. De-methylation and re-methylation are synchronized with the turnover of 
DNMT1 and Tet1 throughout the maturation of Purkinje cells 
The peak heterochromatin appearance of 5mC-im (Figure 1) occurs at the same time as 
peak Dnmt1-im (A, red crossed arrows).  Similarly, the peak euchromatin staining of 
5hmC-im (Figure 1) occurs at the same time as peak Tet1-im (D, red crossed-arrows) in 
PCs at P7.  De-methylation follows progressively, as by P21 many PCs lacked DNMT1 
(B, red arrows), and subsequently were devoid of Tet1 (E, red arrows). The methyl green 
counterstaining reveals 5hmC negative and Tet1-negative PC cell bodies (red arrows). 
Meanwhile, surrounding basket cells (and other interneurons) acquire Tet1 (E, purple 
dots). By P45, as re-methylation of 5mC is occurring, DNMT1-im is notably returned to 
the PC nuclei (C, red crossed-arrows). Similarly, Tet1 is observed parallel with the 
resumed observation of DNMT1-im expression (F, red crossed arrows) in PCs. PCL: 
Purkinje layer; EGL: external granule layer; IGL: internal granule layer. Scale bars: A-
C=20µm; D-F=20µm. 
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Figure 9. Postnatal de-methylation is supported by the diminished immunoreactivity of 
the methyl binding proteins MeCP2 and MBD1  
(A)Marked MeCP2 was found in the nuclei of PCs at P7 (red, crossed arrows) where its 
granular distribution within the nuclei is co-localized at this time point with 5mC (Figure 
1).  A noticeable waning of MeCP2-immunostainning in the PCs is observed by P21 (B, 
red arrows), though not to the extent observed in 5mC at the S-AMe time point. Basket 
interneurons (purple dots), on the other hand, acquire MeCP2 as they for a perimeter 
around the PCs. A similar de-methylation phenomenon is observed with MBD1-im at 
P21 in some but not all PCs observed (D, red arrows). PCs aligned in the deeper regions 
of the cerebellar foliae were more susceptible to this loss. IGL: internal granule cell layer, 
PCL: Purkinje cell layer, ML: molecular layer, Counterstaining: Nissl green. Scale bar: 
A-D= 20 µm. 
 
40 
 
Figure 10. Postnatal loss of 5hmC is synchronized with the loss of downstream 
derivatives 5fC and 5caC in Purkinje cells  
(A)5fC and 5caC are downstream metabolites of 5hmC (catalyzed by Tet enzymes) and 
prevail throughout cerebellar neurons including PCs (red, crossed arrow) and post-mitotic 
granule cells at P7 (A,C).   As 5hmC is de-methylated at P21 (Figure 3), 5fC and 5caC 
are also greatly reduced (B, D, red arrows). On the other hand, as PCs undergo de-
methylation of the 5fC and 5caC derivatives, surrounding basket cells acquire 
immunoreactivity. IGL: internal granule cell layer, PCL: Purkinje cell layer, ML: 
molecular layer, Nissl counterstaining: methyl green. Scale bar: A-B= 50µm, C-D=20µm. 
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1.3.4 Functional Impact of the DNA Methylation Program 
Though the correlation between DNA methylation reprogramming and cellular 
and neural development has been widely documented, its presupposed role in 
transcriptional regulation and the particular transcriptional targets have not been clearly 
outlined. To determine whether these cell-specific, cell-wide demethylation events were 
reflected at the gene level in PCs, we investigated the cerebellar DNA methylation status 
of Grid2, Cacna1g, Itpr1, Ppp1r17, Syt2 and Rgs8, which undergo PC specific turnover 
between P7 and P29. These genes were selected based on their predominant expression in 
PCs during the robust synaptogenesis period according to the Cerebellar Development 
Transcriptome Database (CTD-DB) (http://www.cdtdb.neuroinf.jp/CDT/Top.jsp) (Table 
B-2, Appendix B). Briefly, Grid2 encodes the glutamate ionotropic receptor delta type 
subunit 2, Cacna1g encodes the calcium voltage-gated channel subunit alpha 1g, the 
Itpr1 gene encodes the inositol 1,4,5-triphosphate receptor type 1, and Ppp1r17 encodes 
the regulatory subunit 17 of the protein phosphatase 1. The gene Syt2 encodes the 
synaptic vesicle membrane protein, which is thought to function as a calcium sensor and 
exocytosis. Finally, the gene Rgs8 encodes the regulator of G-protein signaling 8, a 
regulatory and structural component of G protein-coupled receptor complexes. 
Particularly, these selected genes were cross-referenced against a previous high-
throughput analysis identifying differentially hydroxymethylated genomic regions of 
cerebellar DNA between P7 and P42 (Table 2) (Szulwach, Li et al. 2011). The above 
genes met both criteria and were further pursued for methylation-specific restriction 
enzyme (MSRE) digestion qPCR.  
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Table 2. Differentially methylated regions of cerebellar gene targets for DNA 
methylation analysis by restriction enzyme digestion and qPCR 
* Szulwach, K. E., Li, X., Li, Y., Song, C. X., Wu, H., Dai, Q., Irier, H., Upadhyay, A. 
K., Gearing, M., Levey, A. I. et al. (2011). 5-hmC-mediated epigenetic dynamics during 
postnatal neurodevelopment and aging. Nature neuroscience 14, 1607-1616. 
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MSRE qPCR allowed for the quantitative assessment of methylated cerebellar 
DNA across different time points. The PC-preference of the investigated genes further 
allowed a cell-specific examination of PCs in lieu of purified PC DNA. This strategy 
could be used to investigate whether the immunohistochemical distribution of 5mC and 
5hmC could be traced onto functional PC genes during the developmental time course.  
Results demonstrated that DNA methylation reprogramming was not fully unilateral, 
demonstrating both up and downregulation at different loci. For example Grid2 and Syt2, 
which are detected at the synapse, underwent demethylation within the gene body by 
P29, diminishing by 42% (p=0.0037; Figure 11B). Similarly, Syt2 demonstrated a marked 
demethylation in the gene body (95% to 38%; p=0.045) between P7 and P29 (Figure 
11D). However, an examination of independent sites on the Cacna1g gene, encoding a 
low voltage calcium channel that is widely detected in neurons, revealed concomitant 
loss of promoter methylation (72% at P7 to 10% at P29; p=0.0003) and acquisition of 
gene body methylation (9% to 78%; p=0.0018) between the two developmental stages 
(Figure 11F). Although two other sites within the gene body of Cacna1g showed an 
increase in DNA methylation at P29, they were not statistically significant. Additionally, 
the G-protein signaling regulator gene Rgs8 demonstrated a 23% increase in gene body 
DNA methylation between P7 (23%) and P29 (46%) (p=0.0026). Various other 
investigated genes demonstrated that not all examined loci undergo epigenetic 
reprogramming. The promoter and gene body of Ppp1r17 (a regulatory subunit of protein 
phosphatase 1), for example, remained completely methylated through P7 and P29, while 
the promoter and gene body of the Itpr2 gene (an inositol triphosphate receptor) remained 
relatively unmethylated throughout these two stages.  
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Figure 11. Purkinje cell-preferring genes undergo simultaneous de-methylation and 
transcriptional upregulation during peak synaptogenesis  
(A) Diagram of Grid2 gene structure. Transcription start site (TSS): black bent arrow; 
exons: black boxes. Grid2 is transcribed from the Watson strand. A region in the intron 4 
was analyzed. The lower half of the panel is a magnification of the target region. Three 
CpG dinucleotides and one HhaI cleavage site are located in the target region 
(Chr6:64,015,530-64,015,858). Displaying primer (blue, straight arrow), CpG 
dinucleotides (white “lollipops”), and restriction enzyme cleavage sites (red, dashed 
lines).  (B) Analysis of Grid2: This Figure represents DNA methylation changes between 
P7 and P29 following digestion with HhaI. The P7 cerebellum is highly methylated, 
while the P29 cerebellum shows about a 60% reduction in DNA methylation. P-
value=0.0037. Gene expression of Grid2: Quantitative RT-PCR of P7 and P29. Grid2 is 
expressed 3.3 fold higher in P29 than in P7 cerebellum. P-value = 0.0006. (C) Analysis of 
Syt2. We amplified the following genomic region for Syt2: Chr1: 
136603663+136603902. (D) This Figure represents DNA methylation changes between 
P7 and P29 following digestion with HpaII. The P7 cerebellum is almost completely 
methylated, while P29 cerebellum shows about a 60% reduction in DNA methylation. P-
value=0.045. From P7 to P29, Syt2 mRNA expression is increased 4.6 –fold. (E) Analysis 
of Cacna1g. We amplified the following genomic region for Cacn1g: Chr11: 94336884 -
94337233. (F) This Figure represents DNA methylation changes between P7 and P29 
following digestion with Hpa II. The P7 cerebellum is ~ 72% methylated, while P29 
cerebellum shows only 10% methylation. P-value=0.0003. Gene body methylation 
analysis reveals a reciprocal relationship across ages, where P7 methylation begins 
around 10% and spikes to about 80% by P29. Overall gene expression was increased 2-
fold across this time. *p<0.05, **p<0.005 
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These results showed that DNA methylation reprogramming affecting cerebellar 
(particularly PC) development may occur through various genomic regions beyond the 
regulatory promoter. Additionally, as described earlier, DNA methylation changes during 
development are dynamic. Some genes experience accumulation of DNA methylation 
while others observe diminished DNA methylation, indicating that the apparent near-
totality of immunohistological demethylation in PCs requires a closer examination. 
Finally, the functional contribution of DNA methylation reprogramming was confirmed 
by gene expression analysis. Among Grid2, Cacna1g, Syt2 and Rgs8, all genes were 
upregulated by P29 with fold changes of 3.3 (p=0.0006), 1.9 (p=0.0037), 4.6 (p=0.0001) 
and 10.6 (p=0.0001), respectively. Itpr1 and Ppp1r17 transcripts have similarly been 
reportedly upregulated in cerebellar DNA by P42 in a previous study (Szulwach, Li et al. 
2011). Taken together, these results corroborate the early immunological profile of PC 
DNA methylation reprogramming and provide support for the mechanism as a regulatory 
element in cellular and cerebellar progression.  
1.3.5 DNA Methylation Program in the Embryonic Cortex 
To examine whether cell-unique DNA methylation occurs during the 
development of neurons in other developing brain regions, we investigated the DNA 
methylation profile of the embryonic cortex. At embryonic day 17, the cerebral cortex 
exhibits a unique stratified architecture containing multiple neuronal populations in 
various states of maturity. After neural tube closure, neuroepithelial cells begin to 
transform into radial glial cells (RGCs) coincidental with the onset of cortical 
neurogenesis (Kriegstein and Gotz 2003). From the lateral ventricular formation, a 
proliferative ventricular zone is formed, populated by replicative RGCs. This region 
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undergoes asymmetrical cell division, giving rise to RGC clones (cortical neuron 
precursors) and simultaneously producing an intermediate progenitor cell (IPC) which 
migrates outward to become an inhabitant of the adjacent subventricular zone (SVZ). In 
the SVZ, intermediate progenitors undergo 1-3 rounds of symmetrical cell division 
(Noctor, Martinez-Cerdeno et al. 2004). IPCs, distinguishable by their distinct 
morphology and protein expression patterns (i.e. Tbr2 (Englund, Fink et al. 2005)) 
produce cortical neurons, particularly of the upper cortical layer (Tarabykin, Stoykova et 
al. 2001), and olfactory bulb neurons (Lois and Alvarez-Buylla 1993).  Moreover, this 
two-tiered replicative mechanism is believed to be a unique feature of mammalian 
neurogenesis which contributes to the formation of a rather large cortical surface 
(Cheung, Kondo et al. 2010).   
The intermediate zone (IZ) is largely populated by the radial glial processes that 
serve as scaffolds for migrating cortical neurons, which subsequently traverse the IZ and 
settle in an inside out fashion (with newly arriving cells migrating and settling past the 
existing neurons ) in the cortical plate (CP). Interestingly, the IZ has also been found to 
be heavily populated by cortical interneurons originated from the ganglionic eminence 
(Nadarajah, Alifragis et al. 2003). Due to the zonal splitting of the primordial plexiform 
cortical layer by the emerging CP, the oldest and most mature cortical neurons are 
located in the superficial marginal zone (MZ) and the deeper subplate (SP) layers. Like 
the proliferating zones and the intermediate layer, the SP is developmentally transient and 
is believed to play an important role in the functional capacity of subcerebral projection 
neurons (Ghosh, Antonini et al. 1990) and the maturation of layer IV and visual cortex 
elements (Kanold, Kara et al. 2003). The MZ, on the other hand, is made up of 
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glutamatergic Cajal-Retzius (CR) cells and GABAergic interneurons. The secretion of 
the glycoprotein reelin from CR cells has been particularly implicated in the proper 
formation of the cortical plate layers and cortical circuitry (Costa, Davis et al. 2001).  
During normal development, we observed that DNA methylation progresses in an 
orderly and predictable manner in differentiating cortical precursors, parallel to previous 
observations in early neurulation (Zhou, Chen et al. 2011, Zhou 2012). By E17 the VZ 
(Figure.12A–C), the neurogenic layer of the developing neocortex, exhibited strong 
proliferative activity as demonstrated by Ki67 immunoreactivity (Figure.12D) and dense 
Tbr2 positive cells (indicative of intermediate progenitors (IPs)) detaching from the 
ventricular surface and migrating into the upper cortical layers along radial glia fibers 
(Figure.12E). During this time we observed a robust expression of 5mC followed by the 
muted emergence of 5hmC (Figure.12A-B). At the subventricular zone (SVZ), the 
secondary proliferative compartment of the developing cortex, Ki67 positive cells were 
less apparent (Figure.12D), but contained dense Tbr2-im fibers extending from the VZ 
(Figure.12E). Similar 5mC and 5hmC distribution was observed in the SVZ compared to 
the VZ, with only a slight reduction of 5mC (Figure.12A-B) observed. Notably, the 
methyl-CpG binding protein MeCP2 was absent in both ventricular regions (Figure.12C). 
At E17, the IZ was highly populated by Tbr2-expressing IPCs and their vertical 
projections which were originated in the VZ and SVZ (Figure 12E). In this zone, 
proliferation was drastically reduced as marked by the absence of Ki67 
immunoreactivity. 5mC in the IZ resumed levels observed in the VZ while 5hmC 
appeared unchanged (consistently less abundant compared to 5mC) (Figure.12A-B). The 
subplate (SP) featured the first appearance of round-shaped, mature neurons (as 
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characterized by their expression of NeuN) (Figure 12G). The rounded nuclear 
appearance was in sharp contrast to the ellipsoidal shaped nuclei typical of the NeuN-
absent ventricular regions.  The SP also contained the Tbr2 and P2Y1-expressing fibers 
of the migratory IPCs (Figure 12F-G). An interesting divergence of 5mC and 5hmC was 
observed in the SP, where 5mC was present in both round and ellipsoidal-shaped nuclei 
(Figure.12A) while 5hmC was reserved distinctly for the mature, round-shaped nuclei 
(Figure 12B). Further, 5hmC-positive neurons in this region were highly correlated with 
the NeuN-positive cells (Figure.12G) and, next to the MZ, the SP observed the most 
abundant expression of 5hmC. In contrast to 5mC and 5hmC, MeCP2 was minimally 
apparent in the SP (Figure 12C). 
Finally, at E17 the CP contains maturing neurons which will make up the future 
cortical layers. Proliferation was absent in the CP while Tbr2-expressing fibers were 
tapered compared to the IZ and lower layers (Figure 12E). NeuN-expressing neurons 
appeared to be variable within the layer, distributed into three apparently distinct 
sublayers within the CP (Figure 12G). The appearance of these observed borders within 
the layer are likely affected by variable cellular densities and interspersal of migrating 
neurons. Concordant with the three CP sublayers, 5mC immunoreactivity also appeared 
distributed in the three sublayers with an immuno-intensity gradient inversely 
proportional to that of NeuN (middle < top and bottom) (Figure 12A). The distribution of 
5hmC was, in contrast, well-aligned with the NeuN-im pattern (middle > top and bottom) 
(Figure 12B). Similar to the SP layer, 5hmC appeared to only occupy the mature, round-
shaped nuclei, whereas 5mC was more ubiquitously expressed. MeCP2 in the CP 
remained relatively weak (Figure 12C), concentrated at the lower-most CP region.  
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Temporal and spatial cues tightly regulate the transcriptional profiles of emerging 
cells of the cortex. From the emergence of RGCs to the reelin signaling emanating from 
Cajal-Retzius cells in the MZ, the precise expression of scheduled genes may have 
critical implications for cortical development and subsequently cortical function (Costa, 
Davis et al. 2001). As such, elucidating the regulatory mechanisms underlying cellular 
ontogeny may be critically important in developmental disease. Here, we observed that 
DNA methylation patterns of the cortical laminae were aligned with cellular 
differentiation processes in agreement with the epigenetic narrative presented earlier in 
neurulation, hippocampus and cerebellar development. The onset of 5mC at 
neuroepithelial zones has been previously hypothesized to prepare the cell for the 
downregulation of pluripotency genes in the wake of specification (Kim, Park et al. 2014, 
Resendiz, Mason et al. 2014). At the cortical ventricular zones, 5mC was abundant, 
diminishing slightly as progenitors exited the cell-cycle and initiated upward radial 
migration. Subsequently, 5mC was upregulated secondarily as migrating neurons settled 
in their target cortical zones and initiated morphological and functional modifications. 
This cyclical presentation of 5mC is reminiscent of the PC DNA methylation program in 
the cerebellum and supports the notion that cells may undergo various waves of DNA 
methylation reprogramming. Another feature of 5mC expression included indiscriminate 
expression across various cell types within a cortical layer as distinguished by cellular 
morphology.  5hmC, a bivalent epigenetic mark, observed a more straightforward 
progression in the embryonic cortex.  Predictably upregulated in the zones which housed 
the most mature cortical neurons, 5hmC also was distinctively present in the rounded, 
mature cortical cells. These findings echo the presentation of the marker in parallel 
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hippocampal systems (Chen, Ozturk et al. 2013) and align with the presupposed role of 
5hmC in priming cells for activation of genes required for cellular specification.   
The restricted emergence of the methyl-binding protein MeCP2 in the mature 
zones of the embryonic cortex are consistent with previous findings (Kishi and Macklis 
2004, Mullaney, Johnston et al. 2004) and support the dual binding of MeCP2 with both 
5mC and 5hmC (Chahrour, Jung et al. 2008, Mellen, Ayata et al. 2012, Chen, Damayanti 
et al. 2014). This finding challenges the strictly repressive role of the methyl-binding 
protein and implicates the protein in more dynamic transcriptional regulation. Ultimately, 
the epigenetic characterization of the embryonic cortex strengthens the cell-unique and 
stage-dependent DNA methylation program that has been building since the emergence 
of early studies in neural stem cells. This study, across various neural systems and cell 
types, has demonstrated a systematic orchestration of DNA methylation and DNA 
methylation correlates operating in tandem with cellular progression.  
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Figure 12: Comparative phenotypic and DNA methylation dynamics in the embryonic 
cortex 
(A-C) Representative cortical columns from the Chow E17 frontal neocortex 
immunostained with DMP markers (5mC, 5hmC, MeCP2) and (D-G) phenotypic neural 
markers (Ki-67, Tbr2, P2Y1 and NeuN) are presented for comparison of the DMP 
dynamics along the radially progressing corticogenesis of the E17 brain. SVZ/VZ 
(Subventricular Zone/Ventricular Zone); IZ (Intermediate Zone); SP (Subplate; and CP 
(Cortical plate).  
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1.4 DISCUSSION 
1.4.1 Post-Mitotic DNA Methylation Reprogramming: Evidence from the PC 
 Evidence from adult hippocampal synaptic plasticity modeling first illuminated 
the capacity of acute DNA methylation remodeling in the adult brain (Levenson, Roth et 
al. 2006). These findings led the proposition that DNA methylation (as well as other 
epigenetic modifications) may be a mechanism underlying post-mitotic neural plasticity. 
This notion is a meaningful one given that, to-date, the bulk of neural epigenetic 
investigation has focused on early cell commitment (i.e. stem cell to neural progenitor). 
Moreover, the absence of concrete evidence of active (replication-independent) DNA 
demethylases has led many to believe that post-mitotic DNA methylation reprogramming 
was not a serious contender in the realm of plasticity-conferring mechanisms.   
 Here, our study yielded pronounced evidence of post-mitotic DNA methylation 
reprogramming, including a wave of DNA methylation erasure followed by de novo 
methylation. Like the findings revealed in the adult hippocampus, evidence of DNA 
methylation reprogramming were observed acutely, along regulatory and intragenic 
regions of functionally relevant transcripts. Unlike the work of Levenson et al., 
immunological detection suggests that the extent of DNA methylation reprogramming is 
far wider-reaching than the predictable scope of late-onset neural plasticity, at least in the 
cerebellar Purkinje cell.  
 In the absence of cell-replication (passive) DNA demethylation, Purkinje cell 
reprogramming is likely mediated by active mechanisms. Currently, there are two 
proposed pathways by which active DNA demethylation may occur. The first centers 
around the idea of direct 5mC removal via deamination and subsequent base excision 
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repair (BER) or nucleotide excision repair mechanisms (Grin and Ishchenko 2016).  The 
second proposes DNA demethylation occurs through the step-wise modification of the 
methylated cytosine base. For example, oxidation of 5mC could produce 5hmC which 
may be deaminated and subsequently excised by the AID (activation-induced 
deaminase)/APOBEC (apolipoprotein B mRNA editing enzyme complex) (Guo, Su et al. 
2011). Alternatively, 5hmC could persistently be oxidized by TET enzymes to produce 5-
fC and 5-caC. Subsequently, base-excision repair enyzmes such as Thymine DNA 
Glycosylase (TDG) could mediate demethylation of the derivatives, though this strategy 
is likely to be detrimental to the DNA on a large scale (Maiti and Drohat 2011). 
Alternatives to base-excision mediated demethylation are limited to the existence of 
enzymatic removal, which, though observed in some pathways, has yet to be supported in 
the brain (Wu and Zhang 2010). Whatever mechanisms are ultimately revealed, post-
mitotic DNA methylation reprogramming may play a large role in the synaptic 
morphological plasticity that underlies enduring long term depression/potentiation in the 
brain. 
The evidence observed in this study supports a mechanism by which 5mC 
demethylation concurrently affects all known hydroxylated intermediates, as their 
expression was highly dependent on 5mC. However, the fact remains that there is still 
much to learn regarding post-mitotic DNA methylation reprogramming, particularly 
where large-scale demethylation is concerned. Thus far, only one mechanism has been 
supported in the plasticity of the adult brain, that is, TET1-induced oxidation and 
subsequent deamination by the AID/APOBEC mechanism which was observed to occur 
in an activity-dependent manner (Guo, Su et al. 2011). Though attractive, in vitro this 
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mechanism was found to be 5hmC-specific and sequence selective, suggesting that 
perhaps this mechanism works cooperatively with other un-specified deaminases in the 
post-mitotic brain.  
1.4.2 DNA Methylation Programs in Complementary Cell Types 
The cell-wide DNA demethylation and remethylation of the Purkinje cells was 
unique to that cell type within the observed time course. Cerebellar granule neurons in 
contrast exhibited a more simplified DNA methylation program, acquiring stable 5mC 
and 5hmC only after their exit from the cell cycle (which coincided with the onset of 
radial migration from the EGL to the IGL) (Figure 13). The cell-wide acquisition of DNA 
methylation markers may signal the onset of cell cycle exit/neuronal specification. This is 
supported by the DNA methylation program of later-born cerebellar interneurons, which 
follow the neurogenic pattern from the emergence of granule layer interneurons (i.e. 
Golgi) to the later-arriving molecular layer interneurons (i.e. stellate, basket).  
While intrinsic temporal features may play a role in cell-unique DNA methylation 
patterns, it should be noted that even within similarly patterned cells (i.e. granule and 
interneurons), various nuances exist which complicate the extrapolation of generalities 
such as cell-cycle exit- associated DNA methylation acquisition. For example, though the 
two cell categories display similar, protracted acquisition of DNA methylation markers 
during cell cycle exit, it has been reported that cerebellar interneurons may actually retain 
some intermediate state (not ever fully entering G0 phase) (Leto, Bartolini et al. 2009). 
This allows cerebellar interneurons the plasticity to be “re-shaped” by the manipulation 
of extrinsic cues which would otherwise not be possible in a fully committed state. In this 
way, two cell types with apparently similar intrinsic transcriptional and epigenetic 
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courses deviate and call into question how much of the DNA methylation program, if 
any, is mediated by external cues. Interneuron characteristics also challenge the notion 
that cellular milestones such as cell cycle exit are entirely accountable for cell-wide DNA 
methylation reprogramming.  
Another observed developmental phenomenon which shed some contrasting light 
on the DNA methylation program of the PCs was the embryonic cortical landscape. Like 
the post-mitotic DNA methylation “waves” which characterized postnatal PCs, cortical 
progenitors observed comparatively mild DNA methylation reprogramming throughout 
their developmental course, as detectable through immunological evaluation (Figure 14). 
The defining feature of DNA methylation reprogramming in the cortex was not cell-wide 
erasure and de novo methylation rather, a complementarity of 5mC and 5hmC across the 
cortical strata. For example, in the SVZ/VZ, 5mC was pronounced, subsiding in favor of 
5hmC at the SP, where the earliest born (most mature) cortical neurons reside. Two more 
waves of shifting abundance occur within the complex CP layer. The observed 
“redistribution” of 5mC and 5hmC are reminiscent of the intranuclear positioning of the 
two markers which takes place in the cerebellum from P7 to P21. Recall that during the 
early stage, PCs and granule neurons exhibit a mutually exclusive distribution within the 
nucleus, co-localizing in a more “relaxed” euchromatin distribution only during later 
stages (Figure 7). That DNA methylation patterning additionally coincided with the 
genomic re-distribution of gene-specific DNA methylation from the promoter (P7) to the 
gene body (P29) (Figure 11F). Only gene-specific methylation analysis in the cortex will 
decipher whether the same genomic redistributions are in play and mediating 
immunological observations. Certainly, the developmental cortex demonstrates that the 
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cellular DNA methylation program is not always a case of absolute acquisition or erasure, 
but in some cases a more subtle conversion which remains to be substantiated in 
functional cortical gene networks. The cortical pattern does, however, reiterate the 
plasticity of the DNA methylation program in pre-and post-mitotic neurons, supporting 
the observations of Levenson et al in the adult hippocampus and our characterization in 
the cerebellum.  
1.4.3 DNA Methylation Reprogramming as a Functional Mechanism  
Beyond the need to corroborate cell-wide DNA methylation programs within 
functional gene networks, it remains important to understand how and why some genes 
apparently escape reprogramming. For example, though transcriptomes have been well 
characterized across cellular development, fluctuations in gene expression are not always 
attributable to DNA methylation changes (i.e. Ppp1r17, Itpr2 in the cerebellum). The 
obvious answer is that perhaps some functionally relevant genes are regulated by other 
epigenetic mechanisms or even non-epigenetic mechanisms, which begs the deeper 
question, what determines the regulatory mechanisms of a gene? Yet another possibility 
may be the sub-optimality of the available genomic DNA methylation assays. For 
example, in our cerebellar study, MSRE qPCR was not able to distinguish 5mC and 
5hmC methylation. Further, the examination of genomic regions was based on previously 
identified differentially methylated sites and not absolute coverage of the entire gene. 
Due to the relevance of 5mC and 5hmC genomic transitions and the likelihood that DNA 
methylation may be functionally important beyond the promoter, future studies will need 
to adopt more inclusive, unbiased approaches.   
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Finally, there is a need, just as in primordial germ cell reprogramming to better 
understand how if any genomic elements are protected from DNA methylation erasure 
post- mitotically. Equally important is a better understanding of the elements which 
recruit de novo DNA methylation. One report has proposed that TET-mediated 
hydroxylation may serve as an inhibitory mechanism for aberrant DNA hypermethylation 
(Wiehle, Raddatz et al. 2015). Others have proposed that activity-dependent intercellular 
signaling may underlie the recruitment of DNMT3A in the adult brain (required for de 
novo methylation) (Levenson, Roth et al. 2006). Surely we are still in the nascent stages 
of the exploration of epigenetic mechanisms and the future promises many milestones in 
our understanding of the mediators of the DNA methylation program and its fluidity. 
1.4.4 Summary and Conclusions 
The observations made in the postnatal cerebellum and the embryonic cortex 
greatly expand the epigenetic profile of the developing central nervous system. This 
cellular view paves the way for high-throughput genomic methyl-sequencing of cellular 
transcriptomes and strengthens the case for DNA methylation programming as a guiding 
element of neural progression. The distinct morphology and well-documented 
developmental course of the postnatal cerebellum allowed for a cell-specific assessment 
between the first and sixth postnatal weeks. While DNA methylation turnover has been 
documented previously during pre-implantation and during early neural tube formation, 
the cerebellar assessment revealed a post-mitotic population undergoing a large-scale 
demethylation and remethylation not previously reported. Moreover, the reprogramming 
of the cells was corroborated by epigenetic correlates and quantitative molecular 
assessment. Collectively, our observations showcased the cell-unique nature of DNA 
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methylation landscapes, illustrating that DNA methylation reprogramming, though 
detectable on a global scale, is highly dependent on cellular context. This was 
exemplified further across the cortical layers, where DNA methylation status was 
predictably correlated to proliferative, migratory, or synaptogenic status.  
Across all examined systems, recurring motifs included cell cycle exit, migration, 
and cellular maturation as developmental correlates of DNA methylation reprogramming. 
Additionally, 5hmC was consistently observed in mature-state cellular specification, 
which corroborates various reports of 5hmC as an activating marker during cellular 
differentiation (Stroud, Feng et al. 2011, Wu, D'Alessio et al. 2011).  Why some cells like 
cerebellar granule neurons and interneurons apparently undergo unilateral 
reprogramming while others like cortical progenitors and PCs are subjugated to multiple 
waves of DNA methylation reprogramming is a subject requiring further study. This may 
perhaps be rooted in some cellular complexity requiring large-scale transcriptional 
fluctuations to accommodate functional or structural demands. On the other hand, in light 
of the findings of PC gene targets (some of which were not subject to DNA methylation 
reprogramming), it may be entirely possible that other non-DNA methylation factors are 
collaboratively at work mediating transcriptional regulation. As such, it is with caution 
that investigators should attempt to extrapolate gene level to cell-level methylation and 
vice versa. Fortunately, as better epigenetic technologies emerge, complementary 
methods of investigation will become increasingly accessible to fill the gaps between 
cell-wide immunological trends and the precise cellular methylome.  
 While elucidating the cellular specificity and spatial and temporal profiles of 
DNA methylation across developing neural systems is a momentous step forward, much 
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remains to be answered regarding the mechanistic features and consequential outcomes 
of DNA methylation reprogramming. For example, what factors are at work in the 
recruitment of DNA methylating enzymes and their dynamics during reprogramming 
across cells are not known. Similarly, though labeling of MeCP2 and MBD1 was 
performed, a direct-binding analysis of 5mC and 5hmC methyl-binding proteins in the 
future will be needed to fully confirm methylated DNA and methyl-binding protein 
dynamics. By a similar token, teasing out the precise genomic distribution of 5mC versus 
5hmC may reveal important details about the regulatory DNA methylation program. 
Here, MSRE qPCR was indiscriminant toward 5mC versus 5hmC but new methyl-
sequencing strategies will allow deeper and precise examination of the two markers going 
forward.  
 Finally, as previously mentioned, DNA methylation reprogramming as a means 
for structural and transcriptional regulation is likely only partially explanatory. As 
documented in the literature, epigenetic modifications of chromatin often beget others. 
As such, a complete and comprehensive picture of epigenetic reprogramming in the 
developing brain will require an examination of multiple epigenetic modifications in 
tandem. Ultimately, only a complete and accurate account of epigenetic marks, 
recruitment elements, and transcriptional regulators will help to elucidate one of the most 
important questions of reprogramming as a regulatory mechanism, that is, is epigenetic 
modification an obligatory precedent of developmental outcomes or do 
intrinsic/extracellular developmental cues shape epigenetic landscapes associated with 
development?  
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Figure 13. Independent DNA methylation program of Purkinje, granular and basket cells 
during development   
This scheme illustrates the cell-specific epigenetic distribution of the DNA methylation 
marks 5mC (green dots) and 5hmC (red dots) in the nuclei of neurons during 
development of the cerebellum. As cerebellar granule cells (light green) occupy the outer 
external granule layer (EGL
o
), they are still mitotic and devoid of 5mC and 5hmC. 
Immediately after completing mitosis, these granule cells exit the cell cycle and begin 
radial migration through the inner EGL, PCL, and finally into the internal granule layer 
(IGL). As soon as granule cells break through the EGL
o
, they strongly acquire 5mC and 
5hmC, though these two methylation marks are independently distributed in the nuclei of 
granule cells. From P7 forward, mature granule cells of the IGL maintain their 
methylation, though these become homogenously distributed in contrast to pre-migration 
distribution. Independently, Purkinje cells (PC) of the cerebellum exhibit a unique 
epigenetic program. Post-mitotic Purkinje cells generated in the dorsal rhomboid lip at 
E14 and arrived at the Purkinje cell layer (PCL) at E17 and already express 5mC quite 
prominently (and to a lesser extent 5hmC).  As the PC grow in size, it becomes clear that 
5mC are distributed in a granular fashion in heterochromatin, while 5hmC are distributed 
as fine particles in euchromatin.  Remarkably, just prior to PC’s undergoing characteristic 
dendritogenesis and synaptogenesis (P14-30), a dramatic loss of 5mC and 5hmC occurs 
in their nuclei. As Purkinje cells settle into synaptic maturity, 5mC and 5hmC reappear in 
the nuclei though diminished from peak levels observed at P7.  In contrast, the basket 
interneurons closely associated with PCs appear to have acquired a rich expression of 
5mC and 5hmC while PCs undergo de-methylation and re-methylation.   
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Figure 14: The DNA methylation program of the embryonic cortex  
(A)At E17, the embryonic cortex develops in distinct layers progressing from the roof of 
the lateral ventricle (LV). Neuroepithelial (NE) cells sequentially migrate through the 
proliferative ventricular zone (VZ) to the uppermost cortical superficies. (B,C) During 
this developmental progression, cells of the layers are diverse in their maturity state and 
simultaneously unique in their chromatin distribution of DNA methylation markers. 
Specifically, NE cells of the proliferative VZ exhibits strong 5mC (B) followed by a 
weaker 5hmC signal (C). (B-D) As these cells undergo differentiation and radial 
migration into the subplate layer (SP), cellular morphology changes from ellipsoidal to 
larger, rounded nuclei. During this transition, a characteristic rise in 5hmC is observed, in 
contrasts to a weakening of 5mC. € Nuclear morphology and DNA methylation mark 
legend. (B-D,F) As cells reach their target layers within the cortical plate (CP), the 
distribution (immunointensity gradient) of 5mC/5hmC shows opposite trend within 3 
sublayers of the CP (CP1/2/3). SVZ (Subventricular Zone) 
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In conclusion, DNA methylation (and associated epigenetic marks) appear and 
disappear in accordance with the spatial and temporal developmental patterns that are 
unique to individual cell types. This presentation demonstrates an association with cell-
unique gene regulation and markers of cellular specification and provides novel evidence 
of a post-mitotic, reprogrammable DNA methylation developmental program. These 
findings also demonstrate that DNA methylation landscapes do not change “globally”, 
but rather fluctuate as unique signatures of evolving cellular states according to the 
temporal transcriptional requirements rendering the appropriate morphological and 
functional capacity of the cell.  
If the DNA methylation program is a major component of transcriptional 
regulation during development and epigenetic mechanisms are sensitive to external cues 
(see Chapter 2), could the program confer environmental input at the cellular level? The 
answer is likely to impact our understanding of a host of developmental abnormalities. If 
so, DNA methylation landscapes may open a world of diagnostic and therapeutic 
possibilities.  
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CHAPTER 2: DYSREGULATION OF NEURODEVELOPMENT AND DNA 
METHYLATION BY ALCOHOL 
2.1 INTRODUCTION 
2.1.1 Environmental Sensitivity and Heritability of DNA Methylation 
The environmental sensitivity of epigenetic mechanisms has been extensively 
documented. Factors such as nutritional disparity, early-life stress, pollution, substances 
of abuse, and maternal care are just some of the many proposed environmental 
contributors of epigenetic modification (Heijmans, Tobi et al. 2008, Madrigano, 
Baccarelli et al. 2011, Suderman, McGowan et al. 2012). Further, studies performed in 
monozygotic twins have provided valuable evidence for the environmental contributions 
of differential epigenetic profiles (Segal, Montoya et al. 2017). Interestingly, early 
findings demonstrated that epigenetic variability of monozygotic twins can actually begin 
prior to birth, suggesting environmental influencers of the epigenetic code can function as 
early as the prenatal environment (Ollikainen, Smith et al. 2010, Gordon, Joo et al. 2012). 
Since then, a host of prenatal and perinatal investigations have identified factors such as 
folate consumption, predatory stress, and chemical exposures such as alcohol and lead 
(Gonseth, Roy et al. 2015, Sen, Heredia et al. 2015, St-Cyr and McGowan 2015, 
Boschen, McKeown et al. 2016) as DNA methylation-altering environmental factors 
during neural development.  
Importantly, these factors and the subsequent epigenetic modifications have been 
characterized for their persistence in later life (Vineis, Chatziioannou et al. 2017), 
suggesting that environmentally-mediated epigenetic modifications may act as a 
molecular recording mechanisms for environmental information. Moreover, the 
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implications of stable and lasting epigenetic modifications include their evolution and 
adaptability over time, perhaps driving forward or reversing pathological courses already 
in play due to genetic or other factors. Of course, that argument would require a more 
comprehensive understanding of the functional “thresholds” which would render the 
chromatin structure vulnerable to differential transcription, the likes of which are 
rudimentary at this time. Additional considerations would require unraveling whether cell 
types, cell states, and accompanying genomic information experience differential 
sensitivity to environmental impacts. In other words, whether cellular chromatin are more 
vulnerable during a particular organismal phase or perhaps more responsive to specific 
outward influences over others remains largely unknown. Finally, epigenetic dynamics 
must be further defined in the context of genetic interaction. 
The notion of epigenetic memory has in recent years become increasingly 
important due to reports of transgenerational heritability. Occurring through the 
transmission of epigenetic signatures in gametes, environmental factors such as pre-
reproductive stress in females (Zidan, Rezk et al. 2015) and fetal alcohol exposure in 
males (Govorko, Bekdash et al. 2012), among others, have empirically demonstrated the 
heritability of acquired epigenetic change. Though unsubstantiated in human studies to 
date, several lines of epidemiological evidence suggest transgenerational epigenetic 
mechanisms at work in human beings as well (Veenendaal, Painter et al. 2013, Yehuda, 
Daskalakis et al. 2014). Given the known epigenetic erasure which occurs in the germline 
during transmission, it is likely, though not certain, that the mechanisms at work 
protecting the demethylation of elements like the imprinting of certain parental genes 
(Guibert, Zhao et al. 2012, Hackett, Sengupta et al. 2013) may also play a role in the 
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preservation of transgenerational epigenetic signatures. Despite the growing body of 
knowledge, and the ever-expanding implications for epigenetic landscapes, how 
environmental influences are mechanistically transduced into the epigenetic code remains 
poorly understood. At least one environmental element is molecularly poised to offer 
insight into how environmental influences impact epigenetic profiles during 
development.  
2.1.2 Alcohol and Methyl and Acetyl Metabolism 
Alcohol metabolism begins by oxidation into acetaldehyde, a known teratogen. 
Simultaneously, the breakdown of alcohol into acetaldehyde includes the production of 
reactive oxygen species (ROS). The metabolism of alcohol during acute exposure is 
mediated by the enzyme alcohol dehydrogenase (ADH) while chronic alcohol exposure is 
believed to increase metabolism by recruitment of hepatic cytochrome P450 isoform 2E1 
(CYP2E1). Secondarily, an enzyme known as aldehyde dehydrogenase (ALDH) is 
responsible for the irreversible conversion of acetaldehyde into acetate, mainly in the 
liver. The metabolism of alcohol is thought to proceed rather quickly to avoid the 
elevation of acetaldehyde levels. In healthy males, about 77% of ingested alcohol is 
converted to acetate (Siler, Neese et al. 1999), prompting the notion that acetate is 
alcohol’s primary metabolite and complementing reports of low levels of acetaldehyde 
accumulation in the blood after alcohol consumption (Umulis, Gurmen et al. 2005). 
Acetate may bind coenzyme A through the enzyme acetyl-coenzyme A synthetase 
(AceCS1). Acetyl CoA is a major substrate of the cellular energy cycle but may also 
donate an acetyl group to histone proteins through the histone acetyltransferase (HAT) 
family of enzymes. Acetylation of histones is generally thought to facilitate gene 
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activation by altering the binding of DNA to core histone proteins (Zakhari 2013). 
Additionally, acetate is a direct inhibitor of class I histone deacetylases (HDACs) in 
hepatic cells and neurons (Soliman, Smith et al. 2012). Accordingly, the metabolism of 
alcohol has a direct biochemical route toward the alteration of the chromatin structure. 
Furthermore, alcohol variability such as frequency of consumption and age of the 
consumer have been shown to alter the enzymatic activities of ALDH in response to 
alcohol, influencing the accumulation of alcohol metabolites and increasing the 
production of ROS’, which themselves may interfere with histone acetylation (Chrostek, 
Tomaszewski et al. 2005, Mello, Ceni et al. 2008, Brooks and Zakhari 2014).  
Beyond acetyl metabolism and histone modification, alcohol metabolically 
accesses a second biochemical pathway that is closely intertwined with epigenetic 
mechanisms. The sole methyl donor for DNA and histone methylation, S-
adenosylmethionine (S-AMe) (produced through the metabolism of dietary folate, 
betaine, and methionine) is impacted at various metabolic stages by alcohol and alcohol-
derived ROS’. For example, alcohol has been shown to decrease serum folate levels, the 
folate intermediate metabolite 5-methyltetrahydrofolate (5-MTHF), as well as the 5-
MTHF conferring enzyme (Eichner and Hillman 1973, McGuffin, Goff et al. 1975, 
Berlin, Cameron et al. 2010). Downstream, the intermediate 5-MTHF is converted to 
methionine by the enzyme methionine synthase (MS) which is decreased by up to 50% in 
models of alcoholism (Finkelstein, Cello et al. 1974, Barak, Beckenhauer et al. 2002).  
A secondary dietary methyl source is also biochemically impacted by alcohol. 
Choline, upon oxidative conversion to betaine, is enzymatically converted to methionine 
by betaine-homocysteine methyltransferase (BHMT). Like ALDH, the BHMT enzyme 
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appears to exhibit a context-dependent response to alcohol exposure, elevated by acute 
exposures but diminished chronically (Barak, Beckenhauer et al. 1996). Alcohol 
additionally has been correlated with decreased levels of methyl metabolism co-factors 
including B6, B12, and riboflavin (Lumeng 1978, Kanazawa and Herbert 1985, 
Subramanian, Subramanya et al. 2013), which may contribute to the observed alcohol-
related inhibition of methyl metabolism enzymes. Finally, past methionine biogenesis, 
alcohol has been observed to impact role players involved in the production of the 
“active” methyl donor substrate S-AMe. Predominantly, alcohol-induced oxidative stress 
has been shown to decrease both the expression and activity of methyl 
adenosyltransferase (MAT) and the hepatic production of S-AMe and DNA methylation 
(Chawla, Watson et al. 1996, Avila, Carretero et al. 1998, Lu, Huang et al. 2000), though 
the modality of alcohol in S-AMe production and DNA methylation may be more 
complex in other tissues.  
Folate, choline, and methionine metabolism have each been independently shown 
to regulate normal neural development in some capacity (Serrano, Garcia-Silva et al. 
2010, Wu, Dyer et al. 2012). Aside from altering methyl and acetyl metabolism, alcohol 
has also been shown to hinder the transfer of folic acid from mother to offspring, though 
earlier studies reported that transfer is actually elevated by alcohol exposure (Lin 1991, 
Hutson, Stade et al. 2012). This, taken together with the known interaction of alcohol and 
alcohol metabolites in methyl metabolism suggest a practical pathway for alcohol to 
impact neural development. In that vein, it is unsurprising that folate deficiency during 
developmental periods mirror some of the phenotypes of fetal alcohol exposure (Molloy, 
Kirke et al. 2008). 
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Figure 15. Effect of alcohol metabolism on acetylation and methylation of histones and 
DNA  
On the acetylation side (red hemisphere), alcohol is metabolized by ADH and CYP2E1 
into acetaldehyde. This process produces many reactive oxygen species that pour over to 
affect folate metabolism. Acetaldehyde is further metabolized to acetate by ALDH 
enzymes. Acetate is then converted to acetyl-CoA, the acetyl donor for histone 
acetylation enzymes acting on the amino acids of variable histone proteins (center). Once 
established, histone deacetylases can remove the acetyl group. On the methylation side 
(blue hemisphere), dietary folate is metabolized by MTHFR to methyl tetrahydrofolate 
(MTHF). Meanwhile, dietary choline is converted to betaine. Betaine and MTHF both 
serve as the methyl donor for homocysteine conversion to methionine by the enzyme 
methionine synthase (MS). Methionine next becomes “activated” by methyl 
adenosyltransferase enzymes into the fi nal methyl donor form, known as S-
adenosylmethionine (S-AMe). S-AMe is utilized by both DNA methyltransferases and 
histone methyl transferases to the 5’ carbon of cytosine bases or histone tail residues, 
respectively (center). Solid dots: substrate; Stars: enzymes, which are known to be 
affected by alcohol. 
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2.1.3 Fetal Alcohol Spectrum Disorders (FASD) 
Alcohol exposure during gestation may lead to a host of developmental deficits 
manifested across a range of severities. These include but are not limited to craniofacial 
dysmorphologies, delayed growth, microcephaly, intellectual disabilities, and impaired 
psychosocial skills. Classically, children manifesting growth deficiency, facial 
characteristics, and central nervous system damage are diagnosed under the classification 
known as Fetal Alcohol Syndrome (FAS), affecting 2 out of 1000 live births with 
treatment costs estimated around $5.8 billion in the US alone. FAS is a leading cause of 
non-genetic intellectual disability in the Western world; though today, a broader 
classification is used to cover five diagnostic categories linked to alcohol-related 
developmental deficits. Known as Fetal Alcohol Spectrum Disorders (FASD), this 
category (though not itself a diagnostic term) includes affected patients from categories 
including FAS, partial FAS, alcohol related neurodevelopmental disorder (ARND) and 
alcohol related birth defects (ARBD). Under this umbrella, covering the more mild and 
subtle manifestations of alcohol-related disorders, an estimated ten times more patients 
have been identified compared to classical FAS statistics.  
Despite the range of severities existing within FASD, it is believed that many 
more affected individuals escape the diagnostic criteria and progress through life 
unevaluated and untreated (de Sanctis, Memo et al. 2011). It has been proposed that these 
patients who do not present distinct phenotypes in early-life may go on to experience 
manifestations of the exposure in later life, typically involving impaired cognitive 
plasticity and/or maladaptive behaviors (Famy, Streissguth et al. 1998, O'Connor, Shah et 
al. 2002, Burd, Klug et al. 2003). Due to the extensive evaluation of fetal alcohol 
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exposure as a teratogen and the observation that even minimal exposures during gestation 
can affect the developing brain(Zucca and Valenzuela 2010, Valenzuela, Morton et al. 
2012), there is no acknowledged tolerable level of gestational drinking. While largely 
preventable, it is important to consider that almost half of all women of childbearing age 
are drinkers (CDC 2002). Further, considering that nearly half of all pregnancies are 
unplanned (Harper, Rocca et al. 2015) and that pregnancy detection in these cases can 
surpass four weeks, it becomes increasingly clear that there is a subset of the population 
at perpetual risk for acute exposure.  
Finally, recent findings have uncovered evidence revealing that alcohol-mediated 
effects may actually be transmitted even in the absence of direct fetal exposure, 
presumably through the germ line. Interestingly, offspring of alcohol-exposed parents 
included differential expression of critical neurodevelopmental genes as well as genes 
involved in chromatin remodeling and transcriptional regulation (Przybycien-Szymanska, 
Rao et al. 2014). These findings not only greatly expand the window of offspring 
vulnerability to alcohol but also shed important light on paternal contributions of alcohol-
related developmental dysregulation. Indeed, several studies have reported that paternal 
alcohol consumption is associated with low birth weight, reduced cognitive ability, and 
early pregnancy loss (Hegedus, Alterman et al. 1984, Little and Sing 1987, Henriksen, 
Hjollund et al. 2004). Moreover, the gametic preservation of differential DNA 
methylation of the H19 imprinting region in response to paternal preconception drinking 
has been previously observed (Ouko, Shantikumar et al. 2009) and is hypothesized to be 
maintained in some loci through multiple generations (Sarkar 2016).  
2.1.4 Developmental Alcohol Exposure and DNA Methylation 
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The alteration of intrinsic DNA methylation by alcohol during development was 
perhaps best observed by a study utilizing the agouti viable yellow (A
vy
) mouse mutant 
allele. This allele contains a methylation-sensitive region within the A
vy
 locus which is 
responsible for coat color ranging from yellow (unmethylated) to pseudoagouti (highly 
methylated) (Kaminen-Ahola, Ahola et al. 2010). In this study the agouti locus was 
hypermethylated by prenatal alcohol exposure, though, as referenced previously, the 
nature of alcohol on DNA methylation is bilateral, demonstrating hyper and 
hypomethylation across various models. For example, DNA methylation is decreased by 
alcohol at the H19 imprinting control site of sperm, placenta, and the critical NMDA 
receptor gene Nr2b in cortical neurons (Marutha Ravindran and Ticku 2004, Haycock 
and Ramsay 2009, Ouko, Shantikumar et al. 2009).   
Various other tissues and developmental gene targets of alcohol have been 
previously reviewed (Resendiz, Chen et al. 2013) and a screen of methylation profiles in 
alcohol-exposed neural stem cells and embryos have revealed the alteration of over 1000 
genes including various neurodevelopmental genes (Liu, Balaraman et al. 2009, Zhou, 
Zhao et al. 2011). In late gestation models of alcohol exposure, global DNA methylation 
alterations in the hippocampus and prefrontal cortex have been observed (Otero, Thomas 
et al. 2012, Marjonen, Sierra et al. 2015). The functional implications of alcohol-altered 
DNA methylation signatures is substantiated by the findings that developing neural 
systems exposed to DNMT inhibitors present phenotypic aberrations strikingly similar to 
FASD (Zhou, Chen et al. 2011).  Notwithstanding, alcohol has demonstrated histone 
modification capacity including bidirectional dysregulation of histone 3 (H3) acetylation 
and H3 methylation in neural tissues (Guo, Su et al. 2011, D'Addario, Caputi et al. 2013). 
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Similarly, alcohol has been shown to alter the expression of miRNA profiles in neural 
stem cells (Wang, Zhang et al. 2009), with similar studies suggesting that miRNA 
sensitivity varies according to cell type and differentiation state (Miranda 2012). 
Collectively, evidence of alcohol-sensitive epigenetic mechanisms has mounted across 
gene systems involved in cell-cycle regulation, cell survival, early pro-neuron 
commitment, along with a host of genes implicated in developmental syndromes (Figure 
16).  
2.1.5 Cortical Impact of FASD 
One of the hallmark manifestations of alcohol-related developmental disease is 
cognitive impairment of varying degrees (Green 2007, Jones, Hoyme et al. 2010, 
Jacobson, Jacobson et al. 2011, Lebel, Mattson et al. 2012). The underlying factors of 
protracted neurological deficits of FASD include reduced brain volume, corpus callosum 
volume, and grey matter (Nardelli, Lebel et al. 2011, Yang, Phillips et al. 2012). Imaging 
studies in human FASD patients have confirmed cortical abnormalities compared to 
healthy controls (Sowell, Mattson et al. 2008, Yang, Roussotte et al. 2012, Robertson, 
Narr et al. 2016), although whether alcohol increases or decreases cortical areas is 
unclear. It is likely that a variety of variables across studies may contribute to the range 
of observations. As such, and particularly because of the serious implications of cortical 
dysmorphology to the cognitive and adaptive capacity of the offspring, there remains a 
need to continue to evaluate the effect of fetal alcohol exposure on cortical abnormalities.  
Further study demonstrated that the fundamental aberrations of the forebrain may 
have a basis in cortical apoptosis, neurotrophic factors, migration, and/or morphological 
determination (Aronne, Guadagnoli et al. 2011, Chikhladze, Ramishvili et al. 2011, 
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Lawrence, Otero et al. 2012, Riar, Narasimhan et al. 2016, Lebedeva, Zakharov et al. 
2017). Despite what is known or suspected about the molecular underpinnings of alcohol-
related cortical disruption, the corresponding transcriptional targets have not been well-
studied. Additional questions remain including, what are the exposure thresholds of these 
molecular events (i.e. alcohol dosage, time and length of exposure) and what are the 
mechanisms translating the environmental insult to the genome? 
2.1.6 Research Aims 
The action of alcohol on methyl metabolism and DNA methylation biogenesis 
positions aberrant DNA methylation as a potential mechanism for the neuroteratogenicity 
of alcohol. The previous discussion of normal DNA methylation progression during 
cortical development offers a point of reference by which to evaluate alcohol-related 
dysregulation of the program. We hypothesized that the DNA methylation program is 
predictably responsive to fetal alcohol exposure and may be a mechanism informing the 
neurodevelopmental transcriptome of the teratogenicity of exposure.  The investigative 
approach included evaluating parallel DNA methylation makers and methylation 
correlates alongside multiple cues of cortical laminar formation in a mouse model of 
FASD.  We found that fetal alcohol exposure drives cortical abnormalities in the wake of 
DNA methylation dysregulation. These findings shed important light on how fetal insults 
may establish, maintain, and manifest cognitive and behavioral deficits.  
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Figure 16. Epigenetically-modified neurodevelopmental gene targets of alcohol 
Alcohol is a teratogen with known capabilities to alter the epigenome. Highlighted here 
are just a fraction of genes within various biological pathways of known vulnerability to 
ethanol-mediated epigenetic alteration. Also depicted are genes associated with known 
developmental syndromes and their epigenetic alteration. Genes are more specifically 
discussed and referenced in the text. 
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2.2 MATERIALS AND METHODS 
2.2.1 Overview of experimental prenatal alcohol exposure 
In this study, alcohol was administered via liquid diet according to the paradigm 
illustrated in Figure 17A. The time course and types of analysis are summarized in 
Figure 17B. Mice were conditioned to receive the liquid diet prior to mating. After 
conception, the liquid diet was re-introduced and alcohol was administered from E7–E16 
(corresponding to brain development in the late first and second human trimester 
equivalent). The 4% alcohol liquid diet (v/v) administered in this paradigm has been 
reported in previous and parallel studies to produce a range of blood ethanol 
concentrations (BEC) of 100–200 mg/dL (Anthony, Vinci-Booher et al. 2010, Chen, 
Ozturk et al. 2013). Briefly, six non-pregnant females receiving 4% v/v alcohol were 
used for BEC analysis. Blood samples were harvested through the tail vein 2 h or 6 h 
after introducing the fresh alcohol-PMI diet at 10:00 AM during the dark cycle, on 
days 2, 4 and 6 during treatment. Adequate volume of blood (15 µL) was collected in 
heparinized tubes, and plasma was isolated through centrifugation and stored at −80 °C 
prior to analysis with a gas chromatograph (GC, Agilent Technologies; model 6890). 
Each sample was analyzed in duplicate. 
Under these treatments, no significant difference in dam body weight was 
observed from the start of treatment (E7) to E14, though PF and Alcohol groups did 
exhibit lower gestational weights during E15 and E16 (Chen, Ozturk et al. 2013). While 
our previous studies were aimed at the early neural tube (E10) and early brain primodium 
(E15), the current study focused on the stage prior to birth, at the peak of rodent cortical 
layer formation (E17). 
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2.2.2 Animals and treatments 
All mice were used in accordance with National Institute of Health and Indiana 
University Animal Care and Use (IACUC) guidelines. The protocol was approved by the 
Laboratory Animal Resource Center (LARC) animal ethics committee of Indiana 
University. C57BL/6 (B6) (10–14 weeks old, ~20 g body weight) nulliparous female 
mice (Harlan, Inc., Indianapolis, IN) were used in the study. Mouse breeders were 
individually housed upon arrival and acclimated for at least one week before mating. The 
mice were maintained on a 12-h reverse light-dark cycle (lights on: 10:00 PM–
10:00 AM) and were provided laboratory chow and water ad libitum. Mice were then 
randomly assigned to three treatment groups: Chow (N = 7), Pair-Fed (PF, N = 5), and 
Alcohol (Alc, N = 7). Each litter was considered N = 1; the littermates of each dam were 
distributed for the analyses described in the following sections. The PF and Alc groups 
were pre-treated with liquid diet (see below) for 7 days before mating. Females were bred 
with male breeders for a 2-h period (10:00 AM to 12:00 noon). All animals were mated 
daily over a period of no more than 3 weeks, during which time all animals were on 
ad libitum chow and water diets. The presence of a vaginal plug at the end of the 2-h 
mating session was considered as indicative of conceptus, and that hour was designated 
as hour 0 and embryonic day (E) 0. A liquid-diet paradigm was carried out as previously 
detailed (Chen, Ozturk et al. 2013). Briefly, all alcohol treatment groups received 
4% alcohol v/v in liquid diet (Purina Micro-Stabilized Diet [PMI], Purina Mills Inc., 
Richmond, Indiana) as instructed by supplier with 4% w/v sucrose added, and 
administered using a 35-mL drinking tube (Dyets Inc., NY). The PF group was given the 
PMI diet mixture with the addition of maltose dextran (MD) (to substitute alcohol 
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calories). The volume of the PF diet was restricted to that of a matched dam from the 
alcohol group throughout the course of treatment. The Chow group was maintained on a 
standard chow diet and water ad libitum throughout gestation. On E5, pregnant dams in 
PF and Alc groups were placed on an unrestricted PF liquid diet for acclimation. Either 
4% v/v alcohol (Alc group) or restricted volume isocaloric liquid diet (PF group) was 
initiated on E7 through the end of E16, after which all liquid diets resumed standard lab 
chow diet. On E17, dams from all three groups were euthanized for embryo harvest. In 
addition, E16 embryos from Chow groups (N = 4) were specifically harvested for 
developmental stage comparison (Figure 17). 
2.2.3 Embryo isolation and tissue preparation 
After deep CO2 euthanasia, embryos were harvested from dams at E17 by 
removal from the embryonic sack. Each embryo was either immersion-fixed in 20 mL of 
fixative prepared from 4% paraformaldehyde (PFA) for immunohistochemistry or 
immediately dissected for brain tissue and snap-frozen and stored in a −80 °C freezer 
until Western blot or global methylation analysis. Fixed embryos were subsequently 
weighed, dissected for brains, gelatin-blocked, and post-fixed for at least 24 h at 4 °C 
before sectioning was performed for immunocytochemistry (average N: Chow = 5, Alc 
N = 5, and PF N = 4; animal number for each staining is shown in Results). 
2.2.4 Immunohistochemistry  
One Alc and either one PF or Chow brain were embedded in a single 10% gelatin 
block with careful rostrocaudal and dorsoventral alignments. Gelatin blocks were fixed 
with 4% PFA and sectioned in 40-µm thick coronal sections on a floating vibratome 
(Leica Microsystems; Buffalo Grove, IL). The section pairs (Alc-PF or Alc-Chow) were 
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processed equally in all immunohistochemical procedures. The section pairs were then 
cleared of endogenous peroxidases using 10% H2O2 in phosphate-buffered saline (PBS) 
for 10 min and permeabilized with 1% TritonX-100 in PBS for 30 min before incubation 
with a primary antibody diluted in goat kit (1.5% goat serum, 0.1% TritonX-100 in PBS) 
for 18 h at room temperature. Epigenetic antibodies used in this study are summarized in 
Table 3 below. The section pairs were then incubated for 90 min in goat anti-rabbit IgG 
or goat anti-mouse secondary antibodies conjugated with biotin (Jackson 
ImmunoResearch, West Grove, PA) followed by Streptavidin-AP (1:500, Jackson 
ImmunoResearch, West Grove, PA) for 90 min. The immunostaining was visualized by 
incubation in 0.05% 3,3′-diaminobenzidine (DAB) and 0.003% H2O2 over an average of 
3–8 min, followed by counterstaining with methyl green. All stainings were 
photographed under light microscopy for cellular analysis (Leitz Orthoplan 2 microscope; 
Ernst Leitz GMBH, Wetzlar, Germany). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
80 
Table 3. Antibodies used for DNA methylation assessment in the E17 cortex 
Primary Antibodies Company Catalog # dilution 
predicted 
wt. 
5-methylcytosine Eurogentec 
BI-MECY-
0100 1:2000 N/A 
5-methylcytosine Active Motif AM61255 1:2000 N/A 
5-hydroxymethylcytosine Active Motif AM39769 1:3000 N/A 
MBD1 Santa Cruz Biotech. sc-10221 1:200 ~89 kDa 
MeCP2 Cell Signaling Tech. D4F3XP-R 1:1000 75 kDa 
Ki67 Novus Biologicals 
NB110-
89717 1:500 324 kDa 
Tbr2 Millipore AB2283 1:500 58 kDa 
P2Y1 Millipore AB9263 1:1000 ~42 kDa 
NeuN Cell Signaling Tech. D3S3I 1:500 46-55 kDa 
ß Tubulin Abcam  ab15568 1:2000 55 kDa 
GAPDH Abcam  ab8245 1:2000 37 kDa 
Secondary Antibodies         
Goat anti Rabbit biotinylated 
Jackson 
ImmunoResearch 
111-065-
003 1:500 ~160 kDa 
Horse anti Mouse biotinylated Vector  Laboratories BA-2000 1:500 
~152-165 
kDa 
Donkey anti Guinea Pig 
biotinylated Vector  Laboratories BA-7000 1:500 
~152-165 
kDa 
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2.2.5 Densitometry analysis (H score) and cortical thickness assessment 
Upon observing epigenetic immunostainings under a light microscope, the 
immunoreactive nuclei (based on evidence of the brown-color DAB reactions) exhibited 
a differential staining profile within different subcortical regions. In order to reflect this 
differential expression, we employed H scoring for nuclear densitometry analysis (Singh, 
Shiue et al. 2009, Chen, Ozturk et al. 2013) of each cell nucleus within each individual 
selected subcortical region (VZ+SVZ, SP, and CP). 
For the analysis, all immunostained pictures were taken using a Leitz Orthoplan 2 
microscope with a Spot RT color camera (Diagnostic Instruments, Inc., Sterling Heights, 
MI). Bright-field images were taken with consistent setup and exposure time for each 
antibody staining. Immunostained images were converted to the 16-bit color format, and 
staining intensity was measured using Image J (National Institutes of Health, Bethesda, 
MD). To measure the subcortical regions of prefrontal neocortex, a rectangular box of 
equal dimensions (150 μm in width) was selected at the same rostro-caudal level of E17 
coronal brain sections. Lateral ventricle and corpus callosum were considered as 
landmarks of the prefrontal cortex. The staining intensities of marks were defined based 
on the optical density (OP) values of the nuclei in each subregion of neocortex as 
follows: Absent – 0 – (OD = 90–120); Weak – 1 – (OD = 120–150); Moderate – 2 – 
(OD = 150–180); and High – 3 – (OD = 180–210). An equivalent number of cells were 
evaluated across each section so that cell number would not play a role in the H score 
percentages. Overall, the immunohistochemical H score of each subcortical region was 
obtained by the following formula:  
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3 × percentage of highly stained nuclei + 2 × percentage of moderately stained nuclei + 
percentage of weakly stained nuclei, giving a range of 0–400.  
Cortical thickness was assessed using two independent immunostainings: NeuN 
and 5mC. Anterior sections of the frontal cortex were rostro-caudally matched between 
groups and selected for cortical measurements. ImageJ software was used to assess 
cortical thickness (measured from the base of the SVZ to the edge of the MZ). 
Subsequently, individual cortical layers were measured (layers were clearly demarcated 
by cortical cytoarchitecture). 
2.2.6 Cell Counting and Morphometric Analyses 
 Automated cell counts were used to detect cells positive for Ki67 due to the 
presentation of the immunosignal being punctate and homogenous. In this experiment, 
sections stained for Ki67 were processed using Image J software according to the 
following protocol: color deconvolution plugin was used to isolate the brown DAB 
signal, images were inverted to 8-bit, automated thresholding was performed, and 
automated particle analysis was performed on the SVZ/VZ region with the selection 
parameters set to 0.25-1.0 circularity (where 1.0 equals a perfect circle) and size inclusion 
being 50-600 (pixel^2). Results were presented as number of particles (cells) detected per 
sample ±SEM. 
To assess cell density, cortical sections from 5mC staining procedures were 
counterstained by Methyl-Green dye (Nissl) which allowed for the visualization of 5mC 
positive as well as 5mC negative nuclei. After Brightfield imaging under a light 
microscope (see “Densitometry analysis and cortical thickness assessment”), a select 
region targeting the mid cortical plate was binned (0.025mm
2
) across all brain sections at 
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a high magnification. Nuclei were counted using the multi-point counting tool on ImageJ 
software (NIH, Bethesda MA). At least two sections taken from the anterior cortex of 
each subject were averaged for total nuclei/area. Additionally, at least two subjects from 
each litter were represented in the assessment (where n=litter).  
A similar procedure was used to analyze nuclear morphology. Due to the non- 
circularity of some cortical cells, the major and minor axes of each nuclei were measured 
across the anterior CP. In some cases, where nuclei were quite circular, the nuclei length 
and diameter were arbitrarily selected and interchangeable. In cases of non-circular 
morphology, the major (longest) and minor (perpendicular to major) axis were clearly 
distinct and thus represented independently. A straight line tool was used in all cases to 
measure the major and minor axes of the nuclei. Finally, nuclear area was calculated 
based on the following equations: circular area=πr2 (where r=minor axis/2) and ellipse 
area=πab (where a=minor axis/2, b=major axis/2). Distinction between circular and non-
circular nuclei was made if major axis was ≥1.5 times the minor axis. At least 100 nuclei 
from the selected region were measured per cortical section and at least two sections per 
subject were represented in the average. Each N represents one litter in these 
assessments. To help minimize experimenter bias, images were randomly examined, 
meaning, experimental groups were not evaluated as continuous cohorts throughout the 
imaging session.  
2.2.7 Western blot of the methylation-binding protein MeCP2 
Western blotting was carried out to confirm MeCP2 protein expression 
differences at E17 between groups, which were initially observed in MeCP2 
immunostainings. From the preliminary MeCP2 staining, we noticed that MeCP2 was 
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unilaterally upregulated by alcohol across all cortical layers and in various other brain 
regions, such as the hippocampus and cerebellum. As such, Western blots of the entire 
E17 fetal brain were used (N = 4 each) following a standard protocol (Zhou, Patel et al. 
1999, Anthony, Zhou et al. 2008, Mason, Anthony et al. 2012). Nuclear protein was 
isolated from tissue lysates using NE-PER nuclear and cytoplasmic reagents (Thermo 
Fischer Scientific, Waltham, MA), and sample concentrations were evaluated against a 
BSA standard curve at OD595. All samples were run in triplicate on two independent gels 
for each protein examined. Immunoreactive blots were detected using ECL Western 
Blotting Detection Kit (Thermo Fisher Scientific, Rockford, IL, USA; RPN2108) and 
exposed to a biomolecular imaging system (ImageQuant, LAS 4000). Densitometric 
comparisons were made with Image J software. GAPDH density measurements were 
used as loading controls. All changes in protein expression were reported as a percentage 
change compared to Chow and PF groups, with a minimum of four samples/treatment 
group. Statistical analysis was performed by one-way ANOVA on MedCalc software. 
2.2.8 Global DNA methylation analysis 
Fetal brains were isolated and microdissected under a dissection microscope 
(Leica MZ6, Leica Microsystems). Neocortical brain tissues were separated from 
subcortical brain tissue using the borders of the nascent internal capsule as a visual guide. 
DNA extraction and purification were subsequently performed using silica-based spin-
column purification (DNeasy Blood and Tissue kit, Qiagen) according to manufacturer’s 
instructions. Purified DNA was quantified by spectrophotometric absorption at 230, 260, 
and 280 nm, and the quality and concentration were calculated as the A260/A230 and 
A260/A280 ratio (Nanodrop 2000, Thermo Scientific). An average of 100–200 ng of 
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genomic DNA was used for DNA global methylation analysis performed with the 
MethylFlash Methylated DNA Quantification Kit and MethylFlash Hydroxymethylated 
DNA Quantification Kit (Colorimetric; Epigentek Group) according to the manufacturer's 
instructions. OD values were determined using a PHERAstar FSX microplate reader and 
MARS Data Analysis Software (BMG Labtech, Cary, NC). Methylation levels were 
estimated using a standard curve of methylated DNA standards according to the 
manufacturer’s instructions.  Presented values reflect the ratio of methylation relative to 
the control group (normalized).    
2.2.9 Statistical Analysis  
A Kruskal-Wallis test was used for non-parametric statistical analysis to address 
differences between the three groups while Conover post-hoc testing was used to identify 
differences between each of the groups. Statistical analysis was performed using 
MedCalc software. All data are presented as Mean±Standard Error of the Mean (SEM) 
and sample sizes reflect litter number represented.  
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Figure 17: Summary of experimental procedures 
(A) C57BL/6J females were conditioned to receive the liquid diet devoid of alcohol for a 
period of seven days preceding mating. After conception, the liquid diet was re-
introduced at E5 and either alcohol or an isocaloric pairfed diet was administered from 
E7-E16 (equivalent to the late first and second human trimesters). Each color in the 
schema represents a specific treatment: green (standard pellet and water ad libitum), 
yellow (alcohol-free PMI liquid diet), or red (4% v/v alcohol PMI liquid diet ad libitum). 
(B) At E17, brains from each litter across the three groups were processed for either 
immunophenotypic or molecular assessments. Alc (alcohol); IHC 
(immunohistochemistry) and PF (pair-fed) 
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2.3 RESULTS 
2.3.1 Alcohol-Induced Cortical Thinning in the Embryonic Cortex 
A mouse model of FASD was used in this study to evaluate aberrant DNA 
methylation during cortical laminar formation. We observed that alcohol-induced 
aberrations of phenotypic and epigenetic features are associated in the embryonic cortex, 
providing evidence that the disruption of the intrinsic DNA methylation program may be 
a mechanism for the establishment of cortical dysfunction.  
One of the most prominent phenotypes observed in this experimental animal 
model was the occurrence of reduced neocortical thickness, which was consistent with 
previous observations at E15 (Zhou, Sari et al. 2003, Zhou, Sari et al. 2005). A closer 
layer-by-layer analysis revealed a reduction in cortical plate (CP) size (Figure 18J, 
P<0.005) as well as an increase in the VZ and SVZ in proportion to the total cortical 
length (Figure 18K, P<0.005). Further evidence of neocortical thinning was demonstrated 
by the abnormal expansion of lateral ventricles in the Alc group compared to the Chow 
and PF control groups (Figure.18A–C). To examine the molecular contributors of cortical 
thinning in the alcohol-affected cortex, several phenotypic markers were examined across 
the cortical strata.   
2.3.2 Molecular Correlates of Alcohol-Induced Cortical Thinning 
Aberrations of the ventricular zone during corticogenesis may significantly 
impact long-term and phenotypic and anatomical outcomes. The source of radial glia 
proliferation and intermediate progenitor specification, the ventricular regions of the 
cortex are crucial for radial migration of cortical progenitors and early cortical 
specification. Genetic studies have demonstrated that intrinsic and morphogenic signals 
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at the VZ and SVZ precisely govern the emergence of RGCs and IPCs through the 
sequential expression of gene networks. For example, the onset of cortical neurogenesis 
requires the suppression of cell adhesion elements such that neuroepithelial cells may 
adopt the elongated morphology of an RGC. These transitions are thought to be regulated 
at least in part by the expression of key factors such as Pax6 and vimentin, among others 
(Taverna, Gotz et al. 2014). Similarly, a distinguishing feature of SVZ versus VZ abiding 
progenitors appears to be the expression of the transcription factor Tbr2 (Englund, Fink et 
al. 2005). Tbr2 expression during corticogenesis has been linked to cortical folding, 
social behaviors in adults, and early lineage specification of cortical glutamatergic 
neurons (Vasistha, Garcia-Moreno et al. 2015, Belinson, Nakatani et al. 2016, Toda, 
Shinmyo et al. 2016).  
First, we examined the proliferative capacity of cells at the ventricular regions 
using the maker Ki67, a nuclear cell proliferation marker. In the VZ/SVZ, a significant 
reduction of Ki67 (+) cells (Figure.19A-C, P < 0.05) was observed compared to Chow 
and PF controls. This finding echoes the inhibitory effects of alcohol on neurogenesis in 
the hippocampus observed across various models of exposure (Broadwater, Liu et al. 
2014, Gil-Mohapel, Titterness et al. 2014, Golub, Zhou et al. 2015, Xu, Yang et al. 
2015). And while loss of cortical neurons has been previously reported in developmental 
alcohol models (Ikonomidou, Bittigau et al. 2000, Coleman, Oguz et al. 2012), 
diminished proliferation of cortical progenitors as an underlying factor has not been 
previously substantiated in vivo. One study of E18 Tbr2-expressing neuroblasts did 
reveal, however, that though alcohol did not increase apoptosis, cortical basal progenitors 
were arrested in G1 phase (Riar, Narasimhan et al. 2016).  
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Next, we evaluated the expression of NeuN, a nuclear marker of neuronal 
maturity which is observed in post-mitotic neurons. While NeuN was absent in the 
proliferating zones, a significant reduction was observed in the E17 Alc group compared 
to the Chow and PF groups in the cortical subplate (SP)(Figure.19D–F, P < 0.05). In the 
cortical plate (CP), a similar reduction of NeuN expressing cells was detected (Figure 
20H, P < 0.05). Morphological examination of CP cells further demonstrated that alcohol 
hinders the progression of immature progenitors toward mature cortical neurons, as 
denoted by the increased presentation of ellipsoidal shapes in the place of more rounded  
nuclei (Figure 20D-F).  
Further, a notable reduction of Tbr2 immunoreactivity was evident in the E17 Alc 
group compared to E17 Chow and PF control groups (Figure.18A–C). When further 
compared to  E16 Chow stage controls, the E17 alcohol group was anatomically and 
phenotypically reminiscent of E16 Chow controls (Figure.18C–D), indicating a cortical 
developmental delay of around one gestational day. These observations agree with the 
findings of Rair et al in E15-E18 embryonic cerebral cortex (Riar, Narasimhan et al. 
2016).  
2.3.3 The DNA Methylation Program is Modified by Fetal Alcohol Exposure 
Parallel epigenetic assessment was performed alongside phenotypic markers of 
cortical development. DNA methylation in the form of 5mC was elevated in the alcohol 
group ventricular zones, SP, and CP, though statistical significance was only observed in 
the CP (Figure 20G, P<0.05). A secondary feature observed in the 5mC assessment was 
the heterochromatin, punctate expression within the nuclei of alcohol animals. 
Comparatively, control cortices exhibited round nuclei with a euchromatin distribution of 
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5mC within the CP (Figure 20D-F). This feature has been observed in embryonic neural 
tube and hippocampal examinations of previous FASD models (Zhou, Chen et al. 2011, 
Chen, Ozturk et al. 2013) and perpetuates the notion that the intranuclear re-distribution 
of DNA methylation marks like 5mC may be essential intrinsic components of cellular 
development.  
The 5hmC marker demonstrated a similar alcohol-induced hypermethylation in 
the CP, though unchanged in the SP and diminished by alcohol in the SVZ/VZ (Figure 
21D, P<0.05). 5hmC-positive nuclei in the alcohol group did not apparently undergo 
intranuclear re-organization during development. Finally, the methyl-binding protein 
MeCP2 demonstrated a marked alcohol-induced increase (Figure 22F, P<0.05) which 
was concurrent with DNA hypermethylation. Assessed region wide by Western Blot, a 
global increase was concurrently observed (Figure 22E, P<0.005).  
2.3.4 Global versus Cell-Specific Characterization of DNA Methylation in the FASD 
Cortex 
A common representation in previous epigenetic investigations has included the 
“global” assessment of epigenetic change. From previous work, we and others have 
found that DNA methylation (and likely various other epigenetic modifications) are 
context-specific and thus cell-unique. Because of this, global assessments may be limited 
in their ability to accurately portray epigenetic patterns. In order to compare our study 
with previous DNA methylation assessments and to offer a contrasting tissue-wide view, 
we performed an independent molecular 5mC and 5hmC analysis in the E17 neocortex. 
5mC analysis demonstrated that alcohol induced a global reduction in DNA methylation 
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compared to Chow and PF animals (Figure 23A, P < 0.01). Additionally, molecular 
5hmC levels were overall reduced compared to Chow controls (Figure 23B, P < 0.05).  
These observations present a different perspective compared to the patterns 
observed with 5mC and 5hmC in the cortical plate. The inclusion of cortical interneurons 
and non-neuronal cells in the genomic DNA of the cortical tissue or perhaps the mixing 
of cells with differential DNA methylation levels is likely responsible for this contrasting 
pattern. Despite that, alcohol-effects were persistently detectable, even on a global scale 
and speak to the potent nature of the teratogen on the cortical tissue at large.  
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Figure 18: Alcohol reduces cortical thickness and Tbr2-im expression in the E17 frontal 
cortex  
Structural abnormalities were observed during phenotypic investigation. Notably, the 
thickness of cortical plate (J) as well as the entire thickness of frontal cortex (I) were 
reduced in alcohol group frontal cortex as compared to their Chow and PF control 
cortices (A-C). Fetal alcohol exposure also increased the proportion of SVZ+VZ/entire 
cortical thickness (K) as compared to controls. Lateral Ventricle (LV) expansion was also 
observed in E17 Alcohol cortices (A-C). (G) Finally, Tbr2-im (a marker for neural 
progenitor migration) was normally observed as a radially extending fiber ascending 
from the base of the lateral ventricle up to the pial surface. Alcohol noticeably reduced 
Tbr2 immunoreactivity in the CP. E16 Chow brains were used as developmental stage 
controls and more closely resembled the E17 Alcohol developmental state than E17 
Chow (C-D,G-H). Quantitative measurements among the 3 groups were analyzed by 
One-way ANOVA and the difference between paired groups were compared by student t-
test. *P<0.05, **P<0.005. N (structural analysis) = Chow (5), PF (5), Alc (5). N (Tbr2-im 
analysis)=Chow (3) , PF (3), Alc (3), E16 Chow (3). SVZ/VZ (Subventricular 
Zone/Ventricular Zone); IZ (Intermediate Zone); SP (Subplate) and CP (Cortical plate).  
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Figure 19: Alcohol reduces ventricular proliferation and neuronal maturation in the E17 
frontal cortex  
Representative cortical column of E17 Chow (A,D), PF (B,E), and (C,F) Alc group 
coronal sections for Ki67 and NeuN immunostaining. Fetal alcohol-induced reduction of 
Ki67 immunoreactivity was observed mainly in the SVZ/VZ zone, the neuroepithelial 
cellular zones. Quantitative assessment of Ki67+ cells further confirmed an alcohol-
related reduction in the SVZ/VZ zone (G);  N=Chow (5), PF (4), Alc (7). Alcohol 
reduced NeuN-im throughout cortical SP and CP layers (F) compared to Chow (D) and 
PF (C). No significant change was observed between Chow and PF groups. Quantitative 
assessment of NeuN-im was further quantified by single-cell density analysis (H-Scoring) 
across the three groups (H). *p < 0.05. SVZ/VZ (Subventricular Zone/Ventricular Zone); 
IZ (Intermediate Zone); SP (Subplate) and CP (Cortical plate) 
G 
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Figure 20: Alcohol inhibits 5mC and cellular maturity in the E17 cortical plate  
(A-C) E17 frontal cortex across three groups (Chow, PF, and Alc). Red boxed areas in 
CP (A-C) was enlarged in all D-F. While no change in 5mC-im was detected across the 
groups in the SVZ/VZ or SP, 5mC was significantly increased in the Alcohol group CP 
(G). Enlarged CP areas further demonstrated that alcohol induced a morphological delay 
of CP neurons (as observed by their ellipsoidal shape and granular intranuclear 5mC-im 
distribution) compared to the mature, roundedness of Chow and PF CP neurons (D-F). 
*P<0.05.  N=Chow (5) , PF (4), Alc (5). LV (Lateral Ventricle); SVZ/VZ (Subventricular 
Zone/Ventricular Zone); IZ (Intermediate Zone); SP (Subplate), CP (Cortical plate) and 
MZ (Marginal Zone).  
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Figure 21: 5-hmC-im is reduced in the lower cortex but upregulated in the E17 cortical 
plate  
(A) Alcohol reduced 5hmC-im at the cortical SVZ/VZ layers compared to Chow and PF 
controls (B), while no significant change was observed between controls (D). At the SP 
cortical layer, only significant alternation is detected as an increase in PF group as 
compared to both Chow and Alc groups. (A-D) A marked increase of 5hmC-im was 
observed at the CP region in both the PF and Alc groups as compared to Chow group, 
while a significant increment was also evident at the Alc group CP as compared to PF 
group . * P<0.05.  N=Chow (5), PF (4), Alc (5). CP (cortical plate); MZ (marginal zone); 
SP (subplate); SVZ (subventricular zone) and VZ (Ventricular zone).  
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Figure 22: Alcohol-induced MeCP2 up-regulation in the E17 cortex 
(A-C) Representative columns from the frontal of E17 cortex across the three groups.  
(C,F) Alcohol increased MeCP2-im throughout cortical SVZ/VZ, SP and CP layers 
compared to controls. No significant change was observed between Chow and PF groups. 
* P<0.05.  N=Chow (5), PF (4), Alc (5). (D-E) Densitometry of MeCP2 whole-brain 
western blot (WB) showed a significant increase of MeCP2 expression at E17 in the Alc 
group compared to its counterparts. (One-way ANOVA: F=6.95, P<0.05). Post-hoc 
analysis showed no significant difference between PF and Chow groups. Western Blot 
band intensity was normalized to GAPDH as an internal control. N=4 (Chow), PF (3), 
Alc (4). * P<0.05  **P<0.005. WB (Western Blot); blots are presented as cropped 
segments.  
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Figure 23. Quantitative DNA methylation (5-mC and 5-hmC) reveals tissue-wide 
alcohol-related de-methylation in the E17 cortex  
Global DNA methylation (5mC) was significantly decreased in the neocortex at E17 (A). 
Global DNA methylation (5hmC) was also significantly decreased in the neocortex in 
response to fetal alcohol exposure (B). Means of the three groups were compared by non-
parametric Kruskal-Wallis test followed by conover post-hoc test for multiple 
comparisons. *p < 0.05. **p < 0.01. Chow (n=6), Pair-fed (n=6), Alcohol (n=6). 
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Figure 24. Cortical plate density is unchanged by alcohol but nuclear morphology is 
negatively impacted  
Cortical plate nuclear density was unchanged by experimental treatment (p=0.848)(A). 
Nuclear length was decreased by alcohol treatment (B) and nuclear diameter was 
similarly decreased (C). Nuclear area of circular and ellipsoidal neurons was extrapolated 
from major and minor axes. Alcohol nuclear area was significantly decreased compared 
to both Chow and PF control groups (D). Means of the three groups were compared by 
non-parametric Kruskal-Wallis test followed by Conover post-hoc test for multiple 
comparisons. *p < 0.05, **p < 0.005.  
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2.4 DISCUSSION 
2.4.1 Cortical Dysmorphology in FASD 
Head circumference has been commonly used in the assessment of brain 
developmental disorders including some subsets of FASD. A recent study confirmed a 
significant positive correlation between head circumference, brain volume and IQ scores 
in patients (age 5-19) prenatally exposed to alcohol (Treit, Zhou et al. 2016). Moreover, 
the study demonstrated that the relationship was predictable from early to late adulthood, 
indicating that structural deficits persist for a sizable length of time after exposure. These 
findings confirm previous work concluding that gestational alcohol exposure (of varying 
degrees) may lead to developmental growth abnormalities across the brain, manifesting 
most notably in reduced brain volume and corpus callosum malformations (Lebel, 
Mattson et al. 2012). More importantly, these structural abnormalities may be underlying 
factors for the cognitive impairment reported in FASD. For example, callosal 
dysmorphologies have been linked to verbal learning, motor ability, and executive 
function while hippocampal volume has been linked to verbal ability and recall as 
reviewed by Lebel et al (Lebel, Mattson et al. 2012). Interestingly, verbal learning has 
also been associated with structural deficits in the cerebellum and the dorsal frontal 
cortex (O'Hare, Kan et al. 2005, Sowell, Mattson et al. 2008). Though seemingly 
straightforward, the structural-functional impact of alcohol is probably more complex in 
the developing cortex as evidenced by previous studies that have found either no 
significant correlation or alcohol-mediated increases in cortical thickness.  
In reviewing cortical size particularly, as a precedent to the work performed 
herein, the complexity of alcohol on the cortical structure was continually revealed. 
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Disruption of neocortical thickness as a consequence of developmental alcohol exposure 
has been documented in animal studies, including various time courses and doses of 
alcohol (Table 4). Cortical thinning is apparently a continuous effect occurring from mid-
gestation (Zhou, Sari et al. 2004, Aronne, Evrard et al. 2008) to young adulthood in 
rodent models. Alcohol-induced cortical abnormalities, however, are not unilateral and 
vary across different cortical regions postnatally (Abbott, Kozanian et al. 2016). In a 
similar vein, human studies have rarely agreed with the structural effects observed in 
alcohol rodent models. Longitudinal neuroimaging studies of FASD human patients have 
reported that while cortical thinning appears to be a normal feature of both FASD 
adolescents and healthy controls, FASD patients are distinctly affected in the left middle 
frontal, bilateral precentral, bilateral precuneus and paracingulate, left inferior and 
bilateral fusiform gyri (Zhou, Lebel et al. 2011). On the other hand, cross-sectional 
neuroimaging studies have demonstrated that heavy prenatal exposure to alcohol could 
result in cortical thickening up to 1.2 mm in the bilateral temporal, bilateral inferior 
parietal and right lateral frontal cortex (Sowell, Mattson et al. 2008). Another FASD 
adolescent, multi-site study similarly showed thicker frontal, temporal and parietal 
cortices (Yang, Roussotte et al. 2012).  
The diversity of cortical phenotypes may be rooted in variable factors such as 
patient age range, co-morbidities (e.g. ADHD) and exposures (e.g. acute, chronic, 
combinatorial with tobacco, etc.), and other unforeseeable factors rendering them 
incompatible with more controlled rodent studies. A recent analysis by Robertson et al 
compared regional cortical thickness across continuous measures of prenatal exposure 
and found that region-specific cortical thinning was inversely related to dose and 
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frequency of prenatal exposure (Robertson, Narr et al. 2016). Another important 
distinction between human and animal models is the reported effect of alcohol on cortical 
folding (De Guio, Mangin et al. 2014), which may limit the ability to cross reference the 
two types of studies. All things considered, there are many factors to weigh in comparing 
cortical phenotypes across studies. For the purpose of this study, we attempted to 
reconcile our results with cortical phenotypes observed in rodent models of prenatal 
alcohol exposure with comparable Blood Alcohol Concentration (BEC) levels (Table 4). 
Our study demonstrated distinct cortical thinning, which was subsequently examined at 
the cellular level using phenotypic and epigenetic markers.  
2.4.2 Epigenetic Correlates of the Molecular Drivers of Cortical Dysmorphology 
At the base of the cortical column, the neuroepithelial zones demonstrated a 
reduced expression of the proliferation marker Ki67 in our study. Though alcohol-related 
reduction of proliferation in neurogenic zones has been previously observed in the 
hippocampus and thalamus (Leasure and Nixon 2010, Mooney and Miller 2011, 
Broadwater, Liu et al. 2014), few examples have been documented in the cortex (Huang, 
He et al. 2015). In several cases, alcohol-diminished neurogenesis was concomitant with 
regional volume reduction (Kashyap, Frey et al. 2011, Coleman, Oguz et al. 2012) and 
cognitive and behavioral outcomes (Ehlers, Liu et al. 2013, Golub, Zhou et al. 2015). 
Some of the neurogenic gene networks proposed to be altered by gestational alcohol 
include Adora2a, Cxxl1, Dlg4, Hes1, Nptx1, Vegfa, Fgf13, Ndn, and Sox3. Interestingly, 
the study also identified decreased Dnmt expression, suggesting that alcohol may 
dysregulate DNA methylation profiles during proliferation (Tyler and Allan 2014). 
Indeed, our findings relating to the neurogenic zones of the embryonic cortex revealed 
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that 5hmC (though not 5mC) were diminished by fetal alcohol exposure. Similarly, in the 
dentate gyrus, a previous study employing our alcohol model demonstrated reduced 
5hmC in the alcohol group (Chen, Ozturk et al. 2013). The observation that the more 
abundant 5mC was unchanged by treatment in the SVZ/VZ may perhaps be rooted in its 
dual nature in both neurogenesis (mitosis) and the (post-mitotic) production of 
intermediate progenitors, two prominent features of the neurogenic zone. It is possible 
that while 5hmC plays a more linear role in proliferation, 5mC may exhibit opposing 
patterns in mitotic versus post-mitotic events in the region, resulting in an overall 
unchanged signal.  
Despite reduction in proliferation, our laminar assessment demonstrated that the 
neurogenic SVZ/VZ was actually increased in size (relative to the total cortical length) in 
the alcohol experimental group. One possible explanation may be that while alcohol 
reduces proliferation (presumably diminishing cell number in the region), it also hinders 
the progression of basal progenitors, prolonging their occupancy in the SVZ/VZ and 
delaying their migration into the IZ and upper layers. During corticogenesis, intermediate 
progenitors are proposed to account for most of the production of mature cortical neurons 
(Englund, Fink et al. 2005), suggesting that their timely development may bear 
significant functional consequences. Evidence for the delayed progression of intermediate 
progenitors in the SVZ/VZ is provided by the observed reduction of the transcription 
factor Tbr2 both here and in a previous developmental alcohol study (Riar, Narasimhan et 
al. 2016). Tbr2 is thought to be a unique indicator of neuron-fated progenitors and has 
been demonstrated in various studies to be critical for conferring neuronal subtype 
identity. Interestingly, conditional knockout of Tbr2 during corticogenesis produces 
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concomitant reduction of cortical surface (though not cortical thickness) (Mihalas, Elsen 
et al. 2016). Other roles for Tbr2 in neuronal differentiation include cellular migration, 
including subpalial migration of GABAergic neurons to the cortical SVZ (Sessa, Mao et 
al. 2010). In the olfactory bulb, a similar expansion of the subventricular zone-rostral 
migratory stream was observed in response to diminished Tbr2 (Kahoud, Elsen et al. 
2014).  
Additional evidence for the alcohol-delayed progression of neuron-fated 
progenitors in the neurogenic zones was provided by the observed reduction of the 
neuronal marker NeuN in the subplate and cortical plate. NeuN is a DNA/RNA-binding 
protein that is almost exclusively found in post-mitotic neuronal nuclei. Often used as a 
biomarker of neuronal maturity, in previous studies of chronic, developmental alcohol 
exposure, NeuN was decreased in the posterior medial barrel subfield and the motor 
cortex (Powrozek and Zhou 2005, Teixeira, Santana et al. 2014). The results of this and 
other studies corroborate the proposed delayed progression of intermediate progenitors in 
the SVZ/VZ as a consequence of developmental alcohol exposure. In contrast to the 
DNA hypomethylation (5hmC) associated with alcohol in the SVZ/VZ, the DNA 
methylation profile of alcohol in the upper cortical layers was generally 
hypermethylation.  
In the SP, the site of the oldest post-mitotic neurons, 5mC remains unchanged 
though 5hmC demonstrates a reduction compared to nutritional controls (but not Chow 
controls). This decrease parallels the diminished NeuN immunoreactivity observed in the 
SP and echoes various reports of a positive correlation between neuronal maturity and 
5hmC (Song, Szulwach et al. 2011, Szulwach, Li et al. 2011). Interestingly, though 5hmC 
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was reduced with alcohol treatment, the methyl-binding protein MeCP2 was significantly 
increased. Though there is significant co-localization of 5hmC-DNA and MeCP2 in the 
developing cortex (Chen, Damayanti et al. 2014), the inverse 5hmC/MeCP2 response 
here warrants further examination. Additionally, while a recent report found that NSCs 
upregulate and subsequently downregulate protein and mRNA MeCP2 levels following 
alcohol exposure and withdrawal, respectively (Liyanage, Zachariah et al. 2015), the 
dynamics of 5mC/5hmC/MeCP2 remain to be elucidated. While MeCP2 has 
demonstrated a regulatory role in a variety of developmental and disease processes, much 
less is understood to-date about the mechanisms that regulate the methyl-binding protein. 
A few studies have tackled this problem, for example, a MeCP2-targeting microRNA has 
been identified as a regulator of MeCP2 expression and conserved cis-regulatory motifs 
such as G-quadruplexes have been isolated as potential regulators of MeCP2 pre-mRNA 
(Bagga and D'Antonio 2013, Han, Gennarino et al. 2013). While insightful, much 
remains to be elucidated about the regulation of methyl-binding proteins and their 
intersection with methylated DNA.  
In the cortical plate, concordant with decreased NeuN, Tbr2, and decreased CP 
thickness, all three DNA methylation marks (5mC, 5hmC, and MeCP2) were increased in 
the Alc group relative to controls. This was in contrast to the 5hmC profiles observed in 
the SVZ/VZ and SP as well as cortex-wide in global DNA methylation analyses. The 
discrepancy between DNA hypermethylation in the CP and hypomethylation in the SP 
and neurogenic layers may lie in the composition of diverse cell types of the CP. Unlike 
the SVZ/VZ (composed of neuron and glial progenitors) and SP (composed of mature 
neurons and migrating CP neurons), cells represented in the CP include migrating 
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neurons, inhibitory interneurons (deep CP), glial cells, and mature cortical neurons of 
varying specifications (subcerebral projecting, callosal, etc.). The transcriptional 
requirements of differentiating neurons in the CP may respond differently to alcohol than 
premitotic and intermediate cells of the lower layers, which we have previously reported 
demonstrate bivalent action during differentiation (Zhou, Zhao et al. 2011).  Evidence 
that neurons in mature states respond differently to alcohol may be taken from adult 
models of alcohol seeking and post-dependent rats, where DNA hypermethylation has 
been observed (Warnault, Darcq et al. 2013, Barbier, Tapocik et al. 2015).  
2.4.3 Reconciling Cell and Tissue-Wide Epigenetic Analysis in FASD Studies 
Of the few DNA methylation profiles that have been examined in the cortex, all 
have agreed with reported reductions in DNA methylation in primordial and postnatal 
cortical regions in response to fetal alcohol (Garro, McBeth et al. 1991, Otero, Thomas et 
al. 2012). However, all of these studies share the feature of presenting DNA methylation 
as a cumulative cortical product, indiscriminant of diverse cell types. When considered as 
such, these findings agree with our global analyses of DNA hypomethylation in the 
alcohol-exposed cortex (Figure 23). But as unique DNA methylation programs of the 
postnatal cerebellum and normally developed embryonic cortex demonstrated (see 
Chapter 1), analysis of “global” or region-wide homogenates may oversimplify the 
complexity of the epigenetic alcohol response that is observed layer-by-layer.  
A second possibility for the divergent presentation of DNA methylation trends in 
the CP compared to lower layers may relate to differences in cellular density. One report 
observed that prenatal alcohol was associated with an increase in the number of MGE-
derived interneurons in the medial prefrontal cortex (PFC) (Skorput, Gupta et al. 2015), 
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supporting the likely increased cellular density of the alcohol CP. Finally, as shown in 
Figure 20(D–F), differential cellular morphology and intranuclear 5mC distribution in the 
alcohol CP may factor into alcohol-induced hypermethylation in the CP. To examine 
whether cell density or morphology factored into perhaps an overrepresentation of DNA 
methylation in the CP, we performed an analysis across the three groups. We report that 
cell number (as detected by nuclear number/area) was unchanged across all groups 
(Figure 24A). This finding is in line with a previous alcohol study where BrdU 
incorporation revealed no changes in the number of corticothalamic neurons (White, 
Weber et al. 2015). While these findings increase our confidence in the observed DNA 
methylation profile of the alcohol-affected CP, cell density in a restricted area 
measurement may not truly reflect the cell density of the total CP, particularly in light of 
observed decreases in CP thickness.  
Morphometric analysis of cellular nuclei in the cortical plate revealed that while 
cell number was unchanged, nuclear area was significantly compromised by alcohol 
(Figure 24B, P < 0.005). Here, our observations echo the historic findings of alcohol-
impaired PC maturation in the cerebellum, where cell number is unaffected, but nuclei 
are significantly smaller (Volk, Maletz et al. 1981).  However, one previous analysis in 
the medial PFC demonstrated that alcohol was actually associated with increased soma 
size (Lawrence, Otero et al. 2012). Contrasting observations may be attributable to a 
wealth of variations in the experimental paradigm (for example, the mPFC observation 
was performed during an adolescent stage in a perinatal model of alcohol exposure and 
limited to Layer II/III pyramidal neurons). Interestingly, even in the cerebellar analysis, it 
was noted that the impact of alcohol on nuclear size was not persistent in advanced ages. 
107 
Ultimately, our observed alcohol-mediated developmental deficits may begin to offer an 
explanation for cumulative cortical thinning. It should be noted however, that a few 
important contributors were omitted in this study which require future consideration.  
Apoptosis is a common cellular phenotype of developmental alcohol exposure 
(Farber, Creeley et al. (2010), Lebedeva, Zakharov et al. (2017)). Affecting glial and 
neuronal populations, likely through the suppression of neuronal activity (Lebedeva, 
Zakharov et al. 2017), dose-dependent, alcohol-induced apoptosis has been demonstrated 
to peak during the first postnatal week in the neonatal rodent cortex (Ikonomidou, 
Bittigau et al. 2000). As such, assessment of alcohol-related apoptosis was not featured in 
our E17 cortical model though its contributions during prenatal periods might be 
significant. There is a particular need in future studies to consider apoptosis during late 
corticogenesis as intraneocortical circuitry (and consequent neuronal activity) has been 
demonstrably altered around this time point in previous FASD rodent models (El Shawa, 
Abbott et al. 2013). Cell loss due to apoptosis, though not reflected in cell density 
analysis, may be an important contributor of alcohol-related cortical thinning.  
Another limitation of this study was the exclusive use of neuronal migration and 
maturation markers to characterize the developmental background of target CP 
populations that include non-neural cells. In a similar vein, the many inhibitory 
interneurons which inhabit the CP demonstrate a completely different origin site and 
migratory path than the neurogenic SVZ/VZ-radial migration examined here. Aberrant 
tangential migration of medial ganglionic eminence-derived cortical interneurons is 
observed in gestational alcohol models and results in the increased occupancy of 
GABAergic interneurons in the cortex that persists into young adulthood (Skorput, Gupta 
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et al. 2015). Similarly, abnormal radial glial migration and the differentiation of 
astrocytes in the rodent cortex have all been previously reported in response to prenatal 
alcohol exposure (Miller and Robertson 1993, Valles, Sancho-Tello et al. 1996, Aronne, 
Guadagnoli et al. 2011). To date, very few studies have profiled the epigenetic 
characteristics of cortical interneurons and non-neurons independently.  One recent study 
reported that cortical GABAergic interneurons demonstrate a distinct DNA methylation 
program compared to glutamatergic projection neurons, including decreased 5hmC and 
increased CpG 5mC hypermethylation (Kozlenkov, Wang et al. 2016). Another study 
utilized cell sorting techniques to examine the global DNA methylation landscapes of 
neuronal and non-neuronal cells in the cortex. They determined that neurons showed a 
tendency toward general hypomethylation and hypermethylation of astrocytic gene 
networks while non-neuronal nuclei demonstrated hypermethylation of synaptic 
transmission gene networks, likely reflecting the repressive role of global methylation. 
Importantly, this study described the increased variation of neuronal DNA methylation as 
an indicator of increased epigenetic plasticity in neurons. Finally, the authors of this 
study suggested that global cortical DNA methylation patterns largely reflect non-
neuronal cells, and this may not accurately portray the unique DNA methylation program 
of neurons (Iwamoto, Bundo et al. 2011). Collectively these reports offer new insights 
and expand support for the idea of cell-unique DNA methylation dynamics which have 
been described here. Performed under normal conditions in the adult cortex, the 
expansion of a developmental profile and the evaluation of aberrant (disease) state DNA 
methylation reprogramming in purified cortical populations is needed in the future.   
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Some technical considerations should also be addressed at this time. Here, for 
example, the administration of alcohol via a liquid-diet paradigm required the inclusion 
of an isocaloric liquid-diet control group (PF), which mirrored the Chow brain 
anatomically, phenotypically, and epigenetically. The isocaloric pairfed is calorie-
matched to account for any existing nutritional deficiency in the liquid diet model not 
attributable to alcohol itself. While the PF group has been successfully used in various 
alcohol liquid diet models, some epigenetic sensitivity of the liquid-diet (PF compared to 
Chow) was detectable here, particularly in 5hmC analyses. Even though the liquid-diet 
alcohol paradigm allows for control over the alcohol dose and caloric equilibrium in a 
relatively non-invasive method, some epigenetic differences may arise due to inherent 
variations between the Chow and PF diet, such as micronutrition, fat content, and stress 
induced by the yoking of liquid-diet volume to equilibrate caloric content of the alcohol 
and nutritional control group. Though these variables did not perturb normal 
development, they cannot be entirely ruled out as environmental contributors of the DNA 
methylation program.  
Finally, due to the observation of many grades of immunoreactivity across various 
markers in the cortex, we employed a semi-quantitative immunohistochemcial analysis 
known as the H-score (see Materials and Methods, 2.5). Using this algorithm, the 
percentage of cells stained at various intensity levels (arbitrarily defined by the 
experimenter as absent, weak, moderate, and intense) could more accurately reflect the 
abundance of the antigen than traditional cell counting techniques. To ensure that the 
categorical percentages were comparable between groups, cell number was normalized 
within each examined region ensuring that density of cells was not a factor of perceived 
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immunoreactivity. Due to the nature of optical densitometry in our software to range 
from completely black (OD=255) to completely white (OD=0), it was necessary to set 
thresholds which could include “absent” (methyl-green) nuclei as well as the most 
intensely-labeled nuclei (dark brown). Using cortical sections stained for methyl-green 
only, we were able to set these thresholds and subsequently define the OD ranges for 
each of our four immunoreactivity categories. To assuage inherent experimenter bias, 
cortical sections from different groups were examined non-sequentially. Additionally, 
randomized selection of nuclei was performed prior to densitometry analysis. Despite 
each measure taken to minimize the biases of H-scoring, the fact remains that processing 
procedures and the use of the human eye introduce certain variability in IHC (Rimm, 
Giltnane et al. 2007). Moreover, the biophysical properties of diaminobenzidine (DAB) 
as a chromagen monopolize light absorption and limit its visual dynamic range. These 
phenomena cannot be disregarded and suggest that H-scoring should be taken as a 
preliminary analysis to be supplemented by more objective, quantitative methods, such as 
Western Blotting or immunosorbance assays.  
2.4.4 Summary and Conclusions 
Here, we show for the first time that the altered neocortical DNA methylation 
program is concomitant with the aberrant laminar patterning of the neocortex as a 
consequence of embryonic alcohol insult. While a global investigation of DNA 
methylation markers revealed a cortex-wide reduction following prenatal alcohol 
exposure, a more detailed examination of the developing cortical laminae revealed that 
the sub-structural DNA methylation patterning exhibited a far more complex response to 
alcohol. These epigenetic aberrations were bilateral and parallel with many critical 
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corticogenic events including progenitor proliferation, migration, and maturation. As is 
believed to occur in development, these findings together suggest that the dysregulation 
of the normal DNA methylation program serves as a mechanism by which fetal alcohol 
confers abnormal gene expression and consequential deficits associated with cortical 
function.  
Despite the complex DNA methylation distribution of various cell types and 
developmental markers to alcohol exposure, cumulative cortical measures registered a 
measureable alcohol-response which bears significant structural-functional implications. 
Though the precise genomic targets of fetal alcohol insult remain to be elucidated in the 
embryonic cortex another pressing question remains, that is, does epigenetic 
reprogramming by alcohol drive the developmental response or does alcohol (though 
other mechanisms) alter developmental processes which produce aberrant methylation as 
a secondary function? Emerging epigenetic manipulation techniques and high-throughput 
RNA screens offer solutions for future investigations. In the meantime, the ongoing 
characterization of alcohol impacts on developmental epigenetic programs provides 
ample evidence that DNA methylation and transcriptional correlates play a substantial 
role as “readers” and “writers” of environmental insult during development. 
Fetal alcohol perhaps best models this to-date. Exposure has demonstrated the 
capacity to impact the epigenetic signature of the nervous system from the neural stem 
cell stage to the embryonic and the late gestational stages (Figure 25). Impressively, 
many studies have revealed that epigenetic dysregulation may span beyond the course of 
direct insult (in utero), prompting many authors to suggest that an “epigenetic memory” 
is at work recording environmental insults occurring in early development. Though 
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reportedly stable, whether these alterations are cumulative or rectifiable is still unknown. 
Further, the thresholds for functionally meaningful chromatin remodeling will be crucial 
to characterize for future clinical application.  
While the investigation continues, there is mounting evidence to support 
epigenetic mechanisms such as DNA methylation as developmental instructors of 
vulnerability to (among other things) psychosocial deficits, propensity for substance 
abuse, and cancer (Bilinski, Wojtyla et al. 2012, Gonseth, Roy et al. 2015, McCoy, 
Jackson et al. 2017). Alternatively, a growing repertoire of studies is proposing the 
reversible nature of epigenetic memory (Kutanzi, Koturbash et al. 2010, Tompkins, Hall 
et al. 2012) paving the way for a wealth of intervention strategies.  And while the 
sometimes subtle appearance of the epigenetic program may seem marginal, there are 
very clear molecular pathways from external stimuli to biochemical action and lasting, 
sometimes multi-generational encoding.  An exemplary model of this mechanism, 
developmental alcohol is perhaps only the beginning.  
 
 
 
 
 
 
113 
 
Table 4. Summary of cortico-structural alterations induced by alcohol in animal 
models 
Comparison of animal model details and BEC range of different studies 
examining the prenatal alcohol induced cortical phenotypes. Alc (alcohol); BEC 
(blood alcohol level); IP (intraperitoneal injection) and SA: self-administered 
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Figure 25. Epigenetic mechanisms and potential manifestations of fetal alcohol spectrum 
disorders 
Maternal alcohol exposure leads to expansive phenotypes of FASD but the mechanisms 
remain elusive. Besides immediate cellular effects, it is now understood that alcohol 
extensively alters epigenetics during fetal and NSC development through genomic DNA 
methylation, cellular DNA methylation programming, histone modification, transposons 
and miRNA. These epigenetic changes are likely a major upstream disrupter of gene 
transcription leading to primary phenotypes of FASD (e.g., growth retardation and 
neurodevelopmental deficit) and collectively compromise brain function and mental 
faculty as secondary phenotypes in early-life. It is not expected that all epigenetic 
changes lead to transcriptional and phenotypic changes but increasing evidence suggests 
that continuous environmental insults may lead to increased epigenetic abnormality. The 
primary seeding of epigenetic errors and secondary, cumulative epigenetic abnormality 
via abrasive environment (e.g., childhood abuse and stress) may result in a potential 
manifestation of FASD beyond the classical diagnosis in adulthood. Moreover, epigenetic 
errors carried in the germlines may influence the next generations.  
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CHAPTER 3: THE NORMALIZING CAPACITY OF S-ADENOSYLMETHIONINE 
SUPPLEMENTATION IN A MOUSE MODEL OF FASD 
3.1 INTRODUCTION 
3.1.1 Methyl Metabolism in Neural Development 
The importance of fetal nutrition has long been acknowledged. Methyl-related 
nutrition has been particularly scrutinized in neural development. For example, 
polymorphisms on methionine-metabolism enzymes have been linked with fetal growth 
impairments (Beaudin, Perry et al. 2012). Additionally, lower serum levels of folate (folic 
acid) and B12 have been linked with neural tube defects (Kirke, Molloy et al. 1993, 
Shaw, Schaffer et al. 1995). Recently, Wang et al demonstrated that choline deficiency 
during gestation led to the reduction of radial glia, intermediate progenitors, and upper 
layer cortical neurons in the embryonic cortex. This effect persisted up to 4 months in the 
mouse offspring of choline-deficient dams (Wang, Surzenko et al. 2016). Choline 
deficiencies can also lead to fetal neuron apoptosis in vitro (Yen, Mar et al. 2001) and 
prenatal choline has demonstrated the ability to alter hippocampal and cortical gene 
expression (Mellott, Follettie et al. 2007). Unsurprisingly, maternal choline and betaine 
deficiency have been linked to infantile cognitive impairment (Wu, Dyer et al. 2012). 
Similar to fetal alcohol exposure and later-life psychosocial disorders, perinatal choline 
has been correlated with increased risk of schizophrenia in later life (Ross, Hunter et al. 
2013). However, the proposition of methyl-metabolism as a unilateral regulator of neural 
development has been challenged by various studies describing that high levels of dietary 
methyl precursors can induce hyperhomocysteinemia and negatively impact embryonic 
116 
development and cognitive performance (Baydas, Koz et al. 2007, Pickell, Brown et al. 
2011, Mikael, Deng et al. 2013).  
The mechanisms by which nutritional dysregulation exhibit compound action 
against neural development are not well known. Previous work has proposed that 
receptor and transporter deficiency may lie behind nutritionally responsive 
developmental diseases. Particularly, in neural tube defects, diminished folate transport 
and disturbance of folate receptors during pregnancy have been associated with increased 
risk (Cabrera, Shaw et al. 2008, Chen, Yu et al. 2015). Other studies have implicated 
folate deficiency and increased susceptibility to oxidative stress via ERK activation as 
mechanisms of neuropathy (Barrera 2012, Kao, Chu et al. 2014). However, due to the 
parallel phenotypes of methyl insufficiency and surplus, it is likely that the mechanisms 
governing the methyl metabolism-neural development axis are far more complex.  
3.1.2 Nutritional Deficiency and Developmental Epigenetics 
Epigenetic mechanisms as mediators of the methyl sensitive-neurodevelopmental 
pathway have garnered much supporting evidence. Recall that methyl metabolism is a 
principle component of transmethylation reactions including DNA and histone 
methylation (Chapter 2, Figure 15).  First, genomic studies have revealed variations in 
susceptibility to methyl insufficiency during development, likely related to genetic 
variations (Zeisel 2008), which likely impact the epigenome.  For example, mutation of 
the methionine synthase reductase gene (Mtrr) has demonstrated transgenerational DNA 
hypomethylation in liver and uteri, though not in the brain. This differential methylation 
was positively correlated with phenotype severity (growth restriction, neural tube 
malformations, etc.) and gene misexpression. Interestingly, in the placenta of wild-type 
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grandprogeny, differential methylation remained detectable (Padmanabhan, Jia et al. 
2013). This study suggests that the sensitivity of a developing system to folate-
metabolism is significant and likely mediated in some capacity by epigenetic 
transmission. Indeed, DNA methylation profiles of nearly 2,000 newborns revealed vast 
CpG sites that are differentially methylated in response to maternal plasma folate, many 
of which lie on genes related to birth defects and neurological function (Joubert, den 
Dekker et al. 2016).  
More evidence of epigenetic mechanisms as purveyors of 
environmental/nutritional impact on the developing neural system comes from deficiency 
models. For instance, studies of gestational choline deficiency have reported global and 
gene-specific hypomethylation as well as histone hypomethylation on cell cycle control 
elements in the fetal hippocampus (Niculescu, Craciunescu et al. 2006, Mehedint, 
Niculescu et al. 2010). Similarly, a study of neonatal blood from offspring born to 
mothers of variable folate consumption revealed an inverse correlation between folate 
and genome-wide DNA methylation, including genes associated with neural crest 
development and cancer associated genes (Gonseth, Roy et al. 2015). Conversely, a 
human fetal study of severe neural tube defects in a folic-acid fortified population 
demonstrated unchanged methylation of genome-wide repetitive elements, indicating that 
the epigenetic etiology of severe neural dysregulation may be contingent on folate 
deficiency (Price, Penaherrera et al. 2016).  
Just as nutritional deficiency has provided much evidence of epigenetic 
reprogramming during neural development, supplementation strategies have exhibited an 
ameliorating potential, reinforcing the contribution of dietary elements like methyl 
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precursors in regulating the epigenetic landscape during gestation. Substantial evidence 
exists supporting that daily periconceptional folate supplementation can prevent the 
incidence of neural tube defects in humans (Tinker, Cogswell et al. 2010, Viswanathan, 
Treiman et al. 2017). Further, data suggesting that 75% of women of childbearing age in 
the US do not consume adequate folate have prompted the US Preventative Services Task 
Force to recommend daily folate supplementation (Viswanathan, Treiman et al. 2017). 
Maternal supplementation strategies have also manifested ameliorating potential on the 
epigenetic front. For example, long term folic acid consumption during pregnancy has 
been associated with increased cord blood DNA methylation (Pauwels, Ghosh et al. 
2017). In infants born small for gestational age, umbilical cord blood revealed 
hypermethylation at six differentially methylated regions in the imprinted H19 gene. 
However, maternal folic acid supplementation reduced DNA hypermethylation and 
improved growth outcomes in male offspring (Qian, Huang et al. 2016). Finally, in a rat 
model of methyl donor deficiency, two micro RNAs and their targets have been 
previously shown to be upregulated parallel to disrupted brain morphology-outcomes 
which were reversed by the administration of gestational folic acid supplementation 
(Geoffroy, Kerek et al. 2016).   
It should be noted that dietary elements beyond methyl-contribution have been 
implicated in epigenetic modulation and neural development. Fetal iron deficiencies, for 
one, have been linked to chromatin remodeling of the bdnf locus in the hippocampus 
(Tran, Kennedy et al. 2015). Additionally, heat-shock protein induced oxidative damage 
and associated DNA hypomethylation and histone hyperacetylation in chick embryonic 
liver was ameliorated in offspring of zinc supplemented mothers (Zhu, Liao et al. 2017). 
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Equally notable is the evidence that implicates nutritional epigenetics as a mechanism of 
extra-neural disease etiology, such as cardiovascular disease and cancer (Tobi, Lumey et 
al. 2009, Loche and Ozanne 2016). Malnutrition or famine in general has also been 
epigenetically implicated in metabolic syndrome, cardiovascular function and 
inflammation (Tobi, Lumey et al. 2009, Hernandez-Valero, Rother et al. 2013). 
Collectively, substantial evidence supports a role for epigenetic mechanisms as regulators 
of the nutrition-neural developmental axis. While much remains to be understood and 
clarified about how different methyl donors and other nutritional elements manifest 
epigenetic modifications, one model of developmental disease etiology offers significant 
insight. 
3.1.3 Alcohol Disruption of Methyl Metabolism During Pregnancy 
In Chapter 2, the intersection of alcohol and methyl donor metabolism was 
introduced. Briefly, alcohol metabolism has been shown to produce reactive oxygen 
species which inhibit the metabolism of folate, choline, and betaine, dietary methyl 
donors. Additionally, alcohol and alcohol metabolites have demonstrated inhibitory 
capacity on various enzymes involved in methyl metabolism (Figure 15). Do the 
dynamics of alcohol and methyl metabolism persist during pregnancy? Are there unique 
features during that time? Substantial evidence has elucidated the characteristics of 
alcohol-induced methyl metabolism dysregulation during gestation. Indeed several 
studies have reported that plasma methionine concentrations in both dam and fetus are 
different after gestational alcohol exposure (Hewitt, Knuff et al. 2011, Ngai, 
Sulistyoningrum et al. 2015). Historically, chronic alcohol consumption has been 
associated with increased demand for methionine and its subsequent depletion 
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(Finkelstein, Cello et al. 1974). In a similar vein, methyl metabolism genes in the fetal 
tissues have also been shown to be sensitive to prenatal alcohol exposure (Ngai, 
Sulistyoningrum et al. 2015).  
In addition to methyl metabolism, alcohol has been shown to interfere with 
maternal-fetal transmission of methyl metabolic precursors and selectively inhibit the 
ability of exposed offspring to absorb the nutrients in early life. For example, methionine 
and folate absorption in the small intestine of the pregnant rat is disrupted by alcohol 
consumption (Leichter and Lee 1984, Polache, Martin-Algarra et al. 1996, Murillo-
Fuentes, Murillo et al. 2003). Maternal-fetal methionine intestinal transport and altered 
free folate absorption dynamics in the postnatal intestines of alcohol exposed offspring 
have also been reported (Polache, Martin-Algarra et al. 1996, Tavares, Gomez-Tubio et 
al. 1999, Hutson, Stade et al. 2012). Finally, folate receptor activity is reportedly 
decreased by fetal alcohol exposure in offspring rat placenta (Fisher, Inselman et al. 
1985).  
Recall that both developmental alcohol exposure and nutritional insufficiency 
have been independently linked to a barrage of neural insults. In light of the various work 
elucidating the disruptive role of alcohol in methionine metabolism, it is likely that 
alcohol may work by hijacking maternal-fetal metabolomics, thereby conferring a variety 
of teratogenic effects. Evidence for this mechanism in neural developmental 
dysregulation includes parallel alcohol-induced methyl insufficiency and neural deficits. 
For example, in Xenopus embryos, alcohol exposure compromises neural crest cell 
migration in tandem with homocysteine accumulation, an indicator of compromised 
methionine synthesis (Shi, Li et al. 2014). In the postnatal brain of alcohol exposed 
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offspring, methyl metabolism is observed simultaneously with disrupted mRNA 
expression of serotonin and glucocorticoid receptors (Ngai, Sulistyoningrum et al. 2015). 
Fittingly, a recent study identified that deficient choline levels can exacerbate the effects 
of fetal alcohol on hindlimb coordination, hyperactivity and eye opening (Idrus, Breit et 
al. 2017). But perhaps the most substantial evidence for the consequential potential of the 
alcohol-nutrition pathway has come from supplementation studies.  
3.1.4 Nutritional Intervention Strategies in FASD 
On the premise of alcohol-compromised nutrition, various nutritional 
supplementation strategies have been attempted to mitigate alcohol phenotypes. Aside 
from the ameliorating potential of methyl precursor supplementation in alcohol-fed adults 
(Parlesak, Bode et al. 1998, Barak, Beckenhauer et al. 2003, Kharbanda, Rogers et al. 
2005, Bailey, Robinson et al. 2006), various studies have chronicled the developmental 
impact of supplementation across FASD models, predominantly via methionine, folic 
acid, betaine, and choline or synthetic variants. Table B-3 (Appendix B) outlines 
supplementation studies focused on growth anomalies and neurodevelopmental targets. 
During early gestation, various embryopathic effects, including neurocristopathies, neural 
tube defects, and embryonic dysmorphologies have been alleviated by developmental 
supplementation with folic acid (FA), 5-MTHF, and S-AMe, with one study offering that 
the co-administration of vitamin B12 may further enhance the protective action of the 
methyl donors (Xu, Li et al. 2006). However, in a few of these acute paradigms, 
supplementation was unsuccessful as a preventative strategy against neural tube defects 
and some embryonic growth deficits (Graham and Ferm 1985, Padmanabhan, Ibrahim et 
al. 2002).  
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Across supplementation studies performed in chronic alcohol exposure models 
(predominantly rodent), the protective capacity of methyl-donor supplementation 
included cortical neuroapoptosis, neurodegeneration, microcephaly, and growth deficits, 
though in one study, embryopathies were not prevented by methionine+zinc 
supplementation (Seyoum and Persaud 1997) and in others, gross body/brain weights and 
other malformations were similarly unaffected (Downing, Johnson et al. 2011, Hewitt, 
Knuff et al. 2011). Various postnatal and human studies have focused on the behavioral 
outcomes of methyl supplementation in FASD models. While the literature is rarely 
unanimous on any given measure, methyl donor supplementation alleviates alcohol-
induced deficits in learning, memory, hyperactivity, and balance and coordination. On the 
other hand, across all examined studies, locomotor and global cognitive measures have 
consistently lacked a neuroprotective response (Thomas, Garrison et al. 2004, Coles, 
Kable et al. 2015, Wozniak, Fuglestad et al. 2015, Nguyen, Risbud et al. 2016).  
Factors to consider when evaluating previous studies and contrasting outcomes 
include the dose and time of alcohol exposure, the methyl supplement format and the 
intervention period. For example, some studies administer methyl donor cocktails 
(Downing, Johnson et al. 2011, Sogut, Uysal et al. 2017) while others have experimented 
with methionine, betaine, or 5-MTHF. By far, the majority of animal and human studies 
have focused on folic acid and choline supplementation. Additionally, some studies pre-
treat with methyl supplements, others are delivered simultaneously with alcohol, and a 
majority of human interventions are delivered mid-gestation or even post-ethanol 
exposure. Finally, the current body of literature is made up of varying doses of methyl 
supplements and it  is not yet known how this factor impacts experimental outcomes.  
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3.1.5 Neural Targets for Intervention in the FASD Cortex 
Beyond the tissue-wide and functional outcomes that have been continually 
investigated and observed in FASD models, the field of FASD intervention has, along 
with technology, advanced toward an era of gene targeting in intervention strategies. The 
advent of genomic editing tools like CRISPR/Cas9 and transcription activator-like 
effectors (TALENS) has equipped experimenters with the tools for the precise 
investigation and manipulation of disease-related targets. As such, now more than ever 
there is a need to shed light on the specific drivers of alcohol teratogenicity. In the cortex, 
vulnerability to alcohol has been demonstrated across a multitude of targets. 
Compromised cell proliferation in both neurons and glia has been observed in 
prenatal alcohol models (Chikhladze, Ramishvili et al. 2011, Huang, He et al. 2015) and 
further study has elucidated possible gene targets involved in cell cycle regulation 
including cdcs, various cyclins, Mcm5, Plk1, E2f7 and Bub1. Notably, a handful of these 
targets have shown alcohol-induced hypermethylation at their promoter (Hicks, Lewis et 
al. 2012). Prenatal alcohol has also demonstrated inhibitory action on the proper 
specification of radial glial cells, precursors of intermediate progenitors and mature 
cortical neurons. Investigation of many of the genes conferring these processes has 
similarly revealed alcohol-sensitivity, including the early glial pathway genes notch, 
nestin, wnt, and Pax6 in the cerebral cortex (Aronne, Evrard et al. 2008, Hashimoto-
Torii, Kawasawa et al. 2011).   
The aberrant effects of gestational alcohol on cortical migration have been 
identified including the tangential migration of GABAergic interneurons and the radial 
migration of cortical progenitors (Cuzon, Yeh et al. 2008, Aronne, Guadagnoli et al. 
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2011). Migration-associated gene targets implicated in prenatal alcohol studies include 
the heat shock factor 2 (HSF2)-binding genes p35, Dclk1, and Dcx (El Fatimy, Miozzo et 
al. 2014). Ex-vivo models have also identified the TGFß pathway as a target of alcohol 
during neuronal migration (Siegenthaler and Miller 2004). The inhibitory effects of 
alcohol on cortical specification may be attributed to the downregulation of genes like 
Tbr2, an important regulator of upper cortical layer specification (Riar, Narasimhan et al. 
2016). Interestingly, other independent genomic screens have similarly identified a 
variety of cortical specification genes, some of which are intricately connected to the Tbr 
domain. For example, Satb2, Bhlhb5, Id2, Nr4a3, Foxp1, Pou3f2, Ctip2, and Crym have 
all been demonstrably downregulated in an FASD model (Hashimoto-Torii, Kawasawa et 
al. 2011). Finally, the effects of fetal alcohol exposure have been observed in the late-
specification of cortical neurons as well, with downregulation of synaptic targets like 
Nr2b, GluR1, Cb1r, and the adenosine A1 receptor (Bellinger, Davidson et al. 2002, 
Othman, Legare et al. 2002, Toso, Poggi et al. 2005, Subbanna, Shivakumar et al. 2013). 
Surprisingly, while the majority of reports describe alcohol-related inhibition of synaptic 
profiles, some synaptic targets of alcohol appear to be upregulated by prenatal alcohol 
exposure (Marutha Ravindran and Ticku 2004, Toso, Poggi et al. 2005, Kleiber, Diehl et 
al. 2014). From cell cycle exit to receptor distribution on the pre and post-synaptic 
terminals of a cortical neuron, various elements are targeted by prenatal alcohol, likely 
setting the tone for the hallmark cognitive, intellectual, and behavioral maladaptation 
observed commonly in FASD. A concrete understanding of the alcohol-sensitive gene 
networks and their dynamics is an important first step to remediation strategies, including 
nutritional supplementation therapies. Likewise, characterizing genomic regions critical 
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to cortico-development and function may offer molecular parameters for the evaluation 
of disease and therapeutic response. Ultimately, the profiling of important alcohol-targets 
in the developing brain is necessary for gene-targeting strategies such as genetic and 
epigenetic editing in the future.  
3.1.6 Research Aims 
A unique feature of methyl supplementation studies in developmental alcohol 
models is the parallel execution of pre-clinical and clinical investigation. The dietary 
nature of methyl donors and their high feasibility and tolerability in humans (Wozniak, 
Fuglestad et al. 2013) allows for the potentially rapid pace of clinical trials and data 
acquisition. On the other hand, while human trials are offering a wealth of behavioral 
information on the protective action of methyl donors, a gap in our understanding of the 
molecular drivers of methyl neuroprotection still exists. This prompts the need for pre-
clinical investigation of the underlying mechanisms regulating the developmental output 
of converging alcohol-nutritive pathways.  
Some studies have reported that one way methyl supplementation may counter 
perinatal alcohol exposure is through the improved intestinal absorption of dietary co-
factors like zinc (Tavares, Carreras et al. 2000). And while supplementation does not 
appear to restore alcohol-restricted absorption of methyl donors, one study found that 
Selenium+Folic Acid supplementation in a fetal alcohol model enhanced the transporters 
for their respective substrates in the duodenal mucosa (Nogales, Ojeda et al. 2011).  As 
described in Chapter 2, the biochemical proximity of methyl metabolism to DNA 
methylation and the previous demonstration of DNA methylation as a developmental 
regulator beckon the examination of epigenetic mechanisms as mediators of supplemental 
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neuroprotection. Despite this, to-date, very few alcohol+supplementation studies have 
characterized epigenetic changes.  
What has been reported thus far includes the capacity of choline to remediate 
region-wide hypermethylation in the hippocampus, though not in the medial prefrontal 
cortex (Otero, Thomas et al. 2012). Normalization of gene-specific hypermethylation has 
additionally been reported on the POMC gene of adult male offspring (Bekdash, Zhang et 
al. 2013) and in the Igf2 gene (Downing, Johnson et al. 2011). Beyond methylation, 
methyl supplementation has also been shown to normalize repressive histone marks, 
methyltransferase and methyl binding protein expression, and microRNA expression 
(Wang, Zhang et al. 2009, Bekdash, Zhang et al. 2013). An important structure for 
cognition, mobility, and higher order function, the effects of methyl supplementation in 
the embryonic cortex have not been extensively characterized nor examined through an 
epigenetic lens. Here, we aimed to establish the dynamics of epigenetic environmental 
sensitivity through methionine supplementation in a model of fetal alcohol exposure. 
Using S-adenosylmethionine (S-AMe), which is the active methyl donor for DNA and 
histone methylation reactions, we hypothesized that supplementation during chronic 
gestational exposure would exhibit neuroprotective action, possibly conferred through the 
stabilization of the previously described aberrant cortical DNA methylation program. 
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3.2 MATERIALS AND METHODS 
3.2.1 Overview of Experimental Treatments 
In this study, alcohol was administered via liquid diet according to the paradigm 
illustrated in Figure 26. Mice were acclimated to animal housing conditions one week 
prior to mating. After conception, the liquid diet was introduced from E5-E6 and 
experimental treatment was administered from E7-E16 (reflecting the late first and 
second human trimester equivalent). The 4% alcohol liquid diet (v/v) administered in this 
paradigm has been previously published in previous and parallel studies to reach a range 
of blood ethanol concentration (BEC) of 100-200 mg/dL (Anthony, Vinci-Booher et al. 
2010, Chen, Ozturk et al. 2013). Briefly, six non-pregnant females receiving 4% v/v 
alcohol liquid diet were used for BEC analysis. Blood samples were collected via tail 
vein bleeding method 2 hrs or 6 hrs after the administration of fresh alcohol-PMI diet. 
Collections were made 2, 4, and 6 days during the course of treatment, alternating 
between animals so as to provide at least 48 hours between tail bleeds. Adequate volumes 
of blood (15 µl) were collected in heparinized tubes, and plasma was isolated through 
centrifugation and stored at -80°C prior to analysis with a Gas Chromatograph (GC, 
Agilent Technologies; model 6890). Each sample was analyzed in duplicate. A previous 
fetal alcohol liquid diet study in gestating C57BL/6 mice with identical doses of S-
adenosylmethionine administration (10mM) showed that the treatment was well-tolerated 
by pregnant females and did not interfere with alcohol metabolism or BECs levels 
(Gauthier, Ping et al. 2010). Similar studies of choline supplementation have echoed that 
dietary supplementation does not alter peak BEC or interfere with alcohol metabolism 
(Thomas, Abou et al. 2009).  
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3.2.2 Animals and Treatments 
All mice were used in accordance with National Institute of Health and Indiana 
University Animal Care and Use (IACUC) guidelines. The protocol was approved by the 
Laboratory Animal Resource Center (LARC) animal ethics committee of Indiana 
University. C57BL/6 (B6) (10–14 weeks old, ~20 g body weight) nulliparous female 
mice (Jackson Labs, Bar Harbor, ME) were used in the study. Mouse breeders were 
individually housed upon arrival and acclimated for at least one week prior to mating. 
The mice were maintained on a 12 hr reverse light-dark cycle (lights on: 22:00–10:00) 
and provided laboratory chow and water ad libitum. Mice were then randomly assigned 
into five treatment groups for E17 study: Chow, Pair-Fed (PF), Alcohol (Alc), Alcohol + 
S-AMe (Alc+S-AMe), and S-AMe ad libitum (S-AMe).  Each litter was considered N=1; 
the littermates of each dam were distributed among the various analyses performed in this 
study. Chow, PF, Alc, and Alc+S-AMe groups were additionally treated for postnatal day 
(P) 7 analysis, including N≤5 litters per group. Due to the developmental and epigenetic 
similarity of the S-AMe control group to the Chow and PF control groups, the group was 
not included in the P7 analysis.  
Females were bred with male breeders for a 2-hr period (10:00 to 12:00). All 
animals were mated daily over a period of no more than 3 weeks, at which time all 
animals were on ad libitum chow and water diets. The presence of a vaginal plug at the 
end of the 2-hr mating session was considered as indicative of conceptus and that hour 
was designated as hour 0, and embryonic day (E) 0. A liquid diet paradigm was modified 
from a previously detailed study (Chen, Ozturk et al. 2013). Briefly, all alcohol treatment 
groups received 4% alcohol v/v in liquid diet (Purina Micro-Stabilized Diet (PMI), 
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Purina Mills Inc., Richmond, Indiana) as instructed by supplier with 4% w/v sucrose 
added, and administered using 35 ml drinking tube (Dyets Inc., NY). The PF group was 
given the PMI diet mixture with the addition of maltose dextran (MD) (to substitute 
alcohol calories). The volume of the PF diet was restricted to that of a dam paired from 
the alcohol group throughout the course of treatment. The addition of a S-AMe 
supplemented group (Alc+S-AMe) and S-AMe control was included in this study. The 
Alc+S-AMe group was administered the 4% alcohol PMI diet as described above, with 
the daily addition of powdered S-AMe (10mM, Nature Made, Mission Hills CA). A S-
AMe control group was also included, administered via daily unrestricted isocaloric PF 
diet supplemented with 10mM S-AMe.  Finally, the Chow group was maintained on a 
standard chow diet and water ad libitum throughout gestation. On E5, pregnant dams in 
PF, Alc, Alc+SAM, and S-AMe groups were placed on an unrestricted PF liquid diet for 
a 48 hour acclimation to the liquid diet. Experimental treatment was initiated according to 
the designated regimen on E7 through the end of E16. After E16, all dams were returned 
to standard lab chow and water ad libitum. For postnatal litters, dams were allowed to 
give birth, designated postnatal (P) day 0. Approximately six hours after parturition, 
experimental litters (PF, Alc, and Alc+S-AMe) were switched to be nursed by surrogate 
Chow-fed dams until harvest on P7. Surrogate dams had previously given birth no more 
than 48 hours prior to experimental litter births. During surrogacy, litters were randomly 
culled to six pups/litter in order to decrease possible nutritional deficiencies caused by 
within-litter competition.  
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3.2.3 Embryo Isolation and Tissue Preparation  
Dams were placed under deep CO2 euthanasia until completely sedated and 
embryos were harvested from dams at E17 by removal from the embryonic sack. P7 pups 
were weighed and immediately decapitated. Each embryo/pup was either immersion-
fixed in 20 ml of fixative prepared from 4% paraformaldehyde (PFA) for 
immunohistochemistry, flash frozen in liquid nitrogen,  or preserved in RNA later 
(25mM sodium citrate, 10mM EDTA, 70g ammonium sulfate/100mL solution, pH 5.2).  
3.2.4 Immunohistochemistry  
Fixed embryos were subsequently weighed, dissected for brain tissue, and 
assessed for brain weight no more than 48 hours after fixation. Brains taken from each 
group were embedded in a single 10% gelatin block with careful rostrocaudal and 
dorsoventral alignments. Gelatin blocks were fixed in 4% PFA for 48 hrs and sectioned 
in 40 mm thick coronal sections on a floating vibratome (Leica Microsystems; Buffalo 
Grove, IL). For P7, section-pairs (Chow-PF or Alc-Alc+S-AMe) were processed equally 
across all immunohistochemical procedures. For all immunohistochemical experiments, 
sections were cleared of endogenous peroxidases using 3% H2O2 in phosphate buffered 
saline (PBS) for 10 min and permeabilized with 1% TritonX-100 in PBS for 30 min 
(overnight for Vglut1). For nuclear proteins, an additional 30 min incubation in 2N HCl 
was performed. Sections were subsequently blocked in species-specific normal serum for 
60 min prior to primary antibody incubation. Antibodies used are summarized in Table 5 
below. Primary antibodies were diluted in normal serum according to the following 
dilutions and incubations in primary antibody varied from 18-24 hours at room 
temperature. Subsequently, sections were incubated for 90 min in biotinylated secondary 
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antibodies (Jackson ImmunoResearch, West Grove, PA) followed by incubation in 
Streptavidin-AP (1:500, Jackson ImmunoResearch, West Grove, PA) or Universal 
Peroxidase ABC HRP Kit (Vector Laboratories, Burlingame, CA) for 90 min. The 
immunostaining was visualized by incubation in 0.05% 3,3'-diaminobenzidine (DAB) for 
15 min, followed by chromagen activation by 0.03% H2O2 over a range of of 3-8 
minutes. Sections were rinsed and mounted on glass slides followed by counterstaining 
with methyl green (0.05%, Sigma Aldrich, St. Louis, MO). All stainings were analyzed 
under light microscopy for cellular analysis using a Leica DM 6000B microscope (Leica 
Microsystems, Wetzlar, Germany). 
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Table 5. Antibodies used for neurodevelopmental and DNA methylation assessment in 
the S-AMe supplemented E17 cortex 
Primary Antibodies Company Catalog # dilution 
predicted 
wt. 
5-methylcytosine Eurogentec 
BI-MECY-
0100 1:2000 N/A 
5-methylcytosine Active Motif AM61255 1:2000 N/A 
5-hydroxymethylcytosine Active Motif AM39769 1:3000 N/A 
Ki67 Novus Biologicals 
NB110-
89717 1:500 324 kDa 
Tbr2 Millipore AB2283 1:500 58 kDa 
NeuN Cell Signaling Tech. D3S3I 1:500 46-55 kDa 
Vglut1 Millipore AB5905 1:1000 ~62 kDa 
Fezf2 ImmunoBiological Labs 18997-S 1:100 ~65 kDa 
Secondary Antibodies         
Goat anti Rabbit biotinylated 
Jackson 
ImmunoResearch 
111-065-
003 1:500 ~160 kDa 
Horse anti Mouse biotinylated Vector  Laboratories BA-2000 1:500 
~152-165 
kDa 
Donkey anti Guinea Pig 
biotinylated Vector  Laboratories BA-7000 1:500 
~152-165 
kDa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
133 
3.2.5 Densitometry analysis (H score) and cortical thickness assessment  
Epigenetically immunostained nuclei exhibited a variable staining profile within 
different cortical layers. In order to reflect this heterogeneity, we employed H scoring as 
a strategy for nuclear densitometric analysis (Singh, Shiue et al. 2009, Chen, Ozturk et al. 
2013) of each cell within the selected cortical subregion (VZ+SVZ, SP, and CP).  
Images of immunostained sections were taken using a Leica CTR 6000 camera 
and Leica Firecam Software Version 1.7.1 (Leica Microsystems, Wetzlar, Germany). 
Bright-field images were taken with consistent acquisition settings between sections for 
each antibody analyzed. Images were converted to the 16-bit color format, and staining 
intensity was assessed using Image J (National Institutes of Health, Bethesda, MD). 
Calibration was set based on 256 levels of the gray scale. To measure the sub regions of 
prefrontal neocortex, a rectangular box of equal dimensions (150 μm in width) was 
selected at the S-AMe rostro-caudal level of E17 coronal brain sections. Lateral ventricle 
and corpus callosum were used as landmarks to align the prefrontal cortex across all 
groups. Equal amounts of cells were randomly sampled within the designated dimensions 
per group. The intensity of the staining in each selected cell was measured on a black-
white scale (0-256). These absolute intensity values were subsequently classified based 
on the optical density (OD) values according to the following guidelines: Absent-0-
(OD=256-206), Weak-1-(OD=206-156), Moderate-2-(OD=156-106) and High-3-
(OD=106-56). Overall, the immunohistochemical H score of each subcortical region was 
obtained by the following formula: 3 X percentage of highly stained nuclei + 2 X 
percentage of moderately stained nuclei + percentage of weekly stained nuclei.   
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 Cortical thickness was assessed using two independent immunostainings: NeuN 
and 5mC. Anterior sections of the frontal cortex were rostro-caudally matched between 
groups and selected for cortical measurements. ImageJ software was used to assess 
cortical thickness (measured from the base of the SVZ to the edge of the MZ). 
Subsequently, individual cortical layers were measured (layers were clearly demarcated 
by cortical cytoarchitecture). For P7 analysis, a similar process was used, modified to 
include multiple cortical subdivisions including: cingulate cortex, primary motor cortex, 
secondary motor cortex, primary sensorimotor cortex, and forelimb/hindbrain 
sensorimotor cortex. P7 layer measurements were also taken across layer I, layers II-IV, 
layer V, and layer VI.  
3.2.6 Cell Counting and Morphometric Analyses 
Automated cell counts were used to detect cells positive for Ki67 due to the 
presentation of the immunosignal being punctate and homogenous. In this experiment, 
sections stained for Ki67 were processed using Image J software according to the 
following protocol: color deconvolution plugin was used to isolate the brown DAB 
signal, images were inverted to 8-bit, automated thresholding was performed, and 
automated particle analysis was performed on the SVZ/VZ region with the selection 
parameters set to 0.25-1.0 circularity (where 1.0 equals a perfect circle) and size inclusion 
being 50-600 (pixel^2). Results were presented as number of particles (cells) detected per 
sample ±SEM. 
To assess cell density, cortical sections from 5mC staining procedures were 
counterstained by Methyl-Green dye (Nissl) which allowed for the visualization of 5mC 
positive as well as 5mC negative nuclei. After Brightfield imaging under a light 
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microscope (see “Densitometry analysis and cortical thickness assessment”), a select 
region targeting the mid cortical plate was binned (0.025mm
2
) across all brain sections at 
a high magnification. Nuclei were counted using the multi-point counting tool on ImageJ 
software (NIH, Bethesda MA). At least two sections taken from the anterior cortex of 
each subject were averaged for total nuclei/area. Additionally, at least two subjects from 
each litter were represented in the assessment (where n=litter).  
A similar procedure was used to analyze nuclear morphology. Due to the non- 
circularity of some cortical cells, the major and minor axes of each nuclei were measured 
across the anterior CP. In some cases, where nuclei were quite circular, the nuclei length 
and diameter were arbitrarily selected and interchangeable. In cases of non-circular 
morphology, the major (longest) and minor (perpendicular to major) axis were clearly 
distinct and thus represented independently.  A straight line tool was used in all cases to 
measure the major and minor axes of the nuclei. Finally, nuclear area was calculated 
based on the following equations: circular area=πr2 (where r=minor axis/2) and ellipse 
area=πab (where a=minor axis/2, b=major axis/2). Distinction between circular and non-
circular nuclei was made if major axis was ≥1.5 times the minor axis. At least 100 nuclei 
from the selected region were measured per cortical section and at least two sections per 
subject were represented in the average. Each N represents one litter in these 
assessments. To help minimize experimenter bias, images were randomly examined, 
meaning, experimental groups were not evaluated as continuous cohorts throughout the 
imaging session.  
3.2.7 Global DNA Methylation Analysis 
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Fetal brains were isolated and microdissected under a Dissection Microscope 
(Leica MZ6, Leica Microsystems). Neocortical brain tissues were separated from 
subcortical brain tissue using the borders of the nascent internal capsule as a visual guide. 
DNA extraction and purification was subsequently performed using silica-based spin-
column purification (DNeasy Blood and Tissue kit, Qiagen) according to manufacturer’s 
instructions. Purified DNA was quantified by spectrophotometric absorption at 230, 260, 
and 280nm and the quality and concentration was calculated as the A260/A230 and 
A260/A280 ratio (Nanodrop 2000, Thermo Scientific). An average of 100-200 ng of 
genomic DNA was used for DNA global methylation analysis performed with the 
MethylFlash Methylated DNA Quantification Kit and MethylFlash Hydroxymethylated 
DNA Quantification Kit (Colorimetric; Epigentek Group) according to the manufacturer's 
instructions. OD values were determined using a PHERAstar FSX microplate reader and 
MARS Data Analysis Software (BMG Labtech, Cary, NC). Methylation levels were 
estimated using a standard curve of methylated DNA standards provided by the 
manufacturer. Relative methylation (percent of total DNA) was calculated according to 
the following calculations:  
5-mC%=(sample OD-neg control OD)/(slope of the standard curve*input DNA 
(ng))*100% 
5-hmC%= ((sample OD-neg control OD)/(slope of standard curve*5))/input DNA 
(ng)*100% 
Global methylation data were presented as percent of control group values. 
3.2.8 Gene Expression Analysis 
137 
RNA was extracted from cortical tissue by RNA extraction kit (RNeasy Mini Kit, 
Qiagen Valencia, CA) according to manufacturer’s instructions. One microgram of 
cortical RNA was converted to cDNA using the High Capacity Reverse Transcription Kit 
(Applied Biosystems, Foster City CA). Next, 100ng of cDNA was loaded per reaction 
and at least three reactions were examined per gene expression assay per sample. Taqman 
PCR Master Mix was used with Taqman Probes (Applied Biosystems, Foster City CA) 
for an array of neurodevelopmental genes (Table B-4, Appendix B). Relative expression 
was calculated according to the [delta] [delta] Ct method, using the ubiquitous ribosomal 
gene 18S as an internal control.  Reactions were performed on AB Step One Plus Real 
Time PCR System (Applied Biosystems, Foster City CA). 
3.2.9 Methyl-CpG Pyrosequencing 
Site-specific methylation analysis was performed using Pyromark Q24 CpG 
Assay (Qiagen, Valencia, CA). One microgram of gDNA was bisulfite treated using 
Zymo’s EZ DNA Methylation Gold kit (Zymo, Irvine CA). Two microliters of the 
bisulfite-converted DNA was next used as input for pyro-PCR using custom oligos (IDT, 
Coralville IA) or commercial Pyromark CpG Assays (Table B-4, Appendix B) using 
Pyromark PCR Kit (Qiagen, Valencia, CA).  Once PCR product was confirmed by gel 
electrophoresis, 20uL of PCR Product was incubated with CpG Assay reagents and 
sequenced using Pyromark Q24 Workstation (Qiagen, Valencia, CA). PROMO 
transcription factor prediction software was used to generate predicted transcription 
factor binding sites within the analyzed sequence of the gene (Messeguer et al 2002). 
Control oligo was used as a positive control in all assays. Percent methylation of all CpGs 
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in the sequence as well as cumulative methylation was presented within each of the 
differentially methylated regions (DMR) investigated.   
3.2.10 Statistical Analysis 
IBM SPSS Statistical software (Version 24) was used to perform all statistical 
analyses. Comparison of group means was performed by one-way ANOVA, with 
Welch’s correction when groups violated the homogeneity of means test (assessed by 
Levene’s Test of equality of variances). Where statistical significance was observed 
(P≥0.05), either Tukey’s HSD (ANOVA) or Games-Howell (Welch’s) post-hoc analysis 
was carried out. All data are presented as means± standard error of the mean (SEM). All 
birth data were presented as litter averages to account for litter size effects. Across all 
experiments, sample size (n) denotes the number of represented litters within each group. 
A detailed summary of statistics is provided for all quantitative assessments in Table B-5, 
Appendix B. 
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Figure 26. Experimental paradigm for fetal alcohol and S-adenosylmethionine 
supplementation 
(A) Representative scheme of experimental treatment paradigm. Conception was 
designated as embryonic (E) day 0. Liquid diet acclimation was initiated on E5 and 
experimental treatments were integrated into liquid diet from E7-E16. Pairfed (PF) 
groups were calorically matched to Alcohol and Alc+S-AMe groups by volumetric 
restriction to PF diet (alcohol calories supplemented by maltose dextran). All liquid diet 
treatments were terminated on E17 and dams were returned to standard lab diet on that 
day. Harvests were performed on E17 or P7 (arrows). (B) Experimental workflow 
included analyses performed across each of the listed categories at the E17 stage.   
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3.3 RESULTS 
3.3.1 Gestation and Fetal Characteristics 
 Maternal weight and alcohol intake was monitored daily throughout the course of 
this study as alcohol exposure reportedly impacts appetite and feeding behaviors 
(Kokavec 2008). Due to the use of a liquid diet model, combining alcohol administration 
with daily nutrition, alcohol-induced loss of appetite could be severely detrimental. 
However, we report that gestational weight gain was overall unchanged by experimental 
treatment. Moreover, gestational consumption of the experimental liquid diets was 
comparative to nutritional control levels, averaging around 13mL/day (Figure 27 B). 
Finally, because alcohol and alcohol+S-AMe groups were unrestricted in their daily 
access to the diet, we evaluated whether the two alcohol-administered groups consumed 
different amounts of diet (alcohol) throughout gestation. There were no observed 
differences in the consumed liquid diet across the two-alcohol receiving groups on either 
day throughout gestation (Figure 27C) indicating that both Alc and Alc+S-AMe dams 
ingested equivalent amounts of alcohol daily. These levels of alcohol consumption have 
been previously shown in our lab to produce blood ethanol content (BECs) around 120-
160 mg/dL (Anthony, Vinci-Booher et al. 2010, Chen, Ozturk et al. 2013). Additionally, 
several methyl-supplementation studies have determined that the supplementation of an 
alcohol diet with 10mM S-adenosylmethionine does not alter the BEC of a dam 
(Gauthier, Ping et al. 2010).  
 Next we examined the fetal characteristics of the experimental litters across all 
groups. Alcohol-exposed fetuses demonstrated a significant decrease in body weight at 
E17 (Figure 28A, P<0.001). S-AMe supplemented fetuses also showed a decreased body 
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weight compared to Chow and S-AMe controls. However, no intergroup differences were 
found in fetal brain weight. To examine whether deficits in body weight persisted beyond 
the exposure timeframe, we evaluated pup body weights at postnatal day 7. No group 
differences were detectable by P7, in either body or brain weight (Figure 28 C-D). These 
findings are consistent with the notion that body weight impacts are typically observed in 
high dose alcohol studies rather than low dose studies (such as our own) (Abel 1996). 
Finally, neither alcohol nor S-AMe treatment affected the average number of pups/litter.  
 To evaluate the effect of prenatal alcohol on methyl metabolism in our model, we 
examined the expression of the S-AMe-producing enzyme methionine 
adenosyltransferase 2A (Mat2a) in the liver and brain. In the fetal liver, the Mat2a gene 
expression was significantly decreased by maternal alcohol treatment (Figure 29A, 
P<0.0001), consistent with previous reports (Ngai, Sulistyoningrum et al. 2015). Here we 
observed that S-AMe supplementation of the alcohol diet normalized liver Mat2a to 
levels comparable to controls. Interestingly, unrestricted S-AMe access (no alcohol) 
expressed the highest level of the transcript, indicating that methyl supplementation does 
not diminish the expression of Mat2a rather increases it. In the brain, the sensitivity of 
the gene to alcohol exposure was absent, on the other hand, the sensitivity of the cortical 
tissue to S-AMe persisted beyond the liver, where a majority of alcohol and methyl 
metabolism occurs. The findings suggest that at the gene level, fetal alcohol’s influence 
on methyl metabolism may be limited to the fetal liver, unlike S-AMe supplementation, 
which exhibits a more dynamic range.  
To further examine whether alcohol or S-AMe supplementation impacted the 
DNA methylation products 5mC and 5hmC, whole tissue DNA was quantitatively 
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assessed using an immuno-absorbance assay. While both the liver and cortex were 
sensitive to alcohol exposure and exhibited decreased 5mC consistent with diminished S-
AMe production (Figure 29C, cort P=0.05; liver P= 0.028), Alc+S-AMe treatment did 
not produce a significantly different outcome. However, the trend of the S-AMe 
supplemented alcohol group was such that they were not statistically significant from 
control groups. Notably, though the unrestricted S-AMe nutritional control exhibited 
higher than normal Mat2a in the liver and brain, expression of 5mC was comparable to 
Chow and Pairfed controls (Figure 29C). Finally, quantitation of 5hmC revealed no 
changes across groups in either liver or cortical tissue (Figure 29D).  These results 
confirm the sensitivity of methyl metabolism to fetal alcohol exposure in our paradigm 
and illuminate the sensitivity of the liver and cortex to S-AMe supplementation. Finally, 
our results echo previous findings of global DNA methylation patterns (Figure 23) and 
place the effects of methyl-supplementation into perspective on a tissue-wide scale.  
3.3.2 Role of S-AMe supplementation as a Cortical Neuroprotector 
 To interrogate whether S-AMe supplementation of the fetal alcohol exposure 
paradigm could abrogate the growth deficits of alcohol on the embryonic cortex, we 
examined the phenotypic characteristics on a structural, molecular, and genomic level. 
First and foremost, we evaluated whether methyl-supplementation via the active methyl 
donor S-AMe could normalize one of the prominent FASD features previously observed 
in our experimental model-cortical thinning. Recall in Chapter 2 that fetal alcohol 
exposure dramatically reduced the length of the embryonic cortical column. Here, we 
used identical metrics and 1) confirmed the cortical thinning phenotype in a second 
cohort of E17 fetuses, 2) observed the normalizing potential of S-AMe supplementation 
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(Figure 30A, P<0.004), and 3) describe that normalization of the cortical structure is 
preserved beyond the window of intervention, postnatally at the vulnerable sensorimotor 
cortex (Figure 30B, P=0.001).  
 As a secondary measure of cellular growth and to examine (as in Chapter 2) 
whether differing cellular densities were at least partial contributors to our observations 
of alcohol-induced cortical thinning and neuroprotection by S-AMe supplementation, we 
quantified all cells present in a representative fraction of the cortical plate and report no 
differences in total cell number across all groups (Figure 31A). While neither alcohol nor 
S-AMe impacted cell densities in the E17 cortical plate, nuclear size was found to be 
significantly decreased by prenatal alcohol exposure, an effect mitigated significantly by 
S-AMe supplementation (Figure 31B, P<0.0001). Our findings echo the observations 
made in Chapter 2 and expand upon the neuroprotective contributions of S-AMe 
supplementation toward the preservation of nuclear area which may greatly contribute to 
cortical plate size.  
 Layer-specific analysis further revealed that nearly all cortical layers of the E17 
cortex were negatively impacted by alcohol exposure. At the P7 stage, the alcohol-
sensitivity of the sensorimotor cortex appears relegated to layers II-IV and VI. Similarly, 
while the normalizing capacity of Alc+S-AMe occurs in the SP and MZ at E17, it is 
restricted to the VI layer postnatally (Figure A-1, Appendix A). Regardless, total cortical 
thickness trends are echoed at least one week after birth. These results elucidate the 
persistent sensitivity of the cortex to gestational alcohol exposure and are the first to 
describe that S-AMe supplementation can protect against alcohol-induced cortical 
thinning in a lasting manner.  
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 To corroborate the structural findings of our experimental paradigm at a 
molecular level, various critical processes of cortical maturation and expansion were 
investigated. First, cellular proliferation was examined at the neurogenic zones of the 
cortex, the SVZ/VZ. Immunohistochemical detection of Ki67+ nuclei was performed and 
an automated cell counting tool was used to determine whether alcohol and/or S-AMe 
impacted the number of Ki67+ nuclei. We found that alcohol significantly decreased the 
number of Ki67+ nuclei, indicative of reduced proliferation of cortical progenitors and 
radial glial in the SVZ/VZ (Figure 32B, P=0.036), though the transcript for Ki67 was not 
significantly altered by either treatment. S-AMe supplementation did not exhibit 
significantly higher Ki67+ nuclei compared to the alcohol group however, it did not 
significantly differ from controls. These findings support our previous observation that 
alcohol reduces cortical proliferation but suggests that S-AMe supplementation may play 
a limited role in neurogenic proliferation.  
 A prominent regulator of intermediate progenitor conversion in the cortex, the 
transcription factor Tbr2 has been often used as a tool in the identification of cortical 
projection neuron precursors (Kowalczyk, Pontious et al. 2009). Previously, alcohol 
exposure has been shown to induce cytostasis of Tbr2+ populations, likely hindering the 
symmetric division of cortical precursors (Riar, Narasimhan et al. 2016).  Interestingly, 
Tbr2 deletion produces microcephaly-a hallmark feature of FASD (Baala, Briault et al. 
2007). Here we examined Tbr2 nuclei and fibers across the SVZ/VZ, IZ, and CP. Using 
immunohistochemistry we quantitatively assessed the number of Tbr2+ nuclei and found 
that alcohol exposure significantly decreased the detectable Tbr2+ nuclei in the IZ and 
CP (Figure 33B, IZ P=0.015; CP P=0.016), though not the SVZ/VZ as a previous fetal 
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alcohol report has shown (Hashimoto-Torii, Kawasawa et al. 2011). Further, though S-
AMe supplementation was not significantly neuroprotective of Tbr2 in the CP, it 
demonstrated ameliorating potential in the IZ, where migrating intermediate progenitors 
are most concentrated (Vasistha, Garcia-Moreno et al. 2015). Despite the proteomic 
observations, an assessment of Tbr2 mRNA in the cortex did not demonstrate either 
alcohol or S-AMe sensitivity (Figure 33C). 
 A frequent marker of neuronal maturity, NeuN is expressed in the nuclei of post-
mitotic (committed) neurons. Due to the well-demonstrated growth-inhibitory nature of 
alcohol on neurons, we investigated alcohol and S-AMe supplementation’s effects on the 
expression of NeuN in the embryonic cortex. As shown in Figure 34, alcohol 
significantly decreased NeuN in the upper cortical layers (SP, CP), where neuronal 
maturity is most advanced. This finding corroborates several previous reports (Powrozek 
and Zhou 2005, Teixeira, Santana et al. 2014). Though the gene encoding NeuN (Rbfox3) 
does not change in reaction to alcohol or S-AMe at E17, we did observe that S-AMe 
normalized the expression of NeuN protein in the SP and CP (Figure 34C-D, SP 
P=0.035; CP P= ≤0.0001).  
 Finally, to round out our phenotypic assessment of the molecular drivers of 
cortical development, we examined the expression of a presynaptic protein which plays 
an important role in glutamate transport and is expressed in neuron-rich regions. 
Vesicular glutamate transporter 1 (Vglut1) is a vesicle-bound, sodium-dependent 
phosphate transporter distributed at presynaptic membranes, where synaptic vesicles 
reside. Several studies have described the inhibitory action of prenatal alcohol on 
glutamatergic release (Yunes, Estrella et al. 2015) and glutamate receptors (Savage, 
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Montano et al. 1991). In contrast, other studies have reported that developmental alcohol 
exposure may actually increase glutamate release in the fetal cortex (Reynolds, Penning 
et al. 1995). Because glutamate dynamics can be a potent source of cytotoxicity in the 
brain, here, we examined the role of prenatal alcohol on the expression of Vglut1 in the 
cortex. We found prenatal alcohol increased the expression of Scl17a7 (the gene 
encoding Vglut1), though S-AMe did not appear to mitigate this upregulation (Figure 
35G, P=0.035). Immunohistochemical analysis confirmed the action of alcohol on the 
Vglut1 protein in the cortical plate. Comparatively, in this analysis, S-AMe demonstrated 
a protective role (Figure 35F, P <0.0001). Our results ultimately support the findings of 
Reynolds et al and hint that alcohol may abnormally upregulate glutamate transport and 
signaling during late gestation. Interestingly, alcohol-induced glutamatergic increase has 
been linked to increased frequency of excitatory post-synaptic currents in pyramidal 
neurons and anxiety- like behaviors in a third trimester model of FASD (Baculis, Diaz et 
al. 2015).  
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Figure 27. Alcohol does not impact gestational characteristics of experimental dams  
(A)Average weight gain of group dams from weight at conception to weight at E17 (B) 
Average daily intake of liquid diet from start of experimental treatment (E7) to end of 
experimental treatment (E16) (C) Daily Alcohol Intake calculated from average daily 
total liquid diet drinking of Alc and Alc+S-AMe experimental groups (E7-E16); no group 
differences in daily liquid diet or alcohol consumption were detected across gestation.  
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Figure 28. Alcohol transiently inhibits fetal body weight at E17 but does not impact brain 
weight  
(A)Average fetal body weight as determined by average fetal weight/litter at E17; 
alcohol-receiving groups demonstrated decreased fetal body weight though this effect did 
not persist postnatally (B) Average fetal brain weight/litter as determined by dissected 
brain weight at E17 (C) Average body weight of pups/litter as measured at P7 (D) 
Average brain weight of pups/litter as determined by dissected brain weight at P7 (E) 
Average number of pups/litter across all experimental groups. *p≤0.05; **p≤0.005. 
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Figure 29. Alcohol reversibly decreases liver but not brain Mat2a and liver and cortex-
wide 5mC  
(A)Liver Mat2a expression measured by quantitative PCR revealed that alcohol 
decreased the expression of the transcript in the fetal liver at E17, an effect normalized by 
supplementation with S-AMe. Unrestricted S-AMe diet demonstrated the highest 
expression of Mat2a. (B) Brain Mat2a expression did not reflect alcohol-related changes, 
though unrestricted S-AMe access significantly increased the expression of the transcript. 
(C) Liver and cortex 5mC was reduced tissue-wide by fetal alcohol exposure. S-AMe 
supplementation was not significantly different from either alcohol or controls. (D) Liver 
and cortex 5hmC was unchanged across all groups. *p≤0.05; **p≤0.005; ***p≤0.0005.  
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Figure 30. Alcohol- induced cortical thinning is persistently ameliorated by S-AMe 
supplementation  
(A)Cortical length was measured from the base of the SVZ to the roof of the MZ. 
Alcohol-induced reductions were detected across all zones except the MZ. In the SP and 
cumulatively, S-AMe supplementation protected the cortical laminae from Alcohol-
induced thinning. (B) Alcohol-induced cortical thinning persisted into postnatal (P) day 7 
in the sensorimotor region of the anterior cortex, particularly in the II-IV and VI layers of 
the cortex. S-AMe supplementation continued to provide neurprotection from Alcohol-
induced cortical thinning on P7. *p≤0.05, **p≤0.005; SVZ/VZ: subventricular 
zone/ventricular zone, IZ: intermediate zone, SP: subplate, CP: cortical plate, MZ: 
marginal zone. 
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Figure 31. Alcohol reversibly reduces nuclear area in the E17 cortical plate 
(A) Cell density was assessed using the Methyl-Green Nissl stain. Cell number was 
unchanged across groups within a 0.025 mm
2  
area selected from the mid cortical plate. 
(B) Nuclear morphology was evaluated from a random sample of 100 cells within the 
cortical plate. Alcohol group nuclei were significantly smaller than all other groups and 
S-AMe supplementation was neuroprotective against this nuclear size reduction. 
*p≤0.05; **p≤0.005; ***p≤0.0005.  
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Figure 32. Alcohol decreases the number of proliferating cells at the cortical 
neuroepithelium 
(A) Representative images from the SVZ/VZ stained for the cell proliferation marker 
Ki67. Area beneath the black dashed line denotes the SVZ/VZ regions. Black arrows 
demonstrate positively stained nuclei, blue arrows demonstrate Ki67 negative nuclei. (B) 
Average number of Ki67+ cells detected by automated particle analysis tool using ImageJ 
showed significant decline in Ki67+ cells in the Alcohol group compared to controls (C) 
Relative expression of Ki67 mRNA (encoded by the gene Mik67 across cortical tissue 
samples at E17 showed no detectable transcript changes. *p≤0.05; SVZ/VZ: 
subventricular zone/ventricular zone.  
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Figure 33. Alcohol-induced Tbr2 reduction is ameliorated by S-AMe supplementation in 
the intermediate zone 
(A) Qualitative representation from the CP and IZ of brain sections immunostained for 
Tbr2, a marker of intermediate progenitors of the cortex. Top row represent Tbr2+ nuclei 
and fibers in the CP. Bottom row represent Tbr2+ nuclei and fibers in the IZ. Black 
arrows indicate some examples of positively stained nuceli. (B) Quantitative examination 
of Tbr2+ nuclei showed no differences in the SVZ and an alcohol-related decrease in the 
IZ and CP. In the IZ, where Tbr2 abundance was highest, S-AMe supplementation 
demonstrated a protective effect. (C) Quantitative expression of the Tbr2 transcript 
revealed no significant changes across the groups. SVZ/VZ= subventricular 
zone/ventricular zone; CP=cortical plate; IZ=intermediate zone. *p≤0.05.  
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Figure 34. Alcohol-induced NeuN (im) decrease is ameliorated by S-AMe  
supplementation 
(A)Representative cortical sections immunostained for the neural maturation marker 
NeuN. Dashed lines represent the approximate borders of the cortical sublayers at E17. 
NeuN is expressed in the upper layers of the cortex, including the SP and CP (B) Relative 
expression of NeuN mRNA (encoded by the gene Rbfox3) across cortical tissue samples 
at E17 shows no detectable transcript changes (C-D) Measured immunoreactivity of cells 
as determined by H-scoring show a marked decrease in NeuN-im in the Alcohol group in 
the SP sublayer and the CP sublayer. *p≤0.05, **p≤0.005, ***p≤0.0005; SVZ/VZ: 
subventricular zone/ventricular zone, IZ: intermediate zone, SP: subplate, CP: cortical 
plate, MZ: marginal zone.  
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Figure 35. Alcohol increases Vglut1 expression in the cortical plate 
Representative immunoreactivity of Vglut1 in the cortical plate of (A) Chow (B) PF (C) 
Alcohol (D) Alc+SAM and (E) SAM treated offspring. The presynaptic protein mostly 
accumulated at the cellular membrane and can be observed in dense regions of the cell 
perimeter (d, black arrows). In comparison, the perikarya of Vglut1-negative cells is 
observable by methyl-green counterstaining but devoid of presynaptic Vglut1 densities 
(d, clear arrow). (F) The number of Vglut1+ neurons was significantly increased 
compared to controls. S-AMe supplementation significantly diminished this effect. (G) 
Slc17a7 expression (encoding Vglut1) was similarly upregulated by alcohol cortex-wide. 
Alc+SAM in this assay did not mitigate the alcohol-induced upreguatlion. *p≤0.05; 
**p≤0.005 
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3.3.3 Effect of Alcohol and S-AMe Supplementation on Genetic Targets of Cortico-
Development 
 Epigenetic studies have perpetually revealed the tissue and cellular specificity of 
DNA methylation landscapes across development. Similarly, high throughput studies 
continue to observe that DNA methylation is dynamic across genes, and even within 
different genetic elements (i.e. promoter, exon, intron, UTR, enhancer, etc.). As such, the 
future of DNA methylation study is contingent upon narrowing specific cellular 
populations and genetic contexts. With that in mind, we set out to explore the effects of 
fetal alcohol exposure and S-AMe supplementation on various genes across the timeline 
of cortical development in an attempt to narrow the alcohol and methyl-sensitive cortical 
transcriptome for future epigenetic study.  
 While several studies have used high-throughput methods like RNA-Seq to 
identify multitudes of genes and gene pathways altered by prenatal alcohol, to-date 
methyl-supplementation studies (particularly performed in an alcohol-context) have 
investigated only a handful of genes and gene networks. Based on the observation that 
both alcohol and S-AMe supplementation demonstrated significant impact across various 
molecular markers, it was important to investigate genetic correlates as the corresponding 
transcripts were not usually accountable in the E17 tissue. The strategy employed for 
genetic investigation of cortico-developmental genes was coverage spanning the early to 
late embryogenic pathways previously identified to be critical for cortical development 
and forebrain size. 
 One of the earliest pro-neural genes, Ascl1 is expressed from the most nascent 
cortical stages to late corticogenesis. The gene in its earliest context works to oppose the 
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Notch signaling pathway, diverting multipotent cells away from glial fates toward 
cortical progenitors. It is a positive regulator of Cajal-Retizus (MZ layer) neurons and has 
been shown to promote reelin and Tbr2 expression (Dixit, Zimmer et al. 2011). 
Interestingly, postnatally Ascl1 shifts to play a positive regulatory role on both cortical 
proliferation and oligodendrocyte specification, particularly in response to demyelinating 
insults (Nakatani, Martin et al. 2013). Finally, the gene has been identified as an effector 
and direct target of the RhoA suppressing Rnd3, a critical factor for cortical migration 
within the CP (Pacary, Heng et al. 2011).  
 A collaborator of Ascl1, the pro-neural gene Ngn2 has demonstrated similar 
capacity during corticogenesis. Genetic ablation and ectopic expression studies have 
revealed that Ascl1 and Ngn2 play important roles in establishing the ventral and dorsal 
telencephalon, respectively (Casarosa, Fode et al. 1999, Fode, Ma et al. 2000). 
Additionally, the two coordinate early neural specification and migration (Bertrand, 
Castro et al. 2002, Pacary, Heng et al. 2011). During later stages, Ngn2 works 
synergistically with the proneural Ngn1 in the specification of glutamatergic neurons 
deep layers (V/VI) of the cortex (Fode, Ma et al. 2000, Schuurmans, Armant et al. 2004). 
All the while, Ngn1 has the capacity to inhibit gliogenesis via sequestration and inhibition 
of transcription complexes like CPB-Smad and STATs at pro-glial genes (Sun, Nadal-
Vicens et al. 2001).  
Together, this network of early pro-neural genes plays a diverse and coordinated 
role in the early commitment and specification of multipotent progenitors toward neural 
lineages. Ascl1 and Ngn1 have been identified as epigenetic targets during neural 
development (Cimadamore, Amador-Arjona et al. 2013, Hirabayashi, Shiota et al. 2013) 
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and Ascl1 and Ngn2 have demonstrated sensitivity to prenatal alcohol exposure 
previously (Kim, Go et al. 2010). Examination of their alcohol and methyl sensitivity at 
E17 in this study revealed however, that neither of the three pro-neural genes were 
significantly changed by either alcohol of S-AMe supplementation (Figure 36B-D).  
 Next, we investigated genes involved in cortical specification, a process 
proceeding early pro-neural commitment. In the developing cortex, genetic ablation 
studies and ectopic expression studies have identified several key genes temporally 
regulated to produce the major subtypes of the cortex, cortico-cortico (i.e. callosal) 
projecting neurons, corticothalamic, and subcerebral projecting neurons. While Tbr2 
plays an early role in conferring intermediate precursors of cortical neurons, the 
transcription factor Tbr1 is highly expressed in early born (post-mitotic) glutamatergic 
cortical neurons (Hevner, Shi et al. 2001). Tbr1 is positively regulated by Satb2 and plays 
a crucial role in the specification of callosal projecting neurons of layers II-V (Srinivasan, 
Leone et al. 2012). During early cortical specification Satb2 (and to a lesser extent Ctip2) 
is enriched in and important for callosal specification (Alcamo, Chirivella et al. 2008). 
While callosal neurons are specified, both Tbr1 and Satb2 cooperatively act to suppress 
the regulators of the subcortical fate specifiers-Fezf2 and Ctip2 (Srinivasan, Leone et al. 
2012, Leone, Heavner et al. 2015). Subsequently, direct repression of Fezf2 by Tbr1 
binding at the 3’ region particularly promotes corticothalamic identity in layer VI neurons 
(Han, Kwan et al. 2011). The expression of Satb2 and Tbr1 subsides according to 
temporal transcriptional cues, giving rise to the expression of Fezf2 and downstream 
Ctip2 in the formation of deep-layer subcerebral projection neurons (Arlotta, Molyneaux 
et al. 2005, Chen, Wang et al. 2008). Like Tbr2 and Satb2, Fezf2 and Ctip2 cooperatively 
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suppress the callosal fate regulators (Tbr2 and Satb2) to guide cortical neurons toward 
subcortical fates (Canovas, Berndt et al. 2015). Finally, layer VI differentiation is 
mediated by the direct binding and inhibition of Fezf2 by Sox5 (Kwan, Lam et al. 2008).  
Collectively, this regulatory gene network gives rise to the major cortical subtypes 
and dysregulation, ectopic expression, and mutation of these profiles give rise to severe 
cortical phenotypes including microcephaly, intellectual deficiency, and propensity for 
later life diseases such as schizophrenia (Gulsuner, Walsh et al. , Rosenfeld, Ballif et al. 
2009, Zhang, Li et al. 2014).The determination of cortical subtypes via this network has 
been shown to be highly dependent on the timing of repressive elements and the shift to 
effector roles for several of these genes. Intriguingly, genes like Fezf2 have been targeted 
by Polycomb group (PcG) complex proteins, with the level of binding effectively driven 
by histone methylation at the Fezf2 promoter (Morimoto-Suzki, Hirabayashi et al. 2014). 
Moreover, other genes have demonstrated epigenetic regulation during development, 
including the histone methylation of Tbr1 (Büttner, Johnsen et al. 2010), the DNA 
methylation and histone modification of Ctip2 (Marban, Suzanne et al. 2007, Tan, Nishi 
et al. 2012), and the interaction of Satb2 with various chromatin remodeling elements in 
cortical specification (Gyorgy, Szemes et al. 2008).  
In the evaluation of the gene network’s sensitivity to prenatal alcohol exposure 
and the investigation of S-AMe supplementation as a potential neuroprotector, we found 
that while not all genes were altered by alcohol or S-AMe, the two important subcerebral 
fate specifiers, Fezf2 and Ctip2, were impacted. Specifically, Fezf2 was significantly 
reduced by alcohol and this inhibition was significantly ameliorated by S-AMe 
supplementation (Figure 37C, P=0.004). These effects were further corroborated by 
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immunohistochemical evaluation Fezf2 at the cortical plate (Figure A-2, Appendix A, 
P=0.038). Conversely, the Ctip2 transcript was significantly upregulated by alcohol, 
though S-AMe supplementation did not normalize its expression (Figure 37E, P=0.01). 
These results present a possible genetic route for the phenotypic manifestations of alcohol 
and S-AMe supplementation observed earlier in the experimental paradigm.  
3.3.4 Cortex-wide and Gene Specific Alcohol-induced Epigenetic Alteration and S-AMe 
normalization  
Finally, to investigate whether epigenetic correlates existed parallel to observed 
phenoyptic and genetic alterations of the experimental model, we performed gene 
expression analysis of critical epigenetic enzymes, particularly those involved in 
transmethylation reactions (i.e. DNA and histone methylation).  While in Chapter 2 some 
layer-by-layer DNA methylation examination was performed, here we expanded our 
approach to determine whether the normalizing potential of S-AMe supplementation 
could be traced to the epigenome. Due to the highly integrated nature of epigenetic 
modifications during cortical formation, we hypothesized that both alcohol and methyl-
supplementation would impact the cortical epigenome.  
Three critical methylation enzyme classes regulate all DNA and histone 
methylation reactions. The DNMT family regulates both maintenance (DNMT1) and de 
novo methylation, the latter of which is both dynamically performed by DNMT3a and 
DNMT3b during neural development (Watanabe, Uchiyama et al. 2006). The 
methylation of DNA is largely contingent upon the availability of the active methyl donor 
S-AMe, which upon loss of its methyl group to cytosine bases, is transformed to S-
adenosylhomocysteine (SAH). Methylated DNA can subsequently be converted to 
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hydroxymethylated DNA by the TET enzyme family. While all TET isoforms have been 
shown to play a role in neuronal differentiation, TET3 has been specifically identified as 
a critical role player in the terminal differentiation of neurons (Li, Yang et al. 2015). As 
discussed earlier in Chapter 1, TET enzymes may continue the conversion of 
hydroxymethylated DNA (5hmC) to produce 5fC and subsequently 5caC along a 
proposed demethylation pathway which could culminate in the deamination and 
decarboxylation of 5caC by thymidine DNA glycosylase (TDG) or base-excision repair 
enyzmes. Finally, S-AMe may alternatively donate its methyl group toward histone 
methylation. This process is conferred by a variety of histone methyltransferases (HMTs) 
including Ehmt2 (G9a), a conserved repressive histone 3 lysine 9 (H3K9) 
methylatranferase which has been implicated in dysregulated neuronal transcription, 
cognition, and environmental adaptation (Schaefer, Sampath et al. 2009). Unlike DNA 
methylation, histone methyltransfer is a reversible reaction mediated by a class of 
enzymes known as histone demethylases (HDMs), but little about them in the context of 
developmental alcohol models (Kyzar, Zhang et al. 2016).  
Cortex-wide, we investigated the gene expression patterns of DNMTs, TETs, and 
Ehmt2 across our experimental paradigm. We found that while DNMT transcripts are 
largely unaffected by alcohol or S-AMe at E17, the TET3 and Ehmt2 genes were 
significantly upregulated by alcohol (Figure 38 F-G; TET3 P=0.033; Ehmt2 P <0.0001). 
In both cases, S-AMe supplementation markedly prevented the alcohol-induced 
upregulation. Interestingly, an earlier examination of cortex-wide DNA methylation 
(Figure 29 C-D) demonstrated that 5mC but not 5hmC was downregulated by alcohol, 
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and in that instance S-AMe supplementation did not significantly normalize alcohol-
induced conditions.  
Taking a more cell-specific approach, we examined the distribution of 5mC and 
5hmC in the E17 cortex. Guided by our observations in Chapter 2, here we set out to 1) 
confirm the DNA methylation patterns of alcohol-exposed cortices and 2) evaluate the 
role of S-AMe supplementation. In the SVZ/VZ, 5mC showed a trend toward alcohol-
induced signal reduction, though this trend was not statistically significant (Figure 39B). 
In the mature upper cortical layers, the SP and CP, 5mC was significantly increased 
compared to controls (Figure 39C-D; SP P=0.008; CP P=0.023). Notably, the 
supplementation of alcohol with S-AMe prohibited the alcohol induced 
hypermethylation. While our earlier investigation found that 5hmC was dynamically 
altered by prenatal alcohol, in this experimental paradigm, no alcohol or S-AMe related 
alterations of the 5hmC immunosignal were observed (Figure 40). While trends in the 
SVZ/VZ veer toward our previous observation of alcohol-induced decrease of 5hmC, this 
was not statistically significant (Figure 40B, P=0.079). Overall, these results provide an 
alternative DNA methylation landscape for tissue-wide assessments and support our 
earlier findings of alcohol-induced DNA methylation alterations. Additionally, they 
provide evidence of layer-specific methyl-related normalization of the aberrant DNA 
methylation signature in the upper cortex. Taken together with patterns induced by 
alcohol and S-AMe at the genomic level of DNA and histone-methylation conferring 
genes, the case for epigenetic mechanisms as regulators of alcohol teratogenesis and 
methyl-induced neuroprotection is strengthened.  
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Beyond the cellular level, which we have previously addressed as an important 
contextual element of epigenetic dynamics, advances in commercial technology have 
allowed investigators to probe the epigenetic landscape at the nucleotide level. This high-
resolution strategy can be used to pinpoint precise regions of differential methylation 
which may be crucial for the transcription of the gene. The quest for these sites (referred 
hereto as functional DMRs) is a critical step toward the utilization of DNA methylation 
and other epigenetic landscapes as diagnostic tools. To demonstrate the capacity of this 
strategy in the embryonic cortex, we explored the DNA methylation landscape at various 
regions of the transcription factor Fezf2. Recall that Fezf2 is a crucial component in the 
specification of subcerebral fates and subcortical axon pathfinding during late 
embryogenesis. Additionally, Fezf2 plays an earlier role in the rostrocaudal patterning of 
the forebrain and Fezf2- deficient mice have demonstrated reduced neural progenitor 
differentiation, apoptosis, and reductions in forebrain size (McKenna, Betancourt et al. 
2011, Zhang, Li et al. 2014).  
Due to the sensitivity of the Fezf2 transcript to both alcohol and S-AMe 
supplementation (Figure 37C), we set out to probe various regulatory regions for 
differential methylation with the aim of identifying a novel functional DMR. The Fezf2 
gene consists of a 2.7Kb promoter and four exons. Within the gene, a large portion of the 
promoter and a small introductory portion of exon 1 overlap with a CG rich region (CpG 
island). Due to the regulatory importance of the transcription start site (TSS) and areas 
immediately up and downstream, we investigated a 60 bp and 50 bp region of the 
promoter and exon 1, respectively. Additionally, based on an earlier report identifying 
multiple conserved regulatory regions around the Fezf2 locus which are particularly 
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active during cortical formation, we selected a region ~3.5kb downstream of the fourth 
Fezf2 exon, an area hereto referred as enhancer 434. This site is particularly active in 
cortical progenitors and bears direct binding sites for the cortico-developmental genes 
Tbr1, Sox5, NFIB, and FOXG1 (Eckler, Larkin et al. 2014). A detailed illustration of the 
loci and aforementioned regulatory regions can be found in Figure 41.  
Various transcription factors of relevance were predicted to bind the sequenced 
regions including AP-1, a transcription factor enriched during developmental plasticity in 
the sensory cortex (Kaminska, Mosieniak et al. 1995). Interestingly, AP-1 has 
demonstrated brain responsivity to environmental insults such as lead and lithium 
exposure (Ozaki and Chuang 1997, Pennypacker, Xiao et al. 1997). In alcohol treated 
cortical neurons, AP-1 binding and activity was elevated at the critical glutamate receptor 
subunit gene Nr2b (Qiang and Ticku 2005). The transcription factor E2F-1 has been 
implicated in regulation of neuronal cell death and has been identified in a previous study 
to be upregulated by alcohol exposure during early neurulation (Hou, Callaghan et al. 
2000, Anthony, Zhou et al. 2008). Like AP-1, the transcription factor NF-kB has 
demonstrated redox sensitivity in response to alcohol-mediated oxidative stress. 
Particularly, the NF-kB neuroimmune cascade is induced in the frontal cortex by binge 
ethanol administration (Anton, Alen et al. 2017) and its DNA-binding properties 
modulated during alcohol dependence (Mittal, Nathan et al. 1999). Recently, an 
Ayurvedic compound (traditional Indian medicine) Ksheerabala (101) demonstrated the 
ability to prevent the alcohol-induced upregulation of NF-kB in the brain, concomitantly 
reducing measures of neurotoxicity (Rejitha, Prathibha et al. 2015).  
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 In addition to alcohol-sensitive transcription factors, the examined regions have 
been predicted to bind various neurodevelopmental elements, particularly at the 434 
enhancer. Beside the previously described cortical specification genes Tbr1 and Sox5, the 
binding of HES-1 was predicted at the Fezf2 promoter. HES-1 is involved in Notch 
signaling and the repression of neuronal differentiation. Its suppression has been 
implicated in the promotion of cortical neurogenesis (Ciarapica, Methot et al. 2014). 
Finally, the enhancer 434 region was enriched with POU domain transcription factor 
binding. POU domain TFs are a family of regulatory genes identified in the development 
of the mammalian brain (He, Treacy et al. 1989). Detailed investigation has previously 
characterized the spatiotemporal patterns of POU genes in the regional specification of 
the early neuroepithelium as well as laminar specification in cortical development 
(Alvarez-Bolado, Rosenfeld et al. 1995).  
 Here we observed that alcohol induced DNA hypermethylation at the Fezf2 
promoter (Figure 42A, P <0.0001).While S-AMe supplementation demonstrated a 
normalized group average, the effect was not statistically significant. In the exon 1 
region, no alcohol or S-AMe effects were detected (Figure 42B). Finally, in the enhancer 
434, a regulatory region required for Fezf2 expression in the cortex (Shim, Kwan et al. 
2012), alcohol once again induced hypermethylation. In the enhancer, S-AMe 
supplementation significantly mitigated this hypermethylation cumulatively (Figure 42C, 
P=0.038). Total methylation of the promoter region was the highest among the examined 
regions, ranging from 13-23% methylation depending on experimental condition. By 
comparison, enhancer 434 and the exonic region ranged from 8-15%, depending on 
experimental group. Interestingly, the promoter and enhancer share critical regulatory 
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roles and a degree of overlapping transcription factor binding sites and as such are 
proposed to work together with the enhancer 1316 to mediate the dynamic expression of 
Fezf2 during cortical specification (Eckler, Larkin et al. 2014). Here, we observed the 
parallel hypermethylation of the crucial regulatory regions and gene suppression by 
alcohol. Conversely, S-AMe supplementation normalized DNA methylation levels in the 
enhancer region parallel to the normalization of gene expression levels, presenting 
evidence that important Fezf2 regulatory sites may mediate gene regulation via DNA 
methylation status. An interesting thing to note was that methyl-sequencing of regulatory 
regions in alcohol and S-AMe unaltered transcripts (Ascl1, Ngn1, Syt2) revealed no 
differential methylation (Table B-6, Appendix B). While only complete gene coverage or 
site-directed epigenetic manipulation will positively resolve the functional relevance of 
the genomic DNA methylation landscape, our evidence here supports the thematic 
conclusion that indeed DNA methylation alterations play a role in permissible expression 
and consequent phenotypes.  
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Figure 36. Alcohol does not impact early pro-neural gene expression in the E17 cortex  
(A)Gene networks of three pro-neural genes Ascl1, Ngn2, and Ngn1. Arrows indicate 
gene-associated positive regulation and T-shaped lines denote negative regulation. The 
networks represent a partial illustration of the known actions and gene targets of the pro-
neural genes in the developing forebrain. Gene interactions ultimately manifest in 
contributions to broad, corticogenic processes (bold, italic font). (B) Gene expression 
analysis of Ascl1 (C) Ngn2 and (D) Ngn1 in the E17 embryonic cortex revealed no 
alcohol or methyl-sensitivity. 
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Figure 37. S-AMe supplementation partially normalizes alcohol-induced dysregulation of 
cortical specification genes  
(A) Gene networks of the canonical cortical specification pathway including Sox5, Fezf2, 
Ctip2, Satb2, and Tbr1. Arrows indicate gene-associated positive regulation and T-
shaped lines denote negative regulation. Dashed arrow denotes an early corticogenic 
relationship (relative to the remaining network).The networks represent a partial 
illustration of the known actions and gene targets of the cortical specification pathway as 
determined by multiple genetic loss and gain of function studies. Gene interactions 
ultimately manifest in contributions to broad, corticogenic processes (bold, italic font). 
(B) Gene expression analysis of Sox5 (C) Fezf2 and (D) Satb2 and (E) Ctip2 in the E17 
embryonic cortex. While Sox5 and Satb2 were unchanged by experimental treatment, 
Fezf2 and Ctip2 were significantly affected by fetal alcohol. Only the Fezf2 gene showed 
normalization in the presence of S-AMe supplementation. *p≤0.05, **p≤0.005. 
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Figure 38. Alcohol- induced upregulation of the epigenetic genes Tet3 and Ehmt2 is 
mitigated by S-AMe supplementation  
(A) The DNA and Histone Methylation Pathway consists of a series of biochemical 
conversions of cytosine bases (red) and histone proteins and histone tails. Using the 
active methyl donor (S-AMe), DNMT enzymes transfer the methyl group from S-AMe to 
the cytosine base, yielding 5mC and SAH in its wake. Next, TET enzymes, using 5mC as 
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its substrate, are responsible for the conversion of the methylated cytosine into a 
hydroxymethylated cytosine base (5hmC). Consequently, TET enzymes can continue the 
conversion of 5hmC to 5fC and 5caC, which may then go on to deamination and base 
excision repair processes (TDG/BER) in a demethylation path. Alternatively, S-AMe 
may donate its methyl group toward the methylation of histone core proteins or histone 
tails via the HMT enzyme families in a reversible manner. (B-D) Cortex-wide gene 
expression analysis showed that neither alcohol nor S-AMe produced significant 
transcriptional alterations of the DNMT family enzymes. On the other hand, the TET3 
enzyme (F) and the histone methyltransferase Ehmt2 (G) were significantly upregulated 
by alcohol and markedly normalized by the alcohol+S-AMe treatment. *p≤0.05, 
**p≤0.005.  
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Figure 39. Alcohol-induced laminar 5mC upregulation is normalized by S-AMe 
supplementation  
(A)Representative cortical columns immunostained for the methyl marker 5mC at E17 
reveal the layer-specific distribution of 5mC. (B) Semi quantitative examination of the 
average intensity of the nuclear immunosignal in the SVZ/VZ identify a trend toward 
hypomethylation though this was not statistically significant. (C-D) In the mature layers 
of the cortical plate (the subplate and cortical plate), alcohol significantly increased 5mC 
abundance. S-AMe supplementaion of the alcohol liquid diet in all layers demonstrated a 
normalizing trend. *p≤0.05; SVZ/VZ: subventricular zone/ventricular zone, IZ: 
intermediate zone, SP: subplate, CP: cortical plate, MZ: marginal zone.  
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Figure 40. Laminar 5hmC is unaffected by alcohol or S-AMe in the E17 cortex 
(A) Representative cortical columns immunostained for the methyl marker 5hmC at E17 
reveal the layer-specific distribution of 5hmC. (B-D) Unlike 5mC, abundance of 5hmC 
was quantitatively unaffected by alcohol and S-AMe in both the neurogenic and mature 
layers of the cortical column. *p≤0.05; SVZ/VZ: subventricular zone/ventricular zone, 
IZ: intermediate zone, SP: subplate, CP: cortical plate, MZ: marginal zone. 
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Figure 41. Fezf2 gene, regulatory regions, and predicted transcription factor binding sites 
Fezf2 mouse gene contains a 2.7kb promoter, four exons, and two conserved regulatory 
enhancers which are enriched in cortical neurons (Enhancer 1316 not shown). A 60bp 
segment of the promoter directly upstream of the transcription start site (TSS), an 
introductory segment at exon1, and a large portion of the enhancer 434 region were 
chosen for DNA methyl-sequencing. Circles denote predicted transcription factor (TF) 
binding elements. Red circles denote TFs demonstrably modified by alcohol exposure in 
the brain. Blue circles indicate TFs known to be critical regulators of neural and cortical 
development. E: Exon; 434 denotes a conserved enhancer region of the Fezf2 promoter; 
lollipops denote CpG sites within the sequenced region. 
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Figure 42. Fezf2 promoter and enhancer 434 are hypermethylated by alcohol treatment 
and partially normalized by S-AMe supplementation  
(A) CpG methylation (%) distribution at each CpG within the coverage region of the 
Fezf2 promoter. Cumulative methylation (SUM) revealed that alcohol significantly 
hypermethylated the promoter region compared to PF and SAM controls. While S-AMe 
supplementation indicated a normalizing trend, this was not statistically significant. (B) 
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No group differences were detected overall in the exon 1 region (C) Alcohol treatment 
induced hypermethylation at the enhancer 434 region similar to the promoter. In this 
region, the normalizing effect of S-AMe supplementation was statistically significant. 
*p≤0.05;**p≤0.005.  
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3.4 DISCUSSION 
3.4.1 Neuroprotective Role of S-AMe in Alcohol-induced Cortical Deficits 
 Dietary supplementation strategies have been regarded as promising therapeutic 
avenues in developmental disease. Due to the importance of methyl metabolism in neural 
development, developmental disorders with robust neuroteratogenic profiles have been 
particularly eyed for methyl-donor supplementation. As described earlier, methyl-
supplementation across various models of developmental alcohol exposure have been 
previously performed (Table B-3, Appendix B). While the protective range of the 
strategy is expansive, its capacity in corticogenesis has not been closely scrutinized. The 
well-documented disruption of methyl metabolism by alcohol and the demonstrated 
teratogenic impact of alcohol in the embryonic cortex (Chapter 2) prompted our 
examination of methyl-donor supplementation in our FASD model. 
 As discussed previously, while the nuances of alcohol exposure likely play a role 
in the observed outcomes of the cortical structure, in this study our model reliably 
produced cortical thinning in the E17 mouse forebrain. Expanding on those findings, here 
we observed that this prominent alcohol-related feature was substantially ameliorated by 
supplementation with the active methyl donor S-AMe, as cumulative normalization of the 
cortical length was seen in the Alc+SAM group. While previous studies have highlighted 
the ability of methyl-supplements to protect against gross morphological features like 
reduced brain weight and microcephaly (Xu, Tang et al. 2008, Thomas, Abou et al. 
2009), this is the first known report of methyl-supplemented neuroprotection of the 
cortical length. This was in contrast to the most similar examination to-date, performed 
with choline supplementation in six month old lambs (Birch, Lenox et al. 2016) and 
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which failed to observe improved brain volumetrics. However, the absence of regional 
measures (i.e. cortex) and the high-dose binge ethanol paradigm (with BECs twice that 
observed in this FASD model) greatly limit the comparative value of this study with our 
own. Another question that was uniquely addressed here was whether the neuroprotective 
influence of S-AMe was persistent beyond in utero exposure. We observed that in a 
distinct region of the frontal cortex (sensorimotor) at postnatal day 7 (~10 days after the 
final administration of experimental treatments), both alcohol and S-AMe maintained 
their impacts on the cortex. While FASD intervention models throughout the literature 
vary (methyl-donor pretreatment, simultaneous administration, and post-alcohol 
intervention), none to our knowledge have explored neural, molecular characteristics 
through the lens of lasting impact. As such, our study is the first to demonstrate that 
gestational intervention can produce enduring, protective effects on the most vulnerable 
cortical regions. Future longitudinal studies would need to be performed to resolve 
exactly how far into development these phenomena can detectably persist. Moreover, as 
human studies have linked cortical thickness of infants to long-term verbal learning and 
executive function (Nam, Castellanos et al. 2015), it would be interesting to investigate 
whether methyl-based cortical protection could translate into parallel behavioral 
(functional) outcomes within the same study population.  
 In Chapter 2, we set out to examine various potential underlying factors of 
alcohol-induced cortical thinning. Based upon on those findings, here we set out to 
answer whether S-AMe neuroprotection could be traced to each of these phenotypic 
parameters. This was particularly important given that FASD methyl-supplementation 
studies have not focused on corticogenic processes. Only one previous study was found 
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which examined cortical apoptosis. This study reported that prenatal alcohol increased 
apoptotic enzyme activity and apoptosis in the P0 rat, both of which were mitigated by 
folic acid (Sogut, Uysal et al. 2017). Here, we expand the neuroprotective repertoire of 
methyl-supplementation in the FASD cortex by presenting evidence that it mitigates 
alcohol-induced deficits of nuclear area, Tbr2, and NeuN expression, as well as abnormal 
Vglut1 upregulation. From this we can reasonably extrapolate that through the protection 
of multiple indicators (growth, migration, commitment, and functional maturity, 
respectively) S-AMe may collectively negate the deficits of alcohol on the laminar 
cortical structure.  
 Of course it should be noted that S-AMe neuroprotection was not ubiquitously 
observed. A survey of the protective and non-protective effects of methyl-
supplementation in FASD studies (Table B-3, Appendix B) supports the idea that the 
capacity of methyl donor neuroprotection is often limited. Here, a prominent marker of 
cell proliferation (Ki67) was not normalized by S-AMe supplementation during alcohol 
insult. Interestingly neuroprotection of mitosis at the SVZ/VZ has also escaped methyl 
supplementation strategies in a model of methyl-insufficiency (Craciunescu, Johnson et 
al. 2010). It might be the case that pre-mitotic cells of the neocortex are less responsive to 
methyl-supplementation. This would be fitting with lack of neuroprotection observed in 
the SVZ/VZ thickness though a more detailed investigation is required. Though 
proliferation is one of the major phenotypic processes of the cortex, it has been highly 
disregarded in methyl-supplemented alcohol studies to-date. Considering cortical 
neuroprotection in the context of structural preservation, the absence of protected 
proliferation is perplexing (diminished cell number plays a major role in cortical 
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thickness). One may consider that the use of Ki67 as an immunohistochemical marker of 
cell proliferation can perhaps be improved or complimented by a more precise molecular 
proliferation marker such as BrdU. Alternatively, as mentioned in Chapter 2, not all 
cortical cells originate from the neurogenic SVZ/VZ. A large portion of inhibitory 
interneurons proliferate at the medial ganglionic eminence which was not evaluated here. 
It is possible that proliferative neuroprotection may be observed elsewhere in future 
studies.  
3.4.2 Genomic and Epigenetic Normalization of FASD targets via S-AMe 
supplementation 
Despite the observation of cortical normalization across various processes, the 
question remains how methyl supplementation (metabolism) mediates phenotypic 
outcomes on a molecular scale. The most logical starting point is the consideration that 
methyl-supplementation can normalize the aberrant methyl metabolism demonstrated by 
alcohol (for a review see (Resendiz 2016)). Developmentally, alcohol may also alter the 
dynamics of maternal-fetal methyl transport, influencing metabolic and biochemical 
outcomes in the fetus. Previously, in a guinea pig model of FASD, chronic folic acid 
supplementation was protective against reductions in fetal liver folate (Hewitt, Knuff et 
al. 2011). Another study observed improvements in embryonic methyl metabolism 
through the evaluation of hyperhomocysteinemia (homocysteine accumulation results 
from the diminished conversion of the substrate to methionine by betaine-homocysteine 
methyltransferase (BHMT) and methionine synthase (MS)) (Shi, Li et al. 2014).  
Here, to evaluate the role of S-AMe supplementation on the normalization of 
methyl-metabolism, we investigated the enzyme conferring the active methyl donor form 
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S-AMe, MAT2A, in the fetal liver and brain. We found that in the fetal liver, alcohol 
predictably diminished MAT2A expression while S-AMe supplementation normalized 
the expression of the transcript. Because S-AMe metabolism is cyclical in nature (S-AMe 
byproducts are recycled into methionine), we can confidently extrapolate that these 
observations are indicative of cycle-wide trends. In the brain, MAT2A was not apparently 
sensitive to alcohol, though S-AMe supplementation increased MAT2A transcript levels 
(consistent with hepatic trends). Interestingly, this pattern was also observed in the 
Hewitt study, where liver folate but not brain folate was normalized in the presence of 
folic acid supplementation (Hewitt, Knuff et al. 2011). This increased hepatic sensitivity 
may be rooted in the fact that it is the predominant site of S-AMe production by MATs 
(Finkelstein 1990).  
It should be noted that though transcriptional activity of the enzyme was altered 
by the experimental treatment, no enzymatic activity assay was performed. In the future, 
it would be more accurate to supplement gene expression analysis with molecular 
enzymatic assays as ultimately, enzyme activity and not simply abundance is truly 
reflective of metabolic activity. Due to the indirect nature of our methyl-metabolism 
probe, we examined liver and cortex-wide DNA methylation as a secondary function of 
methyl metabolism (S-AMe availability determines, among other things, DNA 
methylation). Consistent with alcohol-diminished methyl-metabolism, we observed liver 
and cortex-wide 5mC hypomethylation, but not 5hmC hypomethylation. Moreover, 
though S-AMe supplementation demonstrated normalizing capacity for liver Mat2a 
expression, the treatment did not normalize alcohol-induced liver nor cortical 5mC 
hypomethylation.  As discussed in Chapter 2, the absence of a treatment sensitivity of 
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5hmC on a tissue-wide scale may be due to 1) the relatively lower abundance of the 
methyl mark (~1/10 of 5mC in the brain and even lower in the liver) and/or 2) the cellular 
specificity of 5hmC in more mature cortical cells (proportionately less than the 
neurogenic cells which make up the cortical column). 
  Regarding the normalizing capacity of S-AMe toward DNA hypomethylation in 
the neurogenic zones, ample evidence across non-alcohol associated hypomethylating 
conditions has previously substantiated the neuroprotective role of S-AMe (Cravo, Pinto 
et al. 1998, Tian, Zhao et al. 2012, Carlin, George et al. 2013). Here, the absence of a 
statistically significant difference between the Alc+S-AMe group and all controls may 
hint at a partially normative effect in lieu of a statistically significant differences between 
the Alc and Alc+S-AMe groups in some cases. This subtlety may perhaps be due the 
diversion of supplemented S-AMe across histone methylation, DNA methylation, and 
polyamine synthesis (Petrossian and Clarke 2011). Another consideration is that due to 
the context-specificity of DNA methylation across development, dietary methyl-
supplementation may similarly exhibit site or cell specific impact. Support for this can be 
taken from the relatively more defined nature of methyl-supplementation in gene-specific 
studies versus global tissue assays. For example, in the male offspring of alcohol-treated 
rats, POMC gene hypermethylation was prevented by choline supplementation (Bekdash, 
Zhang et al. 2013). Alternatively a tissue-wide assay of alcohol-treated rat offspring 
revealed a more complex function, where choline supplementation alleviated 
hippocampal hypermethylation but not cortical hypermethylation (Otero, Thomas et al. 
2012). The context specificity of DNA methylation normalization is also substantiated 
here. Though tissue-wide assays hint at the normalizing capacity of S-AMe, 
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immunohistochemical examination of the cortex (a more cell discriminatory method) 
distinctly demonstrates its role in the normalization of upper layer (SP and CP) DNA 
methylation (5mC). Clearly, the FASD methyl-supplementation literature to-date bears 
an emerging epigenetic view and much more investigation is required to unravel the 
dynamics of methyl supplementation and neuroprotective outcomes. Despite this, 
collective findings are building the case that like alcohol, S-AMe and other methyl 
donors do not unilaterally alter the epigenome. Future studies will have to address the 
mechanisms mediating this proposed methyl-selectivity of the genome and reconcile 
those with alcohol-sensitive epigenetic recruitment elements.  
One crucial aspect of alcohol-related neuroteratogenicity that was not thoroughly 
addressed in this study and which plays a critical role in DNA and histone methylation is 
the direct inhibition of alcohol on the activity of epigenetic enzymes. While donor 
supplementation significantly mitigated cortico-developmental deficiencies and to a 
degree methyl metabolism and DNA methylation, it is important to keep in mind that 
enzyme activity ultimately dictates the rate of methylation. Though technical constraints 
limited our assessment of enzyme activity, a genomic screen of DNMTs, TETs, and an 
HMT was performed. Interestingly our expression analyses revealed that while DNMT 
transcripts were not impacted significantly by alcohol or S-AMe, Tet3 and Ehmt2 (G9a) 
were substantially upregulated by alcohol and normalized by S-AMe. Our observations 
both corroborate and deviate from previous observations made in a choline-
supplementation FASD model. In that report, Ehmt2 expression in the mediobasal 
hypothalamus of adult male offspring agreed with our findings in the embryonic cortex, 
where methyl-supplementation normalized the upregulation of the HMT. Assessing 
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DNMT genes, however, the authors observed upregulation of the DNMT1 transcript but 
erroneously conclude that choline supplementation exerted a normalizing effect. In fact, 
their data shows that choline supplementation actually reduced the expression of DNMT1 
to levels significantly lower than all controls. Their assessment of the DNMT3a transcript 
further revealed that while no alcohol-effect was detected, the gene was significantly 
upregulated by both alc+choline and the choline control. Though significant variations in 
our models restrict our comparison (age, sex, brain region, methyl-donor), collectively 
our data suggest that perhaps HMT sensitivity to alcohol and methyl donors are more 
conserved across development and brain region while DNMTs may be more contextual in 
nature. Our report validates and extends the existing literature by presenting TET analysis 
and identifying Tet3 as a potential contributor to the DNA methylation landscape. 
Though our genomic analysis does not completely reconcile our cortex-wide DNA 
methylation outcomes, it certainly presents evidence that the normalizing potential of S-
AMe supplementation transcends phenotypic observations, complementing molecular 
aspects of methyl-metabolism and DNA methylation, the complexities of which remain 
to be unraveled.  
In continuation of our genomic assessment of S-AMe’s role on alcohol-
dysregulation, various critical neurodevelopmental targets were examined. While early 
pronerual genes did not reveal significant genomic sensitivity to either experimental 
treatment, an important network of cortical-specification genes was demonstrably 
impacted by alcohol and S-AMe. Because nearly all examined genes have previously 
demonstrated developmental sensitivity to alcohol across the literature, it is possible that 
our observational timepoint was beyond the window of transcriptional impact for the 
185 
early pro-neural genes. For example, Ascl1 and Ngn1 play a role in regionalization of the 
cortical neuroepithelium and early neural differentiation (Ma, Sommer et al. 1997). 
Though they go on to play developmental roles in post-mitotic neurons, peak expression 
occurs around E12 (Castro, Martynoga et al. 2011).  Ascl1 and Ngn2 subsequently play a 
role in radial migration and deleterious effects of Ascl1 (up to E14.5) bear demonstrable 
phenotypic consequences (reduction of radial glial migration) in late gestation (Pacary, 
Heng et al. 2011). These results suggest that genomic cortico-developmental changes 
may precede phenotypic presentation and perhaps explain why early proneural gene 
networks are not seemingly responsive to the experimental treatment transcriptionally at 
E17.   
In that vein, we assessed a network of cortical specification genes with mid-late 
peak embryonic expression. These included cotrico-cortico and subcerebral projection 
genes including Sox5 and Ctip2, which, though peak in expression ~E14, continue to be 
genetically relevant as late as P0 (Lai, Jabaudon et al. 2008). Ablation studies also reveal 
that though peak expression of Satb2 (a callosal projection gene) occurs early in 
corticogenesis, it maintains functional axonal guidance capacity as far as E18.5 (Alcamo, 
Chirivella et al. 2008). Finally, the Fezf2 gene plays an extremely dynamic role 
throughout neural development. Expressed as early as E8.5, it plays an early role in 
rostrocaudal patterning and progenitor differentiation. In late gestation, the transcription 
factor maintains a prominent role in subcortical axon pathfinding and uniquely, maintains 
its expression into adulthood where it regulates motor cortex circuitry (Tantirigama, 
Oswald et al. 2014). We indeed found that the subcerebral axonal guidance factors Ctip2 
and Fezf2 were significantly altered by alcohol. Of these, only Fezf2 was significantly 
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normalized by S-AMe supplementation. These results (in addition to the observed 
upregulation of Vglut1) appear to support our proposition that genomic presentation of 
environmental influences may rely on temporal expression, a factor that should be 
considered when genomic elements are investigated in the future. To further support this 
idea, it would be necessary to investigate the early proneural gene network at an earlier 
embryonic time point. Ascl1, for example, does demonstrate both transcriptional and 
epigenetic sensitivity to alcohol in cultured neural stem cells (Lo, Choudhury et al. 2017). 
Our genomic findings also echo an earlier theme which paints S-AMe supplementation as 
possessing a more potent intervention capacity in mature versus early stage cells and 
transcripts.  
As discussed in the epigenetic gene findings, there remains a pressing need to 
understand what makes a gene more liable to alcohol or S-AMe sensitivity. If the answer 
were strictly surrounding DNA or histone methylation mechanisms, it is likely that 
normalization of epigenetic methylation and the conferring enzymes would be prominent 
and neuroprotection ubiquitous-a phenomenon that has eluded a significant portion of all 
methyl-supplement FASD studies, including our own. The more likely scenario is that 
alcohol-induced neuropathy in the fetal organism, though largely rooted in the metabolic 
action of alcohol and methyl donor production, diverts into other pathways beyond the 
reach of restorative supplementation. For example, alcohol metabolism produces harmful 
reaction oxygen species (ROS), the likes of which play roles as second messengers in 
signal transduction, potentially altering gene expression and post-translational 
modification of proteins (Covarrubias, Hernández-García et al. 2008). S-AMe also plays 
a role in the production of glutathione S-transferase, an enzyme critical for the reduction 
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of harmful ROS’ (Tchantchou, Graves et al. 2004)). The interaction of S-AMe and ROS’ 
is just one example of how S-AMe mediated alcohol neuroteratogenicity may utilize non-
epigenetic pathways to confer phenotypic outcomes, reconciling why aberrant DNA 
methylation cannot fully account for the myriad of alcohol-related biological disruption. 
3.4.3 Identification of a Novel, Functional DMR in the Cortical Specification Gene Fezf2 
Ultimately, the epigenetic footprint of alcohol and S-AMe as a supplementation 
strategy was meaningful and far-reaching, presenting prominent structural, molecular, 
and to some degree transcriptional neuroprotection. Combined with the normalizing role 
of S-AMe supplementation on methyl metabolism, layer-specific DNA methylation and 
epigenetic correlates, we attempted to answer whether we could define a novel 
differentially methylated region (DMR) which could substantiate the hypothesis that 
DNA methylation plays a regulatory role in gene expression and the molecular 
transduction of environmental impacts at the nucleotide level. The cortical specification 
gene Fezf2 was selected for proof of concept due to its dynamic roles throughout cortical 
development and it ties to abnormalities in cortical structure and reduction of forebrain 
size (Chen, Wang et al. 2008, Zhang, Li et al. 2014).  
The characterization of this alcohol and S-AMe sensitive target was informed by 
previous literature reporting conserved regulatory regions critical for the expression of 
the gene in cortical progenitors and for subcerebral projection neuron identity and 
connectivity (Shim, Kwan et al. 2012). Additionally, we examined a region of the 
promoter around the TSS which shares several overlapping transcription factor elements 
and is essential for expression. We hypothesized that DMRs would be more likely 
observed in gene regulatory regions and as such, we included an exonic region 
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downstream of the TSS for contrast.  We found that alcohol sensitivity was present at 
both the promoter and enhancer 434, where alcohol hypermethylated the region. This was 
in agreement with our observations of 5mC in the upper layers charged with production 
of subcerebral projection neurons. While S-AMe supplementation did not normalize 
DNA hypermethylation at the promoter, it did so at the critical enhancer. On the other 
hand, the exonic region demonstrated no statistically significant response to either 
alcohol or S-AMe, supporting the notion that DMRs may be confined to regulatory gene 
regions. As Eckler et al propose, however, the enrichment of Fezf2 (and similar 
specification genes) at the upper cortical layers suggests the existence of repressor 
sequences to restrict its expression to the appropriate cells (Eckler et al 2014). How and 
where these are presented in the DNA methylation landscape requires future 
investigation. 
Finally, the absence of 5hmC-specific methyl sequencing prevents us from fully 
understanding the DNA methylation landscape of Fezf2. For example we cannot account 
for existing 5hmC within the gene body (i.e. exons) or other regions which may be 
differentially expressed in response to alcohol or S-AMe. Additionally, while two 
important regulatory regions were presented, there remains a substantial amount of 
uncovered loci which could reveal a more complicated relationship between the 
occurrence of DMRs and gene expression. Advances in epigenetic tools, including 
TALEN technology now allow for the site-directed manipulation of epigenetic effectors, 
including DNMTs and TETs. Their use in verifying the functional contributions of 
suspected regulatory DMRs in the future will be crucial to our understanding of that 
relationship. 
189 
3.4.4 Summary and Conclusions 
 In this study we observed that alcohol-mediated disruption of cortical 
development in late gestation was widespread, reaching elements of cellular maturity, 
migration, fate-specification, and synaptic plasticity. These observations were correlated 
with the alteration of important epigenetic regulators. Consequently, alcohol impacted 
both global and layer-specific abundance of the DNA methylation marker 5mC, which 
has been largely supported as a transcriptional influence in neural development. How 
alcohol achieves molecular outcomes was the major investigative course herein. 
Particularly, the role of alcohol metabolism on the methyl metabolism and DNA 
methylation biogenesis pathways provided rationale that the methyl-donor S-AMe could 
be culpable. As such, we examined whether supplementation of prenatal alcohol with S-
AMe could mitigate epigenetic dysregulation and improve developmental outcomes. 
 We found that S-AMe was a normalizing factor across structural, cellular, and 
morphological aspects of development in the cortex. Moreover, the protective nature was 
detectable at the level of methyl metabolism and DNA methylation as evaluated in a 
layer-specific manner. Probing deeper into the genomic level, we found that both alcohol 
and S-AMe neuroprotection were detectable at nucleotide resolution. Apparently 
selective for regulatory regions, differential methylation patterns of the two external 
stimuli dually impacted gene expression, supporting the regulatory nature of the DNA 
methylation program in the developing cortex.  
 Though prominent, S-AMe neuroprotection was not as widespread as alcohol’s 
impact. In many cases, S-AMe supplemented groups showed normalizing trends but did 
not achieve significance statistically, reflecting a probable muted action of S-AMe in 
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some respects. This limited capacity of methyl supplementation strategies (relative to 
alcohol) has been a feature of much of the FASD literature. Perhaps rooted in the non-
exclusive nature of S-AMe as a DNA methyl donor (it is a critical donor for histone 
methylation and polyamine synthesis), supplemented S-AMe may be diverted toward 
other biological pathways. Another very likely scenario is that alcohol metabolism 
inflicts damage to the cell through non-epigenetic pathways. For example, the production 
of ROS and mitochondrial dysfunction by alcohol has been shown to induce oxidative 
damage in the brain. Overall, the embryonic cortex appears to be a highly responsive 
target of both alcohol and methyl supplementation and more importantly, demonstrates a 
rectifiable nature. This is substantial as a significant population is (knowingly or 
unknowingly) at risk for some level of gestational alcohol exposure. 
 A common observation throughout the evaluation of our findings was that not all 
cell types, phenotypes, or genes responded equally to methyl supplementation. 
Consistently, a pattern emerged pointing to mature cell types and late-specified genes as 
more susceptible to neuroprotection (versus proliferating neruogenic cells, early genes, 
etc.) at the examined age. The selective nature of some genomic regions versus others 
was similarly apparent, indicating that, perhaps, intrinsic context selectively defines the 
response to S-AMe. At this time however, it remains unclear if and how genome context 
could dictate environmental sensitivity of a gene or cell. Additionally, it is not known 
how this mechanism may register stimuli differentially. Another unanswered question 
features the reconciliation of unilateral alcohol and methyl supplementation effects at the 
metabolic level with bivalent outcomes at the genomic, epigenetic, and phenotypic level. 
For example, alcohol has consistently demonstrated an inhibitory role, and methyl 
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supplementation an enhancing role in the methyl metabolism cycle. Examination of DNA 
methylation across various contexts, however, describes the simultaneous up and 
downregulation of various alcohol targets. DNA methylation follows suit, displaying 
hyper and hypomethylation in a gene or cell-dependent manner. The unknown 
mechanisms at work conferring the bivalence of alcohol are apparently also at work 
communicating the normalizing action of S-AMe, as directionality of its effect was 
almost always alcohol-dependent. Importantly, here we observed that S-AMe 
consumption (no alcohol, ad libitum) in and of itself did not overstimulate the production 
of DNA methylation (tissue or cell wide) or negatively impact gene expression or 
phenotypes throughout the cortex. This is important because several lines of evidence 
have demonstrated that over-consumption of dietary methyl precursors can be detrimental 
throughout development (Pickell, Brown et al. 2011, Mikael, Deng et al. 2013). This 
finding hints that alcohol-driven epigenetic dysregulation may not be strictly dictated by  
methyl-donor insufficiency, since unrestricted methyl supplementation observed 
normative epigenetic, genetic, and phenotypic  outcomes. A more thorough investigation 
in the future should reconcile enzymatic activity with the exposure patterns observed 
here. Regardless, our findings speak to the tolerability of S-AMe at this dosage and 
support its potential utility as a therapeutic in developmental disease.  
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COMPREHENSIVE DISCUSSION 
 
In this Dissertation we describe that DNA methylation, as a principle epigenetic 
mechanism, is a dynamic and cell-unique landscape. Developmental study in the 
cerebellum and embryonic cortex revealed that no two cell types experience the exact 
presentation of DNA methylation at any given time. Rather, cells may both acquire and 
lose DNA methylation in unique patterns, or, “programs” that align with their 
developmental events. In support of this phenomenon, epigenetic correlates, including 
methyl-DNA binding proteins, compliment these DNA methylation programs. More 
importantly, developmental DNA methylation may be a crucial component regulating 
gene expression. For example, we demonstrated that key Purkinje cell genes reflect cell-
wide DNA methylation trends at the genomic level. While simultaneous expression 
change was observed, it remains unclear whether DNA methylation precedes expression 
and developmental processes (supportive of DNA methylation as a developmental 
regulator) or whether DNA methylation is a by-product of cellular development. This 
examination also shed light on some important DNA methylation dynamics, including the 
mutual exclusivity of 5mC and 5hmC within the nucleus during the first postnatal week, 
and the gradual overlapping presentation that likely reflects genome-wide DNA 
methylation re-distribution. Additionally, throughout the cerebellum and in the 
embryonic cortex, we observe 5hmC as reliably strengthened in maturing cell types.   
To build evidence for DNA methylation as a regulatory mechanism we 
investigated DNA methylation landscapes in an environmentally-mediated disease-state 
which has been transcriptionally and phenotypically linked to wide-spread brain 
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abnormalities for decades. A mouse model of FASD not only confirmed cortex-wide 
neuropathy (including reduced proliferation, migration, and maturation) but also 
demonstrated cumulative manifestation of the environmental insult at a structural level 
which could underlie a host of cognitive deficits attributed to FASD in later life. 
Interestingly, these events were accompanied by parallel alteration of the cortical DNA 
methylation program, further supporting its sensitivity to environmental exposures and 
relevance as a developmental device. This study importantly showed that though the 
impact of alcohol was identifiable from the tissue to the gene level, the DNA methylation 
profile of prenatal alcohol exposure was divergent across cell types. This recurring 
observation reiterated the cell-specificity of the developmental DNA methylation 
program and implies it as a mechanism that determines how a cell or loci may uniquely 
internalize environmental inputs.  
In order to investigate how alcohol as an external signal could act upon the DNA 
methylation signature (and consequently, gene expression), we exploited a known methyl 
metabolism deficit induced by alcohol. Methyl metabolism has been reported to be 
crucial for early brain development and insufficiency of various metabolites producing 
the active methyl donor S-AMe have been linked to neuropathy and cognitive deficits 
similar to FASD. Because S-AMe is the sole donor for DNA and histone methylation, our 
previous observations of alcohol dysregulation of DNA methylation prompted us to 
examine whether manipulation of S-AMe in the presence of alcohol could inhibit its 
neuroteratogenicity. We found that indeed S-AMe was an effective (though not 
ubiquitous) protector against alcohol-induced structural and phenotypic deficits in the 
cortex. This provided support for our proposition that alcohol as an environmental insult 
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utilized epigenetic pathways to communicate its detrimental action at the cellular level. A 
missing piece of the picture, genomic analysis was subsequently undertaken to confirm 
the regulatory nature of DNA methylation and the environmental sensitivity of relevant 
genomic regions to both detrimental and neuroprotective external stimuli. Through this 
analysis we found that a critical gene involved in cortical fate specification and axonal 
guidance was hypermethylated at regulatory promoter and enhancer sites, and 
simultaneously exhibited transcriptional fluctuations. S-AMe’s protective action was 
once more observed at the nucleotide and transcriptional level, indicating that the same 
dynamics at work in the cellular landscape of the embryonic cortex could be 
demonstrated at the genomic level.  
While the limitations of the work are detailed throughout, much understanding 
was gained from these studies, individually and collectively. The major and recurrent 
themes included the cell-unique nature of DNA methylation patterns. Recall from 
Chapter 1that evolving DNA methylation landscapes have been previously characterized 
during neural specification. The evidence described here confirms those observations in 
vivo and proposes that the DNA methylation program, by shaping the cellular 
transcriptome, may underlie cell-uniqueness.  
Through normal and disease states, our work also highlights the regulatory 
capacity that DNA methylation possesses during development. Beyond spatial, temporal, 
phenotypic, and genomic correlation, DNA methylation analysis at the nucleotide level 
provides evidence that even minute methyl signatures (at critical regions) can suffice to 
alter the course of gene expression. Of course, this proposition requires expansive 
confirmation in the form of multiple genes, gene regions, and 5mC/5hmC discriminatory 
195 
sequencing. Finally, in addition to its emerging regulatory role, DNA methylation is 
capable of internalizing environmental information, positioning the mechanism at the 
forefront of environmentally-driven disease. Interestingly, here we illuminate the dual 
nature of this external communication mechanism, describing that the DNA methylome 
can be driven bimodally by distinct stimuli. Though the particulars of the 
alcohol/methyl/epigenetic triad likely span beyond the limits of methyl metabolism (i.e. 
non-epigenetic elements, alcohol-mediated oxidative stress, enzyme activity, etc.), the 
epigenetic and phenotypic outcomes of alcohol and S-AMe share bilateral characteristics. 
Again, this diversity is likely dictated by genomic elements beyond our current 
understanding but nonetheless demonstrate the sensitivity and rectifiable nature of the 
DNA methylation program in development. The prominent role we have laid out implies 
that normal neural development is likely contingent upon undisrupted epigenetic 
progression. While not likely all-encompassing, DNA methylation may shed some light 
on developmental disease etiology across various environmentally-mediated states in the 
future.  
Epigenetics as a mechanism of organismal diversity has filled a long-held void 
which failed to reconcile intrinsic biological factors with environmental exposures. 
Though the precise molecular mechanisms of environmental transduction have eluded 
researchers, today, epigenetic modifications like DNA methylation are offering answers. 
Uniquely positioned at the intersection of environmental input and epigenetic 
biochemistry, alcohol as an environmental pressure during development offered a 
window by which to view the molecular transduction of environmental inputs (Figure 
43). Through this modality we probed the dynamics of epigenetic mechanisms in 
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response to the environment. The evidence-based concepts built here push forward a 
better understanding and establishment of epigenetic states or signatures which are 
critical to transcriptional regulation, phenotypic, and functional outcomes. Using what we 
learned here, the future of DNA methylation in development promises a wealth of 
possibilities for the landscape as a diagnostic tool. Further, epigenetic editing and 
epigenetic-altering compounds may become useful therapeutic tools in developmental 
disease. 
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FUTURE DIRECTIONS 
 
 The notion that DNA methylation bears capacity as a developmental regulator, 
though continually mounting has taken a back seat in recent years to a shifting focus of 
the field toward the examination of the mechanistic particulars of the feat. As such, the 
future of DNA methylation research will extensively feature genomic methyl profiling 
and targeted manipulation. Methyl profiling will be crucial toward our understanding of 
cell and gene-unique programs as high-throughput assays could clarify the cell-unique 
methylation patterns down to the level of the cellular transcriptome. Additionally, 
methyl-sequencing of disease experiencing patients may aid in the development of 
biomarkers for environmentally-driven disease (a tool already heavily employed in 
cancer and emerging in alcohol disease) (Wittenberger, Sleigh et al. 2014, Liu, Marioni et 
al. 2016). In fact, the use of methyl-profiling of the genome in disease is a crucial 
element toward our understanding of methylation and expression “thresholds” which 
trigger the onset of a disease phenotype. This will be particularly relevant in diseases 
driven by “Latent Early- life Associated Regulation”, which proposes that epigenetic 
landscapes in the somatic cells can enduringly carry early life “experiences” in a 
cumulative fashion which may or may not eventually achieve pathological thresholds 
(Lahiri, Maloney et al. 2009, Maloney and Lahiri 2016). The value of such investigation 
in FASD is extremely relevant as many exposed offspring, through subtlety of early life 
phenotypes, escape diagnosis but maintain a propensity for neural and behavioral deficits 
in later life. Finally, DNA methylation profiles spanning larger regions of the genome 
will additionally clarify patterns which may underlie environmental propensity. 
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Ultimately, the goal is the utilization of DNA methylation signatures as quantifiable 
predictors of life outcomes. 
On the other hand, epigenetic manipulation may be used in vitro to either 
challenge the prevailing theory of DNA methylation as a transcriptional regulator or to 
pinpoint obligatory elements. Further, these tools tackle the “chicken versus egg” 
dilemma that has plagued the field of epigenetics for years. Ongoing work in our lab has 
demonstrated the functionality of epigenetic editing in neural stem cells and confirmed 
the critical nature of DNA methylation at the regulatory promoter of the pro-neural Ascl1 
(Lo, Choudhury et al. 2017). Though the subfield of epigenetic editing has only recently 
taken flight, the strategy of engineering DNA-binding domains to manipulate and 
normalize disease-modified landscapes remains a long-term goal.  
 Reflecting on our current study, recurrent gaps for future consideration included 
the need for a better understanding of not just genomic methylation landscapes, but also 
the interaction of these sites with the appropriate downstream transcriptional elements 
(i.e. direct transcription factor binding, methyl-binding proteins, RNA polymerases, etc.). 
Excitingly, emerging tools including affinity assays and SILAC-based proteomic analysis 
and high-fidelity Fluorescence Lifetime Imaging based Forster Resonance Energy 
Transfer (FLIM-FRET) are beginning to unravel the mechanisms by which sequence 
elements like DNA methylation either recruit or prohibit binding and influence 
transcription (Bartke, Vermeulen et al. 2010, Chen, Damayanti et al. 2014), clarifying our 
understanding of the functional associations of the DNA methylome. These tools will 
likely prove equally useful in our understanding of inter-epigenetic frameworks. While 
not detailed here, cross talk between epigenetic elements (i.e. DNA methylation, histone 
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methylation, microRNAs) is likely prominent and will further add to the complexities of 
DNA methylation as a regulatory mechanism. It will be crucial in advanced epigenetic 
study, to consider the multitude of epigenetic mechanisms which may converge on a 
regulatory region to confer meaningful change.  
 Finally, the promising structural and molecular neuroprotection of S-AMe as a 
dietary intervention strategy beckons further optimization in high-risk pregnancies such 
as FASD. Some literature has proposed that the co-administration of methyl-
supplementation and methyl metabolism co-factors (i.e. vitamin B, zinc, omega-3) may 
enhance the protective reach of methyl precursors, though others have found that this 
strategy is not consistently optimizing (Seyoum and Persaud 1997, Xu, Li et al. 2006, 
Kusat Ol, Kanbak et al. 2016, Sogut, Uysal et al. 2017). Future study of methyl-
intervention across methyl-insufficiency associated developmental disease should further 
probe the differential outcomes of variable methyl supplement source (i.e. folic acid 
versus choline or S-AMe), dose, administration window (i.e. pretreatment versus post-
exposure intervention, etc.), and/or the compound action of multiple donors and co-
factors. Moreover, the identification of novel nutrient-sensitive differentially methylated 
regions (ns-DMRs) here should be followed by the investigation of additional ns-DMRs 
in nutrient-affected developmental disease, as they offer a wealth of opportunity for the 
safe and effective use of dietary intervention which may rival current therapeutics. 
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Figure 43. Environmental signal integration is mediated by methyl metabolism and 
epigenetic regulation of the genome 
Conceptual illustration depicts the dual integrative nature of the methyl metabolism cycle 
toward dietary factors including alcohol and dietary folic acid. The output of the cycle, S-
AMe, is the obligatory donor for DNA and histone transmethylation (middle). DNA and 
histone methylation (along with other epigenetic factors) influence the structure of 
chromatin and, ultimately, the transcription factors which dictate gene expression and 
confer cellular phenotypes. TF: Transcription factor, Me: Methylation, Me-OH: 
Hydroxymethylation, PcG: Polycomb group repressor complex, RNA Pol: RNA 
Polymerases, NSCs: Neural stem cells 
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APPENDIX A 
 
Figure A-1. Cortical Length and NeuN Distribution Across the Cortical Column at P7 
Representative cortical columns of the postnatal (P) day 7 sensorimotor cortex across 
groups stained for the nuclear neuronal antigen NeuN. The cortical column at P7 
maintains a sensitivity to alcohol at the sensorimotor region, where alcohol-induced 
cortical thinning persists. Offspring of groups supplemented with S-AMe are protected 
from cortical thinning. Numerals denote the approximate borders of the six cortical 
layers.  
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Figure A-2. The transcription factor Fezf2 is decreased by alcohol in the cortical plate 
and normalized by S-AMe supplementation 
(A) Representative images of the cortical plate reflecting the immunoreactivity of the 
Fezf2 protein (B) Relative expression of Fezf2 mRNA across cortical tissue samples at 
E17 showed a decreased expression of the transcript in the alcohol, normalized by S-
AMe supplementation (C) A similar pattern was found in the quantitation of Fezf2 
immunoreactivity in the CP. All data are presented as Mean±SEM. *p≤0.05, **p≤0.005; 
CP: cortical plate. N reflect the number of independent litters represented in each group 
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APPENDIX B 
 
Primers used for qmethyl study
Name Sequence Annealing temp
Gsbs_promoter_F ATCATTGTGGTGTCCTGCAA 62
Gsbs_promoter_R CCAGTTGCTGGTGAGAAGGT 62
Gsbs_genebody_F CCTGTAAGACCCGACACCAT 62
Gsbs_genebody_R TATGAAGAGCTGGGCCTGAT 62
Itpr1_promoter_F TCAGACACAAGTTCGCAACC 60
Itpr1_promoter_R GCTTCAGCAGAACATCCACA 60
Itpr1_6835-7035_F CCACCCTCCCCTGTCTATTT 62
Itpr1_6835-7035_R GCAGAGACCAGGATGTAGGG 62
Itpr1_1481-1717_F CGGTCCAGAATGCTCTGTTT 62
Itpr1_1481-1717_R GCACAGTCAATAGGCGTCAA 62
Itpr1_8480-8753_F ACCCACATCACCTTCCTGAG 62
Itpr1_8480-8753_R TCAGCAATCGAGAGAGTCCA 62
Grid2_5625-5953_F CATGTCTGGTGTCTGGCATC 62
Grid2_5625-5953_R TGTTCCTTTCTGGCAGTCCT 62
Baiap2_4867-5122_F GTTGCTGCTCTTGGTCTGGT 62
Baiap2_4867-5259_R CTCAGACACCCCTTCCTGTC 62
Cacna1g_6602-7380_F TCTGCTTCATGCAGGCTCTA 62
Cacna1g_6602-7380_R CATCTCCTTCCTCCTCATCG 62
Cacna1g_0388-0643_F AACAAGATGGGAGGGGAGAC 62
Cacna1g_0388-0643_R TGTGGTGGAAGAACAGCAAG 62
Cacna1g_4907-5732_F TCTTGGTGTTCAGAGGCAGA 62
Cacna1g_4907-5732_R GCTTACCCTGCAGCCAAGT 62
Cacna1g_6856-7487_F GGCTGTGGGTACCAGAGAAA 62
Cacna1g_6856-7487_R ACCCCATCTTGGCAACTG 62
Atp2a3_4894-5532_F CCTGGGAAGCTAGGAAAACC 62
Atp2a3_4894-5532_R AGAGACAGACCTGGGGTGAA 62
Syt2_3350-4406_F ATGTGGATTAGGGAAGATCAGCAT 62
Syt2_3350-4406_R GAGGGACAGTGGACTTCTATTGGT 62
Nrxn2_7997-8822_F GGATCAGGTCAGAAATGTGACAAC 62
Nrxn2_7997-8822_R GCTCACTCATCCTTCAAGGTCTAA 62
Nrxn2_7791-8396_F TGGATTGTTCTATAGGATGGCTCA 62
Nrxn2_7791-8396_R AGAAAACACAGATAAAGGGCTTGG 62
Rgs8_6651-7232_F TCTTTAGGTCCTGGTCCTCTTGTC 62
Rgs8_6651-7232_R GCAGGAACACACACACAAGTACAG 62
Rgs8_7941-8550_F CTCAGTCTCCTAAGAACCCATCCT 62
Rgs8_7941-8550_R TCACCTCAAAGTCTTCACCTCTTG 62
Rims1_6189-6687_F CACACACAATCCTGATGTGAAGAC 62
Rims1_6189-6687_R AGAGCACCAGTGTAAGTGGAGAGA 62
Rims1_2011-2429_F TGGCTAAGTAGGGTTATTTTACCTTC 62
Rims1_2011-2429_R AGGACTGCTTGACAGTCAGGTTTC 62
Rims1_880-1414_F CTAGAGCAAAGAGGATGGAACACA 62
Rims1_880-1414_R CTGACTGCTACACCAATCTTCAGG 62
Fgf14_5025-5307_F TAGAGCCCGTTACTTGGTTCCTAC 62
Fgf14_5025-5307_R CCATTTACTGAAAACACCAAGTGC 62
Gene Assay ID
Amplicon Size
(bp)
Cacna1g Mm00486572_m1 85
Grid2 Mm00515053_m1 86
Syt2 Mm00436864_m1 64
Rgs8 Mm01290239_m1 68
Gapdh Mm99999915_g1 107
TaqMan gene expression assay
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Table B-1. List of Primers for Q-methyl Study and Taqman Probes 
F: forward primer; R: reverse primer. All TaqMan gene expression assays were obtained 
from Applied Biosystems (Thermo Fisher Scientific) and are labeled with the appropriate 
catalog number. 
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Table B-2. Developmental Gene Regulation of Purkinje Cells and Cerebellar Synaptic 
Targets 
Developmental gene expression changes in Purkinje cell characteristic and synaptic 
genes. A. Table of genes predominantly expressed in Purkinje cells of the cerebellum and 
their expression levels at comparable stages of postnatal development. B. Table of genes 
playing prominent roles in synapse formation in the brain and their expression levels at 
comparable stages of postnatal development. Data compiled from CDT-DB database 
(http://www.cdtdb.neuroinf.jp/CDT/Top.jsp) and Szulwach et al 2011
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Table B-3. Methyl-supplementation Strategies Across Developmental Alcohol Models.  
A comprehensive summary of methyl-supplementation studies performed across various 
models of developmental alcohol exposure. Categories include acute and chronic 
embryonic exposure, postnatal exposure, studies focued on behavioral outcomes, and 
human studies. E: Embryonic Day, GD: Gestational Day, PCD: postconception day, P: 
Postnatal Day, C:Choline, C(Cl): Choline Chloride, SAMe: S-adenosylmethionine, FA: 
Folic acid, CDP-C: CDP-Choline, VB12:vitamin B12, MTHF: 5-methyltetrahydrofolate, 
Met: L-methionine, Bet: Betaine, O-3: omega-3 fatty acid, Zn: Zinc 
Alc. Frequency Form Met. Frequency Protective
Acute, Embryonic
300mg/100mL media (E9.5-E11.5) S-AMe 0.05-3mM (E9.5-E11.5) embryopathic effects
2.0-8mg/mL (GD8.5-10.5) FA 0.01mmol/L-1mg/mL (GD8.5-10.5) head length, embryo morphology, microcephaly, neural folds; miR10a; Hoxa1 mRNA
4.0 mg/ml ethanol, (GD8.5-10.5) FA/VB12 FA (10
−5, 10−4 mol/l) or VB12 (10
−6, 10−5 mol/l), GD8.5-10.5 embryopathy, NTD defects
1-4% MTHF microinjection, N/A neurocristopathies; hyperhomocystemia
two doses, 0.0 15 ml/g (PCD 8) FA 5 mg/ml at 1 µl/h (PCD 6-7) N/A
single dose 25% (E7 or E8) Met 70 -150 mg/kg (E7 or E8) cleft palate, limb malformation
Chronic, Embryonic
6.4% (E6-E12 liquid diet) Met+ Zn Zinc (15mg/kg)+ Met (200mg/kg), E6-12
2.4%-7.2% (E6-E22 liquid diet) Bet+FA Bet 1% w/v +FA 60mg/kg (E3-P0) cortical neuroapoptosis, apoptotic proteins
3-4g/kg (GD2-68 (5x week)) FA 2mg/kg, (GD2-68 (5x week)) liver folate
5.0 g/kg (GD6-15) FA 60.0 mg/kg (G1-16) microcephaly, energy production, signal pathways and protein translation genes
5.8g/kg (GD9-birth) cocktail 3SZM methyl diet (2 wks preconception-gestation) embryonic weight, prenatal mortality, vertebral malformations
Postnatal
2.5 g/kg (GD4-41) C 10 mg/kg (GD4-148) N/A
3.0 g/kg (P2-P10) C 100mg/kg (P2-P20) hipp hypermethylation, ameliorated by Choline supp
6.7% (G7-G21 liquid diet) C 642mg/L liquid diet (G11-birth) POMC and histone hypermethylation, DNMT1 and MeCP2
5.25 mg/kg (P4-P9) C 100 mg/kg (P4-30) hyperactivity and increased M2/4 receptor density
6.0g/kg/day (GD5-20) C 250mg/kg (G5-20) brain weight, behavioral outcomes
35%, liquid diet CDP-C 100mg (P0-P21) Pukinje cell maturity
4.8-7.2% (E6-P21 liquid diet) Bet+ O-3 30 mg/100 g (dam wt.),E3-P21 apoptosis and neurodegeneration
Behavioral
5.25 g/kg (P4-9) C 100 mg/kg (PD 11-20, PD 21-30, or PD 11-30) spatial memory, learning
6.0 g/kg (P5) C(Cl) 10 μL of 18.8 mg/ml (P1-5  and P6-20) balance and coordination
5.25g/kg (P4-P9) C(Cl) 100 mg/kg (PD 40 to 60) working memory
5.25 mg/kg (P4-P9) C 100 mg/kg (P10-30) trace eyelblink conditioning deficits
35% (GD 6-20) C(Cl)  25 mg/ml (PD 2 to 21) visuospatial discrimination
6.6 g/kg (PD4-9) C(Cl) 18.8 mg/kg (PD4-30) hyperactivity, spatial discrimination reversal learning
6.0 g/kg (P4-9) C(Cl) 10, 50, or 100 mg/kg (PD 10-30) open field hyperactivity, spatial learning
Human
"heavy drinking" C 750 mg, daily (Avg. 19 weeks-birth) Bayley Mental Development Standard Score
variable C 750 mg, daily (Avg. 19 weeks-birth) hear rate during visual habituation
variable C 500mg, daily (9 mo) long-delay memory
high exposure C 625mg/d (6 weeks) N/A
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Table B-4. Table of Methyl-pyrosequencing Primers and Taqman probes 
All proprietary primer sequences were obtained from Qiagen and are labeled with the 
appropriate catalog number. F: forward primer; R: reverse primer (biotinylated); 
S:sequencing primer. All TaqMan gene expression assays were obtained from Applied 
Biosystems (Thermo Fisher Scientific) and are labeled with the appropriate catalog 
number 
Primers used for methyl pyrosequencing study
Name Sequence Annealing temp
Ascl1_05_F Qiagen, PM00219695 52
Ascl1_05_R Qiagen, PM00219695 52
Ascl1_05_S Qiagen, PM00219695
Ngn1_Promoter1_F TTTTAGGAGGGGGGTTGG 57
Ngn1_Promoter1_R ACCCACCTCAAAACCCCTTAAATAC 57
Ngn1_Promoter1_S CCTCCCTAACCACCT
Ngn2_Promoter1_F GGGAGGAGGTGGTTAGGGA 55
Ngn2_Promoter1_R ATCAACTCCTATAAACACCAAATATAA 55
Ngn2_Promoter1_S GAGGTGGTTAGGGAG
Syt2_02_F Qiagen, PM00208894 55
Syt2_02_R Qiagen, PM00208894 55
Syt2_02_S Qiagen, PM00208894
Fezf2_Promoter_F GGGTTAAGGGATATTTTGGTGATTAGA 54
Fezf2_Promoter_R AACCCAAACCTAAACAAAATTCCT 54
Fezf2_Promoter_S GGGGTTTTTTGAGGT
Fezf2_Exon1_F GGGAGTTAGTTGTTTTTTTTAAAGTTTGAG 55
Fezf2_Exon1_R ACCATACAACCTATCTCTTCTATCACATTT 55
Fezf2_Exon1_S GGGGGAAAGTAGGGTTT
Fezf2_Enhancer434_F GTTGGGAAATAAATAATTTTAAGGTAGTTG 53
Fezf2_Enhancer434_R TCTTTTCTTCCTATCCCAAACAAT 53
Fezf2_Enhancer434_S AGTTTGTTTTTAGAAATATGTTA
Gene Assay ID Amplicon (bp)
Ascl1 Mm03058063_m1 67
Ngn1 Mm00440466_s1 82
Syt2 Mm00436864_m1    64
Fezf2 Mm01320619_m1     76
18S Mm03928990_g1 61
TaqMan gene expression assay
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Figure 27
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
A 0.283 0.354 1.125 14 13 13 13 7 10.0214 11.3462 10.5692 9.9692 10.3943
0.51143 0.28071 0.66152 0.548 0.74228
B 0.391 0.227 1.517 10 10 10 10 13.1269 12.3816 12.0206 13.275
0.56273 0.50341 0.46022 0.40446
C E7 13 12 16.3382 15.8995
0.181 0.685 0.169 0.52548 0.95377
E8 15 12 18.0108 18.0554
0.625 0.966 0.002 0.70357 0.73647
E9 15 12 17.8916 18.5409
0.393 0.389 0.769 0.4378 0.62219
E10 15 11 18.2217 17.4457
0.013 0.615 0.49241 1.42073
E11 15 13 17.0459 16.7571
0.038 0.823 0.46937 1.18227
E12 11 13 17.8325 16.5473
0.412 0.336 0.968 0.71462 1.03633
E13 13 10 16.9853 17.9381
0.112 0.516 0.436 1.18586 0.5536
E14 12 13 18.2874 16.9284
0.803 0.176 1.948 0.71968 0.65862
E15 10 12 18.5684 17.7958
0.509 0.556 0.359 0.7176 1.01055
E16 10 12 17.8721 17.2302
0.99 0.631 0.237 0.99009 0.87517
N numbers Mean ± SEM
Figure 28
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
A 0.115 0.001 5.467 13 10 15 13 5 0.5658 0.5068 0.4914 0.4728 0.5724
0.02705 0.01507 0.0107 0.01336 0.01598
B 0.223 0.31 1.268 7 6 6 5 5 0.057 0.055 0.0548 0.0531 0.0593
0.00252 0.00181 0.00073 0.00174 0.00229
C 0.116 0.84 0.279 8 6 13 5 3.9073 3.8758 3.7375 3.9623
0.12674 0.27122 0.1649 0.2429
D 0.007 0.729 5 6 5 5 0.2966 0.2728 0.2684 0.2666
0.0238 0.01566 0.00495 0.00722
E 0.097 0.978 0.11 12 13 12 16 6 6.5 6.1538 6.5 6.5625 5.3333
0.3371 0.56439 0.71244 0.35479 0.66667
N numbers Mean ± SEM
Figure 29
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
A 0.569 <0.0001 9.803 7 5 9 8 9 18.6775 18.303 19.2365 18.6855 17.881
0.18337 0.13626 0.18782 0.1564 0.15904
B 8 5 9 7 5 18.2086 18.2222 18.2731 17.9459 17.4791
0.07016 0.17032 0.07935 0.06715 0.17089
C Cort 0.017 0.051 7 5 9 8 9 1.0777 1.0205 0.862 0.9336 1.0167
0.04436 0.07404 0.04496 0.11013 0.07862
Liver 0.0417 0.028 8 5 9 7 5 1.016 0.9779 0.691 0.8225 0.932
0.14259 0.11516 0.03653 0.07069 0.14255
D Cort 0.337 0.537 0.792 8 5 9 7 5 1.0084 0.9166 0.8148 0.931 0.9217
0.05759 0.09219 0.06608 0.10351 0.07338
Liver 0.666 0.848 0.342 10 11 8 8 8 1 1.0808 1.0121 0.9963 0.9513
0.09344 0.08937 0.06943 0.0815 0.05607
Mean ± SEMN numbers
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Figure 30 
A HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
SVZ 0.729 0.05 2.546 15 11 13 12 9 236.2667 217 192.4615 216.1667 209.444
10.18003 11.97194 10.14802 7.77996 13.18786
IZ 0.434 0.013 3.47 15 11 13 12 9 358.6 362.0909 291.3845 345.5 335.44
16.77209 19.66652 12.12411 13.05727 15.9104
SP 0.047 0.001 15 11 13 12 9 144.4 148.3636 112.1538 136.5833 135.6667
8.90361 6.83743 4.59912 6.29389 8.21922
CP 0.805 0.028 2.963 14 11 13 12 9 321.6429 290.7273 264.3077 304.25 268
16.70218 13.04823 13.15557 13.2757 13.71536
MZ 0.288 0.046 2.609 14 11 13 12 9 77.2143 73.6364 65.8462 81.25 70.1111
2.38627 4.62262 3.21424 4.06598 5.27163
Total 0.123 0.004 4.328 14 11 13 12 9 1131.5 1091.8182 926 1085.033 1020.888
47.73781 47.62408 24.90289 34.51333 41.50249
B I 0.254 0.16 1.831 8 10 10 10 358.6 362.0909 291.3845 345.5
16.77209 19.66652 12.12411 13.05727
II-IV 0.61 0.002 5.846 8 10 10 10 321.3638 275.548 259.0782 273.334
13.35783 10.59526 9.99467 8.92807
V 0.452 0.218 1.555 8 10 10 10 230.7 225.529 210.7676 220.271
7.61334 6.82727 8.00427 3.95667
VI 0.615 0.018 3.82 8 10 10 10 342.6863 363.014 319.8105 340.9239
6.08174 8.04106 12.34289 8.25141
Total 0.995 0.001 6.628 9 8 9 9 919.9701 909.5708 813.9099 894.8541
18.88182 19.28196 20.25341 17.02551
N numbers Mean ± SEM
Figure 31
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
A 0.677 0.898 0.266 6 8 8 7 6 192.5556 190.9167 192.8 190.444 193.3
2.20549 2.9961 2.1746 1.9084 2.08725
B 0.034 <0.0001 8.194 5 5 5 6 5 0.2285 0.2442 0.1887 0.2525 0.2415
0.00771 0.00778 0.01293 0.0077 0.00673
N numbers Mean ± SEM
Figure 32
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
B 0.669 0.036 2.844 11 9 9 9 7 326.1818 319.4444 255 271.6667 325.2857
18.52017 19.84671 13.38013 17.87689 31.50337
C 0.014 0.358 8 11 9 7 6 16.475 16.3971 16.398 16.2321 15.9931
0.13051 0.13788 0.07956 0.08616 0.24876
N numbers Mean ± SEM
Figure 33
B HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
SVZ 0.022 0.208 12 6 13 8 5 100.5 94.33 92.46 95.75 96.6
0.427 3.98 3.601 3.89 1.469
IZ 0.591 0.015 3.642 9 6 12 6 5 86.67 82.67 76.75 86.83 85.4
2.357 1.58 2.35 2.257 3.44
CP 0.144 0.016 3.485 11 6 12 8 5 93 83 78.83 85 86.2
2.802 2.489 3.239 3.54 0.9695
C 0.385 0.977 0.113 8 9 9 9 4 16.34 16.45 16.348 16.38 16.47
0.1935 0.1437 0.197 0.1128 0.1029
N numbers Mean ± SEM
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Figure 34
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
B 0.599 0.112 2.028 8 7 9 9 6 16.2545 16.3128 16.4042 16.1855 16.1031
0.05407 0.07311 0.07212 0.08329 0.12028
C 0.26 0.035 2.775 16 12 15 14 9 108.2193 114.2537 66.234 109.6958 145.2366
14.93126 17.09372 8.81676 17.92579 25.09812
D 0.003 ≤.0001 8 6 8 8 5 189.9061 135.5317 40.9872 116.1035 186.1549
38.68389 28.20116 10.86077 12.70205 20.02522
N numbers Mean ± SEM
Figure 35
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
F 0.078 <0.0001 12.643 8 7 9 8 5 69.735 72.8571 102.7778 80.8333 68.3
3.55034 3.05059 4.74748 5.08216 0.93005
G 0.26 0.035 2.775 8 6 9 9 6 16.7706 16.8613 16.3064 16.2374 16.7953
0.16142 0.21273 0.0794 0.07286 0.3746
N numbers Mean ± SEM
Figure 36
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
B 0.67 0.055 2.61 8 5 9 9 6 16.8731 16.5978 16.6904 16.7915 16.1694
0.09835 0.18236 0.19015 0.16397 0.11801
C 0.956 0.549 0.774 8 12 9 9 6 17.9911 17.9425 17.6296 17.781 18.0581
0.21437 0.15887 0.20554 0.16811 0.21724
D 0.807 0.157 1.771 8 8 9 8 6 22.2637 21.4591 22.0243 22.1537 21.5282
0.33887 0.27376 0.21806 0.22797 0.29917
N numbers Mean ± SEM
Figure 37
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
B 0.033 0.647 8 11 9 9 6 15.4469 15.3947 15.5607 15.3829 15.4451
0.12166 0.10403 0.06954 0.11869 0.21055
C 0.183 0.004 4.785 8 9 9 9 8 16.6002 16.3064 16.839 16.5301 16.1236
0.16697 0.08689 0.05717 0.13506 0.10759
D 0.431 0.451 0.943 8 8 9 9 6 15.4588 15.4926 15.787 15.4689 15.2794
0.21113 0.26266 0.09489 0.1408 0.22257
E 0.038 0.01 8 13 9 9 6 16.0129 16.1466 15.7544 15.7636 15.9354
0.06173 0.17419 0.03556 0.05608 0.06885
N numbers Mean ± SEM
Figure 38
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
B 0.046 0.256 8 6 9 7 6 15.5996 15.8202 15.4285 15.7175 15.7974
0.14878 0.03323 0.19911 0.07473 0.08026
C 0.135 0.166 1.739 8 5 9 9 6 16.5664 16.8325 16.393 16.5924 16.5897
0.08008 0.09333 0.04947 0.08804 0.23422
D 0.267 0.511 0.837 8 8 9 8 6 21.8189 21.9562 21.601 21.7305 21.8687
0.10344 0.08006 0.16306 0.11781 0.29336
E 0.006 0.945 8 6 9 8 6 18.503 18.3844 18.4605 18.4742 18.6763
0.10743 0.25197 0.15188 0.24121 0.24471
F 0.02 0.033 8 12 9 9 6 14.7215 14.8799 13.4655 14.2254 14.6163
0.35643 0.11493 0.44562 0.21267 0.17038
G 0.575 <0.0001 8.034 8 13 9 7 6 15.5308 15.7742 14.9718 15.3653 15.927
0.11137 0.09689 0.1782 0.12971 0.10624
N numbers Mean ± SEM
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Table B-5. Fetal, Phenotypic, and Genomic Summary of Statistics  
Summary of statistics are presented for each indicated Figure. HOV: Homogeneity of 
Variance statistic, ANOVA: one-way analysis of variance, F: ANOVA F value. N 
numbers reflect litter number represented in each assay. All gene expression assays are 
presented as gene fold changes in the graph though statistical analysis was performed 
using delta Ct values reflected here.  
 
 
Figure 39
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
B 0.734 0.058 2.538 11 7 10 7 7 153.0897 137.4183 71.1351 148.4189 163.2351
24.90935 20.274 16.91295 32.4203 26.07562
C 0.11 0.008 4.275 9 6 9 6 6 51.5951 40.6877 97.8914 40.4939 45.2203
9.161 8.2889 16.67153 9.36787 13.6269
D 0.637 0.023 3.353 8 9 5 6 6 61.8255 67.2669 140.4998 70.8933 64.9849
16.33265 13.73923 15.31996 17.48187 17.68008
N numbers Mean ± SEM
Figure 40
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
B 0.346 0.429 0.998 7 5 8 6 5 158.1197 132.1434 70.3354 148.1909 133.1606
31.52755 23.64219 29.94231 44.9286 27.10446
C 0.658 0.975 0.118 10 9 7 6 5 132.5583 131.0069 144.9134 133.9567 135.464
10.35864 13.75152 17.85435 27.39017 17.18245
D 0.718 0.24 1.452 5 7 7 6 5 70.829 67.2669 115.1993 70.8933 64.9849
16.98646 13.73923 19.45655 17.48187 17.68008
N numbers Mean ± SEM
Figure 42
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
A <0.0001 0.013 7 6 9 8 6 16.1818 13.2 20.9231 18.6923 13.2857
1.72056 0.51208 2.83852 1.88919 0.52164
B 0.48 0.079 2.287 7 6 7 8 6 10.25 10.5 14 14.625 11.625
1.544 0.61914 1.74574 1.52289 1.26685
C 0.031 0.038 8 10 9 9 7 9.125 7.9 14 8.7778 9.8571
0.875 1.19675 1.40216 1.12183 0.70735
N numbers Mean ± SEM
Supp Figure 2
HOV ANOVA F Welchs Chow PF Alc Alc+SAM SAM Chow PF Alc Alc+SAM SAM
B 0.183 0.004 4.785 8 8 9 9 5 16.6002 16.3064 16.839 16.5301 16.1236
0.16697 0.08689 0.05717 0.13506 0.10759
C 0.111 0.038 2.735 11 13 14 14 9 127.511 86.7957 67.6655 99.0575 90.478
18.6457 12.3548 7.8335 14.7767 8.91328
N numbers Mean ± SEM
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Table B-6. Methyl-pyrosequencing of Multiple Neurodevelopmental Gene Targets 
Cumulative methylation analysis of Ascl1, Ngn1, Syt2, and Fezf2 was performed by 
methyl-pyrosequencing. Results are presented parallel to relative gene expression 
Chow (n=5) 13.4±1.56 Chow (n=8) 1.0±0.065
PF (n=3) 15±2.0 PF (n=5) 1.21±0.143
Alc (n=5) 17.2±4.17 Alc (n=9) 1.13±0.140
Alc+SAM (n=5) 15±4.34 Alc+SAM (n=9) 1.05±0.165
SAM (n=2) 12.2±3.5 SAM (n=6) 1.07±0.068
Chow (n=4) 74.4±12.43 Chow (n=8) 1.0±0.209
PF (n=5) 89.4±9.62 PF (n=5) 1.25±0.34
Alc (n=5) 87.2±9.3 Alc (n=9) 1.18±0.165
Alc+SAM (n=4) 73±4.01 Alc+SAM (n=8) 1.07±0.157
SAM (n=2) 72±3.0 SAM (n=6) 1.10±0.261
Chow (n=4) 24.25±0.83
PF (n=4) 24.75±0.95
Alc (n=4) 23.5±1.08
Alc+SAM (n=4) 25±0.79
SAM (n=2) 27±0.0
Chow (n=3) 22.67±3.25 Chow (n=8) 1.0±0.133
PF (n=4) 32.25±13.57 PF (n=8) 1.24±0.107
Alc (n=4) 28±5.93 Alc (n=9) 1.14±0.152
Alc+SAM (n=3) 21±6.13 Alc+SAM (n=9) 0.90±0.106
SAM (N/A) SAM (n=6) 0.97±0.119
Chow (n=4) 16.2±1.84 Chow (n=8) 1.0±0.104
PF (n=5) 13.2±0.99 PF (n=9) 0.99±0.110
Alc (n=5) 21.76.2±3.11*# Alc (n=9) 0.80±0.031*#§
Alc+SAM (n=8) 17.86±2.23 Alc+SAM (n=9) 0.99±0.089
SAM (n=6) 13.29±1.30 SAM (n=6) 1.32±0.177
Chow (n=4) 10.25±1.77
PF (n=4) 10.50±0.84
Alc (n=4) 13.99±1.88
Alc+SAM (n=8) 14.63±1.69
SAM (n=6) 11.63±1.60
Chow (n=4) 9.13±0.88
PF (n=4) 7.90±1.20
Alc (n=4) 14.0±2.14§ƚ#
Alc+SAM (n=9) 7.90±1.40
SAM (n=7) 9.86±1.12
Gene Expression (relative)
Fezf2  Promoter (6CpG coverage)
Sum Methylation (%) Gene Expression (relative)
Ascl1  Promoter (4CpG coverage)
Ngn1  Promoter 1 (9CpG coverage)
Ngn1  Promoter 2 (6CpG coverage)
Sum Methylation (%)
Sum Methylation (%) Gene Expression (relative)
Gene Expression (relative)
Fezf2  Exon 1 (4CpG coverage)
Sum Methylation (%)
Fezf2  Enhancer 434(5CpG coverage)
Sum Methylation (%)
Sum Methylation (%)
Syt2 Promoter (5CpG coverage)
Sum Methylation (%)
213 
analysis. ƚ p≤0.05 vs Chow;*p≤0.05 vs SAM; #p≤0.05 vs PF; § p≤0.05 vs Alc+SAM. 
Neither gene expression nor promoter DNA methylation was significantly altered by 
alcohol or S-AMe supplementation except in the case of the Fezf2 which is detailed in 
Chapter 3 Figure 40.  
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